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Investigation of the importance of individual members of the Nuclear 
Factor-κB family during Helicobacter felis induced gastric 
carcinogenesis 
Michael David Burkitt 
Gastric cancer is the final outcome of a well-defined process of inflammation, 
remodelling of the gastric mucosal architecture and finally carcinogenesis. In 
humans, the trigger to develop gastric epithelial inflammation is infection with 
Helicobacter pylori. Whilst the pathological progression following Helicobacter 
infection has been well described, the reasons why some individuals progress 
towards gastric carcinogenesis, whilst others do not, remain relatively poorly 
understood. 
Previous studies in transgenic mice have demonstrated an association between 
classical pathway NF-κB signalling and Helicobacter induced gastric pathology. 
However the roles of specific NF-κB family members and of alternative pathway NF-
κB signalling have not previously been investigated. We hypothesised that 
individual NF-κB proteins would play specific roles in determining the onset of 
Helicobacter induced gastric pathology, and that these pathways may influence the 
eventual outcome of Helicobacter infection. 
To address these hypotheses we used transgenic mice with constitutive deletions of 
NF-κB1, NF-κB2 and c-Rel, along with the established H. felis model of murine 
gastric cancer. Animals were studied at 6 and 48 weeks post infection. 
NF-κB1 null mice developed gastric inflammation and atrophy even without 
infection when aged to 1 year. These animals also developed more advanced gastric 
atrophy and metaplasia when infected with Helicobacter felis for 1 year. c-Rel null 
mice demonstrated similar epithelial pathology to wild-type mice, but following 
long-term infections developed significant atypia in infiltrating lymphoid cells, in 
keeping with c-Rel playing a role in gastric lymphomagenesis. In contrast NF-κB2 
null mice developed minimal pathology at both 6 and 48 weeks following infection, 
and hence appear to be resistant to gastric corpus atrophy in response to 
Helicobacter felis infection.  
These findings confirm the previously known role for classical pathway NF-κB 
signalling in epithelial cancers, and suggest that this is an NF-κB1 specific effect, 
rather than being mediated by c-Rel. We provide the first description of c-Rel null 
mice showing enhanced gastric lymphomagenesis, and also describe profound 
resistance to Helicobacter induced gastric pathology in mice with abrogated 
alternative pathway NF-κB signalling, a pathway that has not previously been 
investigated in studies of epithelial carcinogenesis.  
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1 Introduction 
1.1 Gastric structure and function 
The stomach is a saccular organ with a muscular wall that, in humans, lies beneath 
the diaphragm, in the left hypochondrium of the abdomen. It forms a reservoir for 
ingested food and controls the flow of gastric contents into the small intestine. 
Mechanical disruption of food boluses and initial digestion of proteins occur in the 
stomach. 
The whole mucosal surface of the human stomach, and the distal two thirds of the 
murine stomach, is lined with a columnar mucosa that is folded into discrete 
entities called glandular units, or more commonly glands. Gastric glands are 
specialised to secrete mucus, hydrochloric acid, zymogens and intrinsic factor under 
the joint control of hormones produced by neuroendocrine cells within the gastric 
mucosa and the autonomic nervous system.  
Anatomically the human stomach is separated into cardia, fundus, body or corpus 
and the pyloric antrum (see Figure 1-1). The gastric cardia surrounds the insertion 
of the oesophagus and is the transition point between oesophageal squamous 
mucosa and columnar mucosa. The cardia is defined histologically by a short 
segment of mucus secreting glands immediately below the gastro-oesophageal 
junction. Histologically and functionally these glands are similar to those found in 
Fundus
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Figure 1-1: Gross anatomy 
of the stomach 
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the gastric antrum. The fundus of the stomach is that portion of the stomach that, 
when lying supine, is superior to the oesophageal opening. The fundus is an 
anatomically defined segment of the gastric corpus, and shares a common function 
and epithelial structure with the rest of the corpus. It has glands that are specialised 
to secrete acid, intrinsic factor and pepsinogen, as well as several hormones. The 
antrum is specialised to produce mucus and secrete gastrin, and hence has a 
different microscopic appearance to the corpus. The flow of gastric luminal 
contents out of the stomach is controlled by the pyloric sphincter and pressure 
differences across the pylorus. 
Rodent gastric morphology is quite variable. Some rodents, including the guinea pig, 
have a fully columnar lined gastric epithelium similar to the human, whereas many 
others have a forestomach lined with squamous mucosa. In the mouse, Mongolian 
gerbil and rat, the forestomach simply extends the chamber lined with glandular 
mucosa whilst hamsters and voles have forestomachs that form distinct 
compartments proximal to the true stomach (1). Despite the difference in gastric 
morphology, the mucosa of the corpus and antrum of the mouse are structurally 
and functionally similar to the equivalent parts of the human stomach. 
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1.1.1 Structure of gastric mucosa 
The gastric gland is separated into the pit, which begins at the luminal surface and 
extends down into the gland, the isthmus of the gland, the neck and the gland base 
(Figure 1-2). The proliferation of cells and subsequent differentiation into specific 
adult lineages differ between the antrum and corpus. (2) 
1.1.1.1 Corpus gland structure 
The corpus gland has pepsinogen-secreting chief cells at its base, parietal cells 
extending from the base of the gland through the isthmus and into the neck of the 
gland, and mucus-secreting neck cells towards the top of the gland. In addition to 
these there are occasional neuroendocrine cells, which are located throughout the 
glands. 
1.1.1.1.1 Proliferating zone 
Microscopy following in-vivo pulse labelling with tritiated (
3
H) thymidine shows that 
the majority of proliferating cells in the gastric corpus are located in the isthmus of 
the gland (3). Cells cycle approximately every three days, and specific lineages of 
mature cells are generated through different precursors. Three significant 
Figure 1-2: Line drawing representative 
of structure of corpus (A) and antral (B) 
gastric glands. 
Modified from Lee 1985 (2) 
B A 
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immediate descendants of proliferating cells have been described; the pre-pit 
precursor, the pre-neck precursor and the pre-parietal cell. These cells undergo 
distinct differentiation processes to generate each of the adult gastric cell lineages 
(3). 
1.1.1.1.2 Pre-pit precursors and their subsequent differentiation 
Pre-pit precursors migrate from the isthmus towards the gastric lumen. They are 
the shortest lived lineage in the corpus, with mean survival in the mouse of 3.1 days 
(4). These data have been supported by other work in both the rat, where a mean 
survival time of 3 days has been observed (5) and in the human where survival 
times have been estimated at either 3 days (6) or 4-6 days (7). Their principal role is 
as a mucus-secreting lineage. Reflecting this function, both pre-pit precursor cells 
and mature mucus-secreting cells have multiple cytoplasmic granules (4). After 
migration through the pit to the gland surface, cells degenerate, undergoing either 
apoptotic or necrotic cell death at the surface of the gland. The cellular remnants 
are either extruded into the gastric lumen, or phagocytosed. 
1.1.1.1.3 Pre-neck precursors and their subsequent differentiation 
Glands of the murine corpus contain an average of 67.5 chief cells, whose 
distribution is limited to the base of the gland (8). 
3
H-thymidine labelling studies 
have shown that these cells originate in the isthmus of the gland as pre-neck cells, 
before migrating down the gland to the neck region. In the neck of the gland, these 
cells continue to differentiate, initially becoming mucus-secreting neck cells, before 
entering the base of the gland. These cells complete their differentiation as they 
migrate to the base of the gland, where they become chief cells secreting 
zymogens. This lineage undergoes either necrotic or apoptotic cell death with either 
dissolution of the cellular remnants, engulfment by macrophages, or resorption into 
adjacent epithelial cells (8). The differentiation process for this cell lineage takes 14 
days, and cell death occurs on average 190 days after cell division (3).  
1.1.1.1.4 Pre-parietal precursors and their subsequent differentiation  
Unlike pit and neck cells, parietal cells differentiate within the isthmus of the gland. 
One day after tritiated thymidine injection, radiographs demonstrate the labelling 
22 
 
of pre-parietal cells, recognisable by the presence of microvilli similar to those seen 
in parietal cells. These cells differentiate into mature parietal cells over 
approximately 3 days (9). 
Following differentiation, parietal cells migrate towards both poles of the gland, 
with approximately 14% migrating towards the top of the gland in the mouse. They 
survive for an average of 54 days within the mucosa (9). Parietal cells migrating 
towards the base of the gland have most vitality during their transit through the 
neck of the gland (9). During their transit to the base of the gland, parietal cells 
undergo apoptotic or necrotic cell death and are then either shed into the lumen of 
the gland, or phagocytosed by chief cells or macrophages.  
1.1.1.1.5 Endocrine cells 
One of the key mechanisms maintaining gastric epithelial homeostasis is the 
endocrine control exerted by the secretions of neuroendocrine cells scattered 
throughout the gastrointestinal mucosa. In the stomach, a number of different 
neuroendocrine cells can be defined on the basis of their secretory function. The 
specific functions of some of these cells have been further defined since the original 
studies investigating the origin of the gastric mucosal lineages, but like the other 
gastric lineages, neuroendocrine cells also arise from dividing cells in the isthmus of 
the gland. These cells survive for several months before undergoing apoptotic or 
necrotic cell death (10). 
1.1.1.2 Antral gland structure 
The gastric antrum occupies the distal third of the gastric mucosa and surrounds the 
pylorus. Glandular units are shorter than in the corpusand composed of mucus 
secreting cells, their precursors and scattered neuroendocrine cells (2). The 
difference in gland structure reflects the fact that the gastric antrum is specialised 
to secrete mucus, rather than zymogens and hydrochloric acid.  
1.1.1.2.1 Proliferating zone 
Antral glands immunostained either for proliferation markers such as Ki67 or 
stained following Bromodeoxyuridine (BrdU) administration show that the 
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proliferative zone of the antral gland is towards its base both in man (11, 12) and in 
mouse. 
3
H-thymidine administration labels 5.3% of cells in the murine antrum (13), 
suggesting that this is the proliferating compartment. Similarly, in man, 4.8% of 
gastric antral cells have shown uptake (11). The antral proliferating zone is nearer to 
the base of the gland than in the corpus, with cells migrating from the base of the 
gland towards the mucosal surface (11). 
1.1.1.2.2 Mucous cells 
After continuous 
3
H-thymidine infusion, cells of the gastric antrum are progressively 
labelled from the base of the gland to the mucosal surface, with the majority of 
antral cells being labelled by 3 days. This suggests that the origin of the adult cells of 
the gastric antrum is the proliferative zone in the same tissue, and that the mean 
time for gland turnover is 3 days. Daughter cells arising from the proliferative zone 
migrate towards the surface of the gland, progressively differentiating towards 
adult mucus cells, with increasing numbers and density of granules for 
approximately 24 hours (13). Approximately two thirds of the mature cells arise as a 
result of cell division in the proliferative zone at the base of the gland, whilst the 
remaining third originate from further mitotic events in the isthmus where there is 
a mixed population of undifferentiated cycling cells and partially differentiated cells 
in the process of migration (14).  
1.1.1.2.3 Neuroendocrine cells of the antrum 
As in the corpus, the antrum has small numbers of neuroendocrine cells. In the 
antrum, the predominant neuroendocrine cell is the G-cell, which secretes gastrin. 
G-cells have been shown to be long-lived and to originate from the proliferative 
cells in the gland base in both hamsters (15) and mice (16). 
1.1.2 Stem cells and the origin of the gastric mucosa 
Because gastric epithelium consists of several different cell lineages, is replaced 
regularly, and is derived from morphologically similar proliferating cells, it has been 
hypothesised that the proliferating cells arise from a tissue specific stem cell. Stem 
cells, by definition, are long lived, able to divide asymmetrically to generate a 
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number of different differentiated cell types, and also able to divide symmetrically 
to repopulate their own niche (17, 18).  
Investigation of gastric stem cells has focussed upon demonstrating that gastric 
glands are generated in a clonal manner, showing the likely location of stem cells 
(achieved with experiments described in 1.1.1), attempting to label specific cells as 
stem cells and finally isolating specific putative stem cells and demonstrating their 
ability to regenerate cells of different gastric lineages in ex-vivo models. 
1.1.2.1 All adult gastric lineages originate from a single stem cell 
The dynamic histology studies described in section 1.1.1 above suggest that a single 
type of proliferative cell in gastric glands is able to populate the entire gland. This 
evidence relies solely on morphological features, which preclude definitive 
distinction between cell types. Male / female aggregation chimeric mice have been 
used to investigate the origin of gastric glands (19). These animals are 
predominantly male or female, but a single cell from an animal of the opposite 
gender is added at the blastocyst stage. Using in situ hybridisation for pY353, a 
specific Y-chromosome repeat marker, it is possible to trace cells that originate 
from the chimeric embryonic cell. In these mice the majority of gastric glands are 
concordant with the animal’s gender, but occasionally whole glands appear to be 
derived from the implanted chimeric cell, demonstrating a common origin for all 
lineages within an individual gland (20). 
Further evidence for the clonality of gastric glands has been achieved using a 
transgenic mouse model using the lacZ reporter gene which generates β-
galactosidase. β-galactosidase cleaves x-Gal (5-bromo-4-chloro-3-indolyl- β-D-
galactopyranoside) into 5,5'-dibromo-4,4'-dichloro-indigo, an insoluble blue dye. 
This allows the expression of lacZ to be traced at single cell resolution in standard 
histological sections (21).  
Mice with a lacZ reporter construct under the control of the ubiquitously expressed 
HMG CoA reductase promoter inserted into the X-chromosome have been used to 
trace cell lineages through the gastric mucosa. Male mice and female mice that are 
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homozygous for the lacZ reporter constitutively express β-galactosidase, and hence 
all cells exposed to x-Gal are stained blue. In contrast, female mice that are 
heterozygous for the x-linked lacZ construct have 50% of cells that express lacZ, due 
to random X-inactivation. This is a heritable effect; the daughter cells of lacZ 
positive stem cells all express lacZ, those of lacZ negative cells do not. Studies using 
this system have demonstrated that in early postnatal mice, 85.1% of fundic glands 
and 75% of pyloric glands had a polyclonal mixture of β-galactosidase expressing 
cells. The proportion of glands showing this polyclonality decreases over time, and 
at 42 and 105 days postnatal this falls to 11%. Based on Mendelian ratios these data 
suggest that gastric glands are generated from an average of 3 progenitor cells in 
the antrum, and 3.74 progenitors in the corpus. Lower numbers of mixed glands in 
adulthood are explained by the observation of gland fission as the principal means 
of increasing gland number. In this process, there is a division of a gastric gland 
from base to pit, resulting in a doubling of gland number. This process results in a 
gland that is derived from its parent. The observed reduction in number of β-
galactosidase positive cells suggests that these fission events result in new glands 
that are derived from cells that represent only some of the stem cells responsible 
for generating the parent gland (22). 
In addition to studies demonstrating the small number of progenitor cells required 
to generate a mature gastric gland, the β-galactosidase reporter system has been 
used to show that a single clone of cells can give rise to all types of mature gastric 
cell. ROSA26 reporter mice constitutively express LacZ. In these mice, the whole 
gastric epithelium stains in the presence of x-Gal. However treatment with N-ethyl-
N-nitrosourea (NEU), a mutagen known to disrupt the ROSA26 locus, results in loss 
of β-galactosidase expression in a small number of gastric glands, implying 
disruption of the ROSA26 locus in the progenitor cell for that gland. β-galactosidase 
negative glands continue to generate all adult cell lineages, implying that these 
originate from a common stem cell. 
1.1.2.2 Individual gastric stem cells can be identified 
ROSA26 mice and male/female chimeric mice help to quantify the number of cells 
from which gastric glands are derived, and demonstrate the multipotency of cells 
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within the gastric gland, but do not directly allow attribution of stem characteristics 
to an individual cell.  
Utilising a modification of the ROSA26 reporter mouse, an elegant method of 
investigating markers of stem cells has been developed. Inducible cre recombinase 
is expressed under the control of the promoter for a candidate gene of interest. 
When these mice are crossed with a mouse with a cre dependent LacZ construct at 
the ROSA26 site, a model is generated whereby LacZ expression is initiated in cells 
that express the gene of interest. If this gene is activated in the stem cell 
population, then transient activation of this cell’s cre-recombinase will result. Such 
transient activation results in not only short term LacZ expression, but in persistent 
LacZ expression, both in the stem cell and in all daughter cells of that stem cell. This 
model has been used to examine the roles, both of the Villin promoter (23), a 
promoter sequence that is ubiquitous in the intestine, but rarely expressed in the 
stomach, and the Wnt signalling target Lgr5 (24). The importance of Wnt signalling 
in gastrointestinal stem cells has been demonstrated through several lines of 
evidence. Proliferating cells in the GI tract accumulate β-catenin, a marker of 
canonical Wnt pathway activity (25). Inhibition of the Wnt pathway, either by 
overexpression of a Wnt signalling inhibitor, or by deletion of β-catenin (26), stops 
epithelial cell proliferation, and constitutive activation of the pathway through APC 
deletion is an almost universal step in sporadic colon carcinogenesis. Lgr5 is a 
downstream target gene of Wnt signalling, that was first identified as being up-
regulated in colon cancers, but it is now also recognised to be expressed in 
proliferating cells in the colon, small intestine and stomach, and is hence an ideal 
candidate for investigation as a marker of stem cells (27). 
Villin is expressed only infrequently in the stomach, but marks a cell lineage that can 
repopulate an entire gland with all adult cell lineages, when the organism is first 
stressed by administration of interferon-γ (23). 
In contrast, Lgr5 is very widely expressed throughout the pre-natal stomach, and 
continues to be expressed in a high proportion of adult antral glands, but not in the 
corpus of adult mice. This provides good evidence that Lgr5 is a marker of the antral 
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stem cell, but it remains unclear what molecular mechanisms control the stem cell 
niche in the corpus. 
1.1.2.3 Lgr5 positive cells can generate adult gastric lineages ex-vivo 
Using mice that express an enhanced green fluorescent protein (eGFP) on the Lgr5 
promoter, it has been possible to select by fluorescence-activated cell sorting 
(FACS) individual cells from a digestion of gastric antrum that express abundant Lgr5 
(24). When these cells are grown in growth media containing Wnt3A to activate 
classical Wnt signalling, 9% become adherent and begin to divide. These cultures 
can be maintained ex-vivo for multiple passages, over at least 3 months, and they 
develop into “organoids” with typical gland like structures (24). Under these 
conditions the cells that make up the organoids are typical of mucus-secreting cells, 
however if exendin 4 (a glucagon-like peptide I agonist that has been shown to 
promote neuroendocrine cell proliferation (28)) is added to the culture medium, the 
organoids differentiate towards a neuroendocrine cell type. This demonstrates the 
multipotency of cells derived from the murine gastric antrum, which highly express 
Lgr5. 
1.1.3 Gastric function 
The stomach breaks up food boluses into a liquid medium, and initiates proteolytic 
digestion. A number of highly conserved mechanisms achieve this across species, 
including rhythmic muscular contractions inducing specific forces optimised to 
shear food boluses and initiate emulsification of fats, and exocrine secretion of 
hydrochloric acid, zymogens and intrinsic factor. In addition to these digestive 
functions, the stomach also forms a barrier protecting the rest of the individual 
from noxious chemical and antigenic gastric contents.  
1.1.3.1 Mechanical disruption of food boluses 
In-vivo imaging studies of human gastric contractions have been performed using 
real time ultrasonography and echoplanar MRI (29). These techniques have been 
coupled with computer modelling to demonstrate that retropulsive jet-like motions 
and eddy formation within the gastric contents are the predominant mechanisms 
leading to mechanical breakdown and emulsification of food boluses, and that the 
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key determinant for the efficiency of this mechanism is the viscosity of the gastric 
contents (30). Whilst these studies begin to give insight into normal gastric motility 
in-vivo, they as yet have not addressed questions regarding precise pressure effects 
within the gastric lumen, and data have yet to be published from imaging of 
individuals with pathological gastric motility. 
1.1.3.2 Gastric exocrine secretion 
Much of the stomach’s digestive function is achieved through exocrine secretion. 
Chief cells secrete zymogens that are activated in the presence of gastric acid, 
which is itself secreted by parietal cells. Parietal cells also secrete intrinsic factor, a 
peptide that is essential for vitamin B12 absorption. Gastric acid and proteolytic 
enzymes would be hazardous to the gastric mucosa without the secretion of 
protective mucus, which forms the first barrier between the mucosal surface and 
the gastric luminal contents. 
1.1.3.2.1 Secretion of mucus 
The mucus layer is estimated to be between 100 and 200 μm thick in the gastric 
antrum. It is generated by the secretion of highly glycosylated mucins, which are of 
a very high molecular weight, and which oligomerise to form a viscoelastic gel 
matrix. MUC2, MUC5AC, MUC5B and MUC6 are all secreted forms of mucin that 
form mucus gels in the gastrointestinal tract. In the stomach, expression of secreted 
mucins is dominated by MUC5AC and MUC6 (31). Trefoil factors are a group of 
three proteins that are secreted at specific sites in the GI tract, in a pattern that 
mimics that seen in mucin secretion. Trefoil factors 1 and 2 are secreted in the 
stomach in close association with MUC5AC and MUC6 respectively, whilst trefoil 
factor 3 is limited to the intestine, and associated with MUC2 in health. A specific 
trefoil factor receptor has yet to be defined, and because of the close association of 
mucin and trefoil factor secretion, it is tempting to hypothesise that they function in 
direct and exclusive association with one another (31). Yeast 2 hybrid systems have 
confirmed the ability of trefoil factors to bind to their respective mucins, which 
supports this hypothesis (32). However more recent evidence has shown that 
expression of all three trefoil factors can be induced in the gastric mucosa under 
certain stress conditions. In Sprague-Dowley rats a
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associated with an up-regulation of all three trefoil-factors, and similarly in the AGS 
gastric cancer cell line hypoxia induced the expression of all of the trefoil factors 
(33). This evidence suggests a more complex role for the trefoil factors in acute 
gastric injury that has yet to be fully defined. 
Into the mucus matrix, a solution of bicarbonate ions and water is secreted. 
Because of the viscous nature of mucus the bicarbonate diffuses away from the 
mucosa slowly, maintaining a pH gradient from the mucosal surface to the outer 
aspect of the mucus layer. Lysozyme is also secreted into the gastric mucus. This 
enzyme is negatively charged and binds to mucins within the mucus layer, 
destroying bacterial peptidoglycans, thereby having a direct antibacterial action.  
1.1.3.2.2 Acid secretion  
Hydrochloric acid is secreted exclusively by the parietal cells that have a specific 
H
+
/K
+
 ATPase present in intracellular canaliculi. This ATPase consists of α and β 
subunits, both of which are essential for the secretion of acid (34, 35). ATP binds to 
and is dephosphorylated by the proton pump, in response to either an increase in 
cyclic AMP, or activation of a number of calcium dependent signalling cascades. In 
response, hydrogen ions are pumped against a concentration gradient into the 
gastric lumen, whilst potassium ions are transported intracellularly. Chloride ions 
are passively transported into the lumen in parallel with this process. This initiates 
the digestion of proteins by disrupting their quarternary and tertiary structures. It 
also cleaves zymogens into their active enzymes and generates an environment that 
is noxious to the vast majority of microbiota.  
In humans, the gastric luminal contents are maintained at approximately pH 2. 
Physiological studies in man have been conducted, monitoring changes in intra-
gastric pH in response to a meal, and to quantify gastric acid output due to the 
same stimulus. In response to a food bolus (tested at pH 6.0), there is an initial 
increase in luminal pH as expected, but over the course of 1 to 2 hours gastric pH 
returns to the basal level. These experiments demonstrated that at baseline the 
stomach generates less than 1 mEq (synonymous with 1mmol, assuming HCl 
secreted) per 10 minutes. In response to a meal, there is a rise in the rate of acid 
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production, peaking at 8mEq per 10 minute period 1 hour after ingesting a meal 
(36). These data demonstrate that gastric acid secretion is both a tightly regulated 
and a highly inducible physiological response. 
The secretion of gastric acid is highly conserved amongst vertebrates. Amongst 
mammals only the duck billed platypus and its fellow Monotremes lack gastric acid 
secretion mechanisms (37).  
Gastric acid secretion appears to have been established in the common vertebrate 
ancestor some 400 million years ago, as evidenced by the presence of acid secretion 
systems in all five classes of jawed vertebrate. The common mammalian ancestor, 
from which both Monotremes and all other mammals are thought to have 
segregated from birds, amphibians, fish and reptiles just 160 million years ago. 
Sequencing of the platypus genome has demonstrated complete loss of several 
genes related to gastric secretion, including both H
+
/K
+
 ATPase subunits and gastrin. 
This suggests that Monotremes lost their acid secretion system, and subsequently 
have evolved very different mechanisms of digestion to those of other mammals. 
This appears to be a rare example of divergent evolution by loss of a functionally 
related group of genes. The platypus uses grinding pads in a bill rather than teeth to 
render its arthropod rich diet into a fine powder, this then enters the achlorhydric 
stomach, before being absorbed through a short small intestine that lacks villi (38). 
1.1.3.2.3 Secretion of zymogens 
The chief cells of the corpus secrete at least five zymogens. These are proteolytic 
enzymes that rely upon an aspartate residue in their active site to initiate protein 
cleavage. They are secreted as precursor proteins (see Table 1-1), which have N- 
terminal activation segments. At neutral pH, the activation segment occupies the 
protein binding site, maintaining the protein in an inactive form. On exposure to an 
acidic environment, the activation segment and terminal part of the active protein 
undergo a conformational change, which releases the activation segment from the 
proteolytic site, resulting in enzymatic activity. This leads to autocatalysis, cleaving 
the activation segment from the protein and permanently activating the enzyme 
(39). The relative expression of different zymogens differs amongst species; humans 
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produce both pepsinogen A and progastricsin, whilst rodents express only 
progastricsin. Since the murine genome has an apparently functional pepsinogen A 
locus, but lacks transcription of this gene there is a hypothesis that the pepsinogen 
A locus may have been deactivated. 
Table 1-1: Zymogens and their active enzymes 
Precursor Active enzyme 
Pepsinogen A Pepsin A 
Pepsinogen B Pepsin B 
Progastricsin Gastricsin 
Prochymosin Chymosin 
Pepsinogen F Pepsin F 
1.1.3.2.4 Secretion of intrinsic factor 
Intrinsic factor is a glycoprotein essential for the absorption of vitamin B12, 
cobalamin. It can be secreted by a number of foregut cell types, but in the human, is 
secreted by gastric parietal cells. This molecule has two cobalamin binding domains 
joined by a bridging domain. After binding of cobalamin, the complex is transported 
to the terminal ileum, where it binds to a receptor and is absorbed. Receptor 
binding requires intrinsic factor, and hence vitamin B12 absorption requires intrinsic 
factor secretion (40). Intrinsic factor is secreted in significant excess for the 
absorption of vitamin B12 in normal stomachs, but in the context of significant 
parietal cell loss in gastric atrophy, inadequate amounts of intrinsic factor are 
generated, resulting in vitamin B12 deficiency syndromes. 
1.1.3.3 The stomach as an immunological organ 
Maintenance of a barrier between gastric contents and the host is achieved through 
a multi-layered system. The first obstacle to bacterial colonisation is gastric acid, 
which generates a noxious environment discouraging colonisation by 
microorganisms. The mucus layer then provides a physical barrier between 
microorganisms and the mucosa. If colonising organisms are able to interact with 
the mucosal surface, activation of the innate immune system is able to induce 
generic microorganism killing mechanisms, and trigger the adaptive immune 
response. 
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1.1.3.3.1 The gastric microbiota 
Most microorganisms exposed to the gastric environment are destroyed by the 
luminal pH. The majority of microorganisms are adapted to survive in pHs ranging 
from 5-7. Only those, such as Helicobacter pylori, that have developed specific 
adaptations to modify their microenvironment, and rare acidophilic bacteria, can 
thrive in this acidic environment. The healthy stomach nonetheless contains 
representatives from a number of different bacterial phyla. Historical studies using 
culture based techniques were unable to accurately quantify or specify organisms 
that colonise the stomach, with only organisms originating in the oropharynx being 
isolated, hence those organisms that were isolated were considered to be transient 
in nature rather than true colonisers; Helicobacter species, and in the human H. 
pylori in particular were considered to be the only colonisers of the stomach (41). 
Non-culture based molecular techniques have recently shown a more diverse 
microbiota in both healthy stomachs, and those of patients with a variety of gastric 
disease. One such study isolated 1833 clones from 23 healthy adults. Five phyla, 
Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria and Fusobacteria 
dominated these clones. Two-thirds were from organisms that had previously been 
isolated from the oropharynx, suggesting either gastric colonisation from sources 
further up the GI tract, or representing bacteria that only transiently occupy the 
stomach. The remaining third of isolates provide stronger evidence for primary 
gastric colonisation, as they have not been isolated more proximally in the GI tract 
(42). A subsequent study, aiming to investigate differences in gastric microbiota 
between patients with gastric cancer and those with histologically normal gastric 
epithelium confirmed colonisation by the same five bacterial phyla (43). From these 
data, it is clear that, as with the rest of the GI tract, a specific microbiota persists in 
close relationship to the host gastric mucosa. 
1.1.3.3.2 Physical barriers 
The mucus layer described in section 1.1.3.2.1 provides the first physical barrier to 
the epithelium. The mucosal surface is also protected throughout the GI tract by 
other membrane bound mucins. MUC1 is the archetypical membrane bound mucin. 
It is expressed throughout most secretory mucosa, including the GI tract, and is 
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anchored in the cell membrane by a trans-membrane domain. Its extracellular 
domain has variable numbers of tandem repeat peptides that are heavily 
glycosylated (44). This heavy glycosylated surface impedes bacterial adhesion. Mice 
with transgenic deletion of MUC1 are more susceptible than their wild-type controls 
to gastric colonisation with both Campylobacter jejuni (45) and Helicobacter pylori 
demonstrating that this protein has a significant inhibitory effect on epithelial 
colonisation. MUC4 is also a membrane bound mucin, and is thought to play a role 
in carcinogenesis. It is up-regulated in some human tumours, and has been shown 
to inhibit the binding of the epidermal growth factors erb-B2 and erb-B3, which is 
important in the transduction of growth signals by both of these receptors (46). 
The final physical barrier to microbial translocation is the epithelial monolayer itself. 
Cells of the gastrointestinal epithelium are tightly held together at their apical poles 
by tight junctions (zona occludens), formed from the transmembrane protein 
occludin, which is anchored to the cytoskeleton by ZO1, ZO2 and ZO3 (47). These 
junctions provide physical support to the mucosal structure and inhibit diffusion 
along basolateral surfaces of the epithelial cells.  
Further down the basolateral surface of epithelial cells are adherens junctions (zona 
adherens). The transmembrane components of this complex are cadherin and 
nectin. The intracellular component of cadherin is anchored to the cytoskeleton by 
α- and β-catenin interactions, whilst nectin is anchored to the cytoskeleton by 
afadin. These junctions provide further mechanical support to the epithelial cell, 
and maintain epithelial cell polarity (48). 
At the basal aspect of the epithelial cell, focal adhesions are formed by integrin 
heterodimers. The extracellular component of these directly interacts with the 
extracellular matrix, whilst several adaptor proteins link the cytoplasmic component 
to the actin cytoskeleton (49).  
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1.1.3.3.3 Innate immune responses 
The epithelial cells of the GI tract form an important part of the innate immune 
system. Apical surface expression of toll-like receptors including TLR-2, TLR-4 and 
TLR-5 detect bacterial peptidoglycan, lipopolysaccharide and flagellins respectively, 
and are efficient downstream activators of classical pathway NF-κB signalling and 
other innate immune pathways. Organisms that successfully enter an epithelial 
cell’s cytoplasm may also be recognised by the pattern recognition proteins NOD1 
and NOD2 that are also potent activators of the innate immune response. 
Recognition of bacteria by these domains can result in the activation of a variety of 
intracellular signalling pathways, including MAP kinase, NF-κB and autophagy. 
Activation of this system results in cytokine release, which orchestrates several 
different possible outcomes, ranging from epithelial cell death to microorganism 
killing and antigen presentation.  
1.1.3.3.4 Adaptive immune response 
The adaptive immune system is directly represented by dendritic cells that reside in 
close proximity to the gastric epithelium and extend micropoda into the gastric 
lumen. These cells are the most effective antigen presenting cells of the adaptive 
immune system (50). They sense antigens in the lumen and present them to naïve 
T-cells that then orchestrate the adaptive immune response. 
Gastric epithelial cells also express cathepsins, proteases that breakdown 
endocytosed antigens into a size that is suitable for binding to MHC class II proteins 
for presentation to naïve T-cells, suggesting a role in direct antigen presentation to 
cells of the acquired immune system.  
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1.1.3.4 Controls of gastric function 
Neurological and endocrine mechanisms combine to control gastric secretion, 
gastric homeostasis and satiety. 
The stomach is innervated by the autonomic nervous system, and many of the 
epithelial cell types express muscarinic receptors that receive neurological stimuli. 
Neuroendocrine cells are scattered throughout the gastric mucosa and secrete a 
variety of different peptides as summarised in Table 1-2. These hormones have both 
paracrine and endocrine activity. 
 
1.1.3.4.1 Control of satiety 
Interest in a direct gastric mechanism for control of food intake has been sustained 
for several years, but it is clear that there is a complex relationship between 
endocrine drive for nutrition and higher neurological function. Ghrelin is secreted 
by X/A cells, a distinct group of neuroendocrine cells that are the second most 
common in the oxyntic mucosa. They make up 20% of the neuroendocrine cells in 
the oxyntic mucosa of both rats and humans and act upon the medulla oblongata 
and hypothalamus through GHS-R1a receptors. Ghrelin has a clear orexigenic effect 
in-vitro, but its effects in-vivo are more complex (51). Chief cells secrete leptin, a 
peptide that has a generally anorexigenic effect.  
Table 1-2: Endocrine control over gastric secretion and homeostasis 
Cell Type Hormone Receptor Target cell type Primary effects 
G-cells Gastrin CCK-2 Parietal cells 
ECL cells 
Stimulates acid secretion 
Growth factor 
ECL cells Histamine Histamine 2 Parietal cells Stimulates acid secretion 
D-cells Somatostatin Somatostatin 2 G-cells 
ECL cells 
Parietal cells 
Inhibits gastrin secretion 
Inhibits histamine 
secretion 
Inhibits acid secretion 
X/A-like 
cells 
Ghrelin GHS-R1a Hypothalamus, 
medulla (51) 
Orexigenic stimulus 
Chief 
cells 
Leptin ObR Vagal afferent 
fibres 
Anorexigenic stimulus 
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1.1.3.4.2 Control of gastric acid secretion 
Neurological control of gastric acid secretion is mediated through autonomic 
innervation of the stomach. Parietal cells have activating M3 muscarinic receptors 
(35, 36), stimulation of which results in increased intracellular calcium and 
subsequently to H
+
/K
+
 ATPase activation. In addition, D-cells, which are the third 
most common neuroendocrine cell type in the corpus (making up slightly less than 
20% of the neuroendocrine cells at this site), have M2 and M4 type muscarinic 
receptors (37). When stimulated, these receptors reduce cyclic AMP levels, which 
leads to a reduction in somatostatin secretion, and subsequent increase in gastrin 
production.  
Gastrin is the main endocrine drive that stimulates acid secretion. It is produced by 
antral G-cells, that make up the majority (>70%) of the neuroendocrine cells of the 
gastric antrum (52). It is secreted in response to a number of luminal stimuli, 
including the presence of amino acids and dietary amines. Calcium receptors on the 
surface of the G-cell also sense luminal calcium and adjust the gastrin secretory 
response (53) with increased calcium resulting in increased gastrin secretion. 
Gastrin is secreted into the gastric vasculature and binds to CCK-2 receptors, 
expressed on the surface of gastric enterochromaffin-like (ECL) cells and parietal 
cells (54). Binding of gastrin to ECL cells results in the secretion of histamine. 
Histamine acts in a paracrine manner by binding to type II histamine receptors on 
the parietal cell. This step amplifies the secretagogue signal, as binding of both 
histamine and gastrin to their respective receptors on the parietal cell increase acid 
secretion.  
Continued gastrin secretion is inhibited by the secretion of somatostatin that is 
produced by D-cells, which make up around 20% of the neuroendocrine cells of the 
oxyntic mucosa. D-cells are in close proximity to the parietal cells and are able to 
sense luminal pH. Their secretion of somatostatin then acts on G-cells, parietal cells 
and ECL cells to directly and indirectly affect drivers of acid secretion. At rest, these 
pro- and anti-secretory mechanisms are in equilibrium, resulting in low levels of 
basal acid output. In response to either a luminal stimulus up-regulating gastrin 
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secretion, or a neurogenic stimulus removing the inhibition of acid secretion 
exerted by somatostatin, gastric acid output is rapidly adjusted.  
1.1.3.4.3 Control of epithelial cell turnover 
To maintain a dynamic equilibrium of proliferating cells and dying cells in the gastric 
epithelium, close regulation of these two mechanisms must be maintained. Gastrin 
is a key mediator in the control of both of these events in the gastric epithelium. 
1.1.3.4.3.1 Proliferation 
Observations in patients with hypergastrinaemia due to Zollinger Ellison syndrome 
(ZES) provided the first observation of gastric mucosal proliferation in association 
with elevated gastrin levels (55). The first direct evidence of gastrin acting as a 
mucosal growth factor came from the administration of exogenous gastrin to dogs 
in 1972 (56). Increased mucosal proliferation has also been shown in rodent models 
including Mastomys. Administration of an H2 receptor antagonist renders these 
animals hypergastrinaemic, and in response they develop gastric gland elongation 
and increased numbers of proliferating cells (57). In human subjects, 
3
H-thymidine 
labelling studies have shown that exogenous administration of gastrin results in 
increased cell proliferation (58). 
In addition to generalised epithelial cell proliferation, specific neuroendocrine cell 
proliferation in the stomachs of patients with ZES has been recognised since 1974 
(59). Pharmacological induction of achlorhydria with either proton pump inhibitors 
or H2 receptor antagonists has also been shown to cause ECL cell hyperplasia in 
rats, chickens, hamsters and guinea pigs (60, 61). This effect is mediated through 
hypergastrinaemia, as demonstrated by the fact that ECL cell hyperplasia is not seen 
in rats treated with these drugs following antrectomy (60). Human studies 
examining this phenomenon are discordant. A study of 33 patients treated with 
omeprazole for an average of 5.6 years failed to show any significant changes in ECL 
cell number (62), whilst another study investigated 61 patients treated with a 
proton pump inhibitor for 7.8 years on average (63). This study demonstrated that 
54% of individuals had diffusely increased numbers of neuroendocrine cells in the 
corpus.  
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Gastrin is the hormone with most data backing up its role as a stimulator of cell 
proliferation, however there is evidence that ghrelin provides a proliferative signal 
as well (64). 
1.1.3.4.3.2 Apoptosis 
In addition to effects on proliferation, gastrin signalling also increases susceptibility 
of normal gastric epithelial cells to apoptosis in-vivo. Mastomys treated with H2 
antagonist drugs have a 2 fold increase in apoptosis compared to untreated animals 
(57). When transgenic mice that constitutively over express gastrin are subjected to 
either γ-irradiation or Helicobacter infection, the number of apoptotic cells 
observed in the gastric mucosa is elevated in comparison with similarly treated 
wild-type animals (65, 66). In humans, gastric biopsy samples from individuals with 
both H. pylori infection and hypergastrinaemia show increased apoptotic indices 
compared to control samples (65). 
The effects of gastrin on apoptosis are however complex. Several cell culture 
models of gastric cancer have shown that cancer cells receive pro-survival signals 
through gastrin signalling. In the MKN-45 human gastric cancer cell line, inhibition 
of CCK-2 receptor signalling is associated with increased sensitivity to apoptosis and 
up-regulation of Bax and Bcl-2 (67). Similarly, gastrin has been shown to inhibit AGS-
GR cell apoptosis through an mcl-1 dependent mechanism (68). Overall these data 
demonstrate that as well as regulating the proliferation of gastric epithelial cells, 
gastrin also plays a role in the orchestration of cell fate in the gastric mucosa. 
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1.2 Gastric cancer 
The fundamental processes that lead to carcinogenesis in diverse tissues are similar. 
The widely cited article “The Hallmarks of Cancer” by Hanahan and Weinberg in 
2000 proposes six characteristics of carcinogenesis: self-sufficiency in growth 
signals, insensitivity to growth-inhibitory signals, evasion of apoptosis, limitless 
replicative potential, sustained angiogenesis, and tissue invasion and metastasis. 
Whilst these six features have become widely accepted, more recently the addition 
of inflammation as a seventh characteristic has been suggested (69). Links between 
inflammation and cancer have been recognised since the 19
th
 century, when 
Virchow described a “lymphoreticular infiltrate” in association with tumours (70, 
71). Since then, a number of tumour types have been associated with specific 
causes of chronic inflammation. In hepatocellular carcinoma and cervical cancer, 
the initiators of inflammation are infectious agents, hepatitis B virus and human 
papilloma virus respectively. The cause of inflammation may however be non-
infectious, as is probably the case for cigarette smoking and lung cancer and gastric 
acid-mediated inflammation leading to Barrett’s oesophagus and oesophageal 
adenocarcinoma. The increased incidence of colon cancer in patients with 
ulcerative colitis or colonic Crohn’s disease is a prime example of an idiopathic 
inflammatory process leading to an increased risk of cancer in the affected organ. 
Furthermore, some autoimmune mediated inflammatory processes can lead to 
increased risk of malignant disease in otherwise unaffected tissues as shown in a 
recent cohort study investigating the outcomes of admissions to United States 
Veterans hospitals (72). This study highlights the association between both local and 
systemic inflammation and gastrointestinal cancers. A cohort of 4,501,578 male 
patients was followed for a mean 12 years. Of these 289,000 had at least one 
defined autoimmune disease, and 96,000 developed a gastrointestinal tumour 
during follow up. Several established associations between autoimmune disease 
and gastrointestinal tract cancers were confirmed, for example the relative risk of 
gastric carcinogenesis in patients with pernicious anaemia was 3.17 (95% CI 2.47-
4.07), similarly primary biliary cirrhosis was shown to confer a relative risk of 
hepatocellular carcinoma of 6.01 (95% CI 4.76-7.57). In addition to these 
associations however, an increased risk of gastric cancer was also observed in 
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patients with PBC (odds ratio 1.66, 95% confidence interval 1.10-2.51). Searches of 
“Web of Science” and “Pubmed” suggest that this observation is novel, although 
other studies that could have potentially addressed the same question have been 
significantly smaller and only published in abstract form to my knowledge (73). This 
study was not designed to address the mechanism behind such an association, but, 
if confirmed, the association of a distant autoimmune disease with gastric 
carcinoma may offer new insights into the pathogenesis of this disease. This is of 
particular relevance since the specific molecular mechanisms that link chronic 
inflammation to carcinogenesis are only now becoming apparent. Recent work has 
implicated the NF-κB family of transcription factors in modulating cancer risk in 
several models of inflammation-associated cancer, including colitis-associated 
cancer and chemical hepatitis-associated hepatocellular carcinoma (74-76), whilst 
genetic risk data also emphasise the importance of many inflammatory mediators in 
modulating an individual’s risk of developing gastric tumours, supporting the 
hypothesis that inflammation is critical for carcinogenesis.  
1.2.1 Origin of cancer in the stomach 
There are conflicting hypotheses as to the cellular origin of epithelial tumours, the 
cancer stem cell hypothesis and the stochastic model. The stochastic model 
proposes that all the cells within a tumour have equal malignant potential, with 
each cell being capable of expanding into a clone of malignant cells. The cancer 
stem cell hypothesis suggests the maintenance of a hierarchy of cells, with a cancer 
stem cell (which may have originated from any cell type) proliferating to produce 
both clones of itself and aberrantly differentiated progenitor and differentiated 
cells. These two models not only lead to different approaches to the academic study 
of carcinogenesis, but also influence the objectives of potential therapies. In the 
stochastic model, cure can only be achieved by excision or killing of all tumour cells, 
whilst in the cancer stem cell model, removal of, or induction of senescence in, the 
cancer stem cell removes malignant potential. 
In the stomach, there is mounting evidence for the existence of a cancer stem cell. 
Wnt signalling is important in the normal gastric stem cell niche, and there is also 
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evidence of its importance in carcinogenesis. Humans with germline mutations of 
APC that result in the nuclear accumulation of β-catenin and hence activation of 
classical WNT signalling have a 10 fold increase in their risk of developing gastric 
cancer. Sporadic intestinal type gastric cancers have been reported to have nuclear 
accumulation of β-catenin in 29% of cases , and to have mutations in the β-catenin 
gene in 7 of 17 (26.9%) intestinal type gastric adenocarcinomas (77). It has also 
been reported that deletion of Apc specifically in the Lgr5 positive cells of the 
stomach leads to gastric adenoma formation, providing further evidence for cells 
with stem cell characteristics playing a role in gastric carcinogenesis (24). The final 
piece of evidence that supports a cancer stem cell rather than a stochastic model of 
carcinogenesis comes from studies using xenografted mice. SCID mice xenografted 
with CD44 (a candidate cell surface marker of stem cells) positive gastric cancer cell 
lines develop tumours containing a polyclonal mixture of CD44 positive and CD44 
negative cells. This confirms that tumour cells differentiate after engraftment, 
supporting the cancer stem cell hypothesis (78). 
Whilst a cancer stem cell hypothesis is supported by these findings, it remains 
unclear from which, if any, of the adult gastric lineages the cancer stem cell 
originates. The link between Lgr5 activity and antral adenoma formation would 
support a role for the native gastric stem cell in carcinogenesis; however studies 
investigating the potential of bone marrow derived stem cells to repopulate the 
gastric stem cell niche have cast doubt upon this.  
Houghton and Wang (79) studied gastric carcinogenesis in response to Helicobacter 
felis infection in female C57BL/6 mice that had undergone bone marrow 
transplantation with marrow derived from either LacZ ROSA26 mice, or male GFP 
expressing mice. Both of these models can be used as reporters for epithelial cells 
derived originally from cells of the bone marrow. After short term (6 weeks) H. felis 
infection, mice transplanted with the LacZ ROSA26 construct demonstrated a peak 
in induction of epithelial apoptosis, and β-galactosidase positive cells began to 
appear in the gastric mucosa. Following chronic infection with H. felis (12-15 
months), both reporter mechanisms demonstrated that atrophic and metaplastic 
glands were derived from the transplanted bone marrow. These data suggest that 
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the repopulation of gastric glands with stem cells derived from the bone marrow 
may be an important step in carcinogenesis in this tissue. These studies have been 
criticised due to the need for high dose whole body irradiation as a precursor to 
bone marrow transplantation, a process that may have marked effects on the 
gastric stem cell niche. The pattern of pathology observed in response to 
Helicobacter felis infection in these studies is internally consistent (80) and is similar 
to results reported by independent groups working with the same infection model 
under different animal house conditions (81). The Houghton and Wang group also 
attempted to assess whether mice subjected to bone marrow transplantation were 
susceptible to engraftment of bone marrow derived cells into the gastric mucosa 
either without further stimulus, or after induction of gastric ulcers by submucosal 
injection of acetic acid. In neither case were significant numbers of bone marrow 
derived cells observed in the gastric mucosa, suggesting that Helicobacter felis 
infection, rather than the transplantation protocol, is responsible for repopulation 
of the stem cell niche with bone marrow derived cells. 
1.2.2 Epidemiology  
Gastric adenocarcinoma is the fourth commonest malignancy worldwide. An 
estimated 989,000 cases were diagnosed in 2008 (82, 83) representing 7.8% of 
incident cancers. These figures reflect an age standardised, world standardised 
incidence of 14.1 cases per 100,000 individuals. Gastric cancer accounts for 9.7% of 
cancer related deaths, and is the second commonest cause of cancer related death 
worldwide, causing 738,000 deaths in 2008 (83). 
In the UK, an average of 7897 cases of gastric cancer, and 5395 deaths were 
reported per year between 2005 and 2007. This represents an incidence of 13.6 
cases per 100,000 men and 5.5 cases per 100,000 women (ONS Cancer and 
Mortality in the United Kingdom 2005-2007). Median age at diagnosis for men in 
the UK is estimated to be within the range 65-69 years, and slightly older (70-74 
years) for women (interquartile range 60-79 years for both sexes) (84). There is also 
a link between deprivation indices and gastric cancer incidence in the UK. Data from 
the 1990s examining cancer risk in Scotland demonstrated that individuals in the 
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least deprived quintile of population had an age standardised incidence of 12.7 
cases per 100,000, whilst those in more deprived quintiles had significantly (p<0.01 
by linear regression on log rates) higher incidence, with an age standardised 
incidence of 20.2 cases per 100,000 population in the most deprived quintile (85).  
1.2.2.1 Incidence of gastric carcinogenesis varies geographically 
There are large deviations from the world standardised incidence of gastric cancer: 
Botswana reports 0.3 cases per 100,000 population, whilst the Republic of Korea 
reports 41.4 cases per 100,000 population. These differences reflect differences in 
disease pathology but probably also in the reporting of epidemiological statistics. 
Epidemiological data for cancer incidence is collated by the International 
Association of Cancer Registries, with most recent data being published in the 
document “Cancer Incidence in Five Continents – IX” (86). As these data are 
gathered prospectively, and through professional sources, it is likely that these 
figures accurately reflect the number of cases observed by each registry. These data 
do not however reflect any cases that may not come to medical attention due to 
limited access to medical services, nor does it inherently reflect the denominator of 
population size. In countries that regularly hold a census, data are likely to be less 
than 1 census period old. In regions where a census is not regularly held, the 
estimate of total population is more difficult and is likely to rely on extrapolations 
from small samples. Even in areas with a regular census there is potential for 
significant error, as cancer statistics are usually reported more frequently than 
census surveys are performed. Estimates of inter-census population change in large 
populations can also introduce significant errors in disease reporting ratios (87) . 
Despite potential reporting bias, there is a clear geographical pattern of gastric 
cancer incidence, (Figure 1-3). In the Far East, disease incidence is very high, whilst 
Sub-Saharan Africa has the lowest incidence. The USA and Western Europe also 
have relatively low rates of disease, whilst Eastern Europe, the Middle East and 
South America have an intermediate incidence of disease. These differences in 
incidence presumably reflect differences in the risk factors for gastric cancer 
discussed below. Specific differences in Helicobacter virulence factors, diet and 
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smoking can be relatively easily defined, but fail to explain the degree of observed 
variation in incidence. A number of genetic studies have demonstrated 
heterogeneity of risk attributable to polymorphisms in different populations, and 
this may also impact upon the differences in incidence observed globally. 
1.2.2.2 Reduction in incidence of gastric cancer world wide 
The current rates of gastric cancer belie the fact that disease incidence is falling 
dramatically (see Figure 1-4). In the UK, the number of cases per 100,000 
population has fallen steadily from 21.7 cases in 1975 to 12.8 in 2008. This trend is 
recapitulated in all regions that have been studied (82), and in those areas where 
statistics are available from earlier years, there is evidence that the decline in 
gastric cancer incidence has been more long standing (e.g. Finland where incidence 
has been falling since first statistics were recorded in 1963). In some regions there 
have been successful public health initiatives that have reduced lifestyle derived 
risk. In Finland, for example, significant reductions in population consumption of 
salt and smoked and dried fish have coincided with a reduction in gastric cancer. 
Similarly over this timescale, tobacco use has been reduced amongst the Finnish 
population (88, 89). 
The reasons behind the global decrease in gastric cancer incidence have not been 
adequately explained, but there are correlations with improved sanitation in the 
earlier years of the dataset. Subsequent administration of antibiotics and 
bacteriostatic agents may also have led to serendipitous eradication of Helicobacter 
Figure 1-3: Geographic spread of age standardised incidence of gastric cancer per 100,000 males (82) 
45 
 
pylori. It could be hypothesised that the targeted eradication of Helicobacter has 
been the predominant driver for this decline in gastric cancer, but the fact that 
incidence has been falling for significantly longer than H. pylori has been treated 
suggests that this is probably not the case. 
1.2.3 Malignant pathology of the stomach 
95% of primary tumours arising in the stomach are adenocarcinomas. These lesions 
are divided pathologically into diffuse and intestinal types, a classification defined 
by Lauren (90) following the publication of a case series in 1965. This series 
demonstrated that 53% of tumours clearly retained a glandular structure, whereas 
33% had a diffuse, poorly differentiated microscopic appearance. In addition to the 
difference in tumour structure, it was observed that tissue surrounding tumours 
that retained a glandular structure frequently had inflammatory (88%) and 
metaplastic (81%) changes. These tumours were also shown to have different 
gender and age distributions (65% male in intestinal type c.f. 54% male in diffuse, 
mean age of 55.4 years in intestinal type cancers, c.f. 47.7 years in diffuse) and 
there was a difference in prognosis. Patients treated with curative intent for 
intestinal type gastric cancer had a 1 year survival of 88%, but those treated for 
diffuse gastric cancer had a 1 year survival of only 68%. Because of these 
differences, gastric tumours of diffuse and intestinal type were considered to be 
Figure 1-4: Falling incidence in gastric cancer reporting over time in multiple cancer registries 
(data from Globocan 2008) (82) 
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distinct entities. Subsequent studies, particularly linking intestinal type tumours to 
chronic Helicobacter pylori infection, have confirmed this distinction. 
The remaining 5% of gastric tumours include gastrointestinal stromal tumours, 
gastric neuroendocrine tumours and gastric extranodal marginal zone B-cell 
lymphomas arising from mucosa associated lymphoid tissue (MALT lymphomas).  
The aetiology of the rarer epithelial tumours of the stomach provide interesting 
comparisons with adenocarcinomas. Both adenocarcinoma and neuroendocrine 
tumour formation is promoted by elevated circulating gastrin concentrations. 
Gastric neuroendocrine cell tumours are composed of cells that have signs of 
differentiation towards an ECL cell phenotype, with expression of chromogranin A 
and histamine (91). 85% of these tumours arise in individuals with pre-existing 
conditions causing hypergastrinaemia, either pernicious anaemia or Zollinger-Ellison 
syndrome, and in some cases retain sensitivity to gastrin, such that elimination of 
excess gastrin secretion can result in tumour regression. Animal models provide 
evidence that gastrin is also important in gastric adenocarcinoma formation. The 
transgenic INS-Gas mouse has a human gastrin mini-gene transgenically expressed 
under the control of the rat insulin promoter, resulting in constitutive 
hypergastrinaemia. Three quarters of these animals develop spontaneous gastric 
adenocarcinomas over 20 months; they also have an accelerated onset of both 
Helicobacter pylori (92) and Helicobacter felis (93) induced gastric cancer, 
developing carcinomas after 7 months of infection. 
Gastric MALT lymphomas also share aetiology with gastric adenocarcinoma. A 
recent systematic review included data from 1308 published cases and 
demonstrated that 88% of reported cases of MALT lymphoma are associated with 
Helicobacter pylori infection. In many cases, eradication of H. pylori results in the 
regression of this tumour , and whilst this is adequate sole therapy only in early 
stage disease that is limited to the mucosa and sub-mucosa, it is also an important 
part of the therapy in all stages of Helicobacter associated MALT lymphoma (94) . 
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1.2.3.1 Helicobacter pylori 
 
 
Helicobacter pylori is a gram negative, spiral rod shaped bacterium that requires a 
microaerophilic environment to prosper. It is highly adapted to survive in the gastric 
environment (Figure 1-5 B). Its presence in the stomach, and association with 
gastric pathology had been debated over almost a century before it was successfully 
cultured by Marshall and Warren in 1984 (95). Helicobacter pylori is a widely 
distributed human pathogen, infecting approximately 50% of the global population 
(Figure 1-5 A) (96). Phylogenetic studies suggest that it has colonised humans for at 
least the last 58,000 years, and that distinct strains have evolved in geographically 
distinct populations subsequent to the migration of modern humans from East 
Africa (97-99). Its role as a pathogenic organism in man was confirmed by the 
demonstration that the organism could colonise a healthy volunteer and induce an 
acute gastritis (100). Since its discovery, Helicobacter pylori infection has been 
associated with both benign and malignant pathology in man. It is strongly 
Figure 1-5: Helicobacter pylori infection 
A: Prevalence of Helicobacter infection modified from Parkin 2006 (94) 
B: H+E stain of Helicobacter felis colonisation of gastric antrum 
C: Timeline of Helicobacter associated discoveries 
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associated with peptic ulcer disease, with recent epidemiological studies attributing 
a relative risk of peptic ulcer disease of 6.77 (95% CI 2.85-16.10) to Helicobacter 
pylori infection (101), and along with the reduction in incidence of Helicobacter 
pylori colonisation, there is a trend towards fewer cases of peptic ulcer disease 
worldwide (102).  
Epidemiological data linking chronic infection with Helicobacter pylori with gastric 
cancer led to its designation as a class I carcinogen in 1994 (103, 104), whilst the 
significance of the work leading to the culture of Helicobacter was recognised in 
2005 with the award of the Nobel Prize for Physiology and Medicine to Marshall 
and Warren (Figure 1-5 C). 
More contentiously, Helicobacter pylori infection has also been linked to a number 
of extragastric conditions, including ocular adnexal lymphoma (105) and ischaemic 
heart disease (106). 
1.2.3.1.1 Helicobacter specialisation to occupy the gastric niche 
Helicobacter pylori has evolved to occupy a niche in close proximity to the gastric 
mucosa. It colonises a region not more than 25µm from the surface of epithelial 
cells, and resides within the bicarbonate-containing mucus layer. The mucus layer 
therefore provides some defence to the bacterium against the hostile gastric pH, 
but H. pylori has also evolved a urease enzyme that catalyses the hydrolysis of urea 
into CO2 and ammonia. Studies in gnotobiotic piglets have demonstrated that this 
enzyme is essential for H. pylori to successfully colonise the gastric mucosa (107). 
The rapid turnover of the gastric mucus layer means that to maintain its niche H. 
pylori also requires motility, which is achieved through flagellae. Again studies of 
motile and non-motile H. pylori in gnotobiotic pigs have shown that this motility is 
essential for effective colonisation of the gastric mucosa (108). 
Helicobacter pylori infection also interacts with secreted gastric mucins. Marked co-
localisation of MUC5AC and colonising Helicobacter pylori has been observed with 
reports of up to 99% of colonising organisms being found in mucus made up of 
MUC5AC rather than MUC6 derived gels (109). More recent studies have confirmed 
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the interaction of Helicobacter pylori with the Lewis B blood group antigen, which is 
expressed within the glycosylated portion of MUC5AC. The co-localisation of these 
binding partners has been demonstrated in both gastric tissue and Barrett’s 
oesophagus with aberrant expression of MUC5AC (109, 110). The Helicobacter 
adhesion molecule blood group antigen binding protein A (BabA) has been shown 
to interact with the Lewis B antigen (111). In addition to the reported binding of 
Helicobacter to the gastric mucins, there are reports of changes in gastric mucin 
expression in patients with Helicobacter pylori infection, with elevated MUC5AC and 
MUC6 reported in the antrum and elevated MUC5AC reported in the corpus (112).  
1.2.3.2 Pathological progression to gastric cancer 
The observation of intestinal type gastric tumours in association with intestinal 
metaplasia is now recognised to be a late stage of a chronic pathological process 
that develops over several decades in man. The process begins with superficial 
gastric inflammation, which over time leads to morphological changes to the gastric 
gland structure. The changes in gland structure are stereotypical, beginning with the 
replacement of parietal cells with mucus cells in gastric atrophy, and later 
progressing to metaplasia, dysplasia and eventual malignancy. This stereotypical 
sequence was first hypothesised by Correa on the basis of epidemiological evidence 
(113). At the time of Correa’s publication, Helicobacter pylori had not been cultured 
and hence could not be attributed as an initiator of this sequence. However 
subsequent studies have supported both (114)this pathological sequence and 
Helicobacter infection as its initiating factor. 
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1.2.3.2.1 Superficial gastritis 
Acute gastritis is rarely observed as it is often asymptomatic and frequently occurs 
at a young age. The reported cases are usually either serendipitous, as in the case of 
a gastroenterology research fellow who developed symptoms following the 
handling of gastric juice samples, or in the original case demonstrating the 
pathogenicity of Helicobacter pylori through deliberate infection (100). These cases 
are typified by a nuclear polymorph infiltrate into the gastric mucosa, along with 
transient reduction in gastric acid output and epithelial cell exfoliation. Studies in 
rats have demonstrated that intra-gastric administration of Helicobacter pylori 
lipopolysaccharide can induce a similar pathological response, implicating 
lipopolysaccharide as a mediator of acute gastritis (115). Gastric colonisation with 
Helicobacter pylori also results in the activation of both NOD1 in gastric epithelial 
cells and Toll-like receptors on dendritic cells within the gastric mucosa (114). 
Together these stimuli result in the recruitment of nuclear polymorphs into the 
gastric mucosa and subsequent T-cell recruitment into the gastric mucosa . 
The initial neutrophilic response fails to clear Helicobacter pylori from the gastric 
mucosa, and a chronic lymphocytic inflammation begins to predominate, with Th1 
polarised T-cell responses and recruitment of B-cells that set up an antibody 
response to H. pylori (116) . This response begins with the production of IgM 
antibodies that amplify the immunological response, but rapidly leads to the 
formation of lymphoid follicles with differentiation of B-cells into plasma cells 
committed to generating a mucosa-protective IgA response (117). Even this 
response is inadequate to clear H. pylori in the majority of cases, hence the immune 
system continues to be exposed to antigen and immune follicle formation persists. 
1.2.3.2.2 Atrophic gastritis 
When chronic superficial gastritis has been present for a prolonged period of time, 
structural changes can occur in the gastric mucosa. Repetitively injured oxyntic 
glands are replaced either by fibrous tissue, or by mucus cells. This histopathological 
lesion is described as gastric atrophy and is associated with consequent changes to 
the gastric environment: the gastric pH is elevated, stimulating enhanced gastrin 
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secretion, which in turn stimulates proliferation of gastric mucosal tissues. This in 
turn can lead to further proliferation of mucus cells and ECL cells.  
The eradication of H. pylori has been extensively studied as a treatment for gastric 
atrophy, with mixed results from a number of interventional trials. Historical studies 
of chronic gastritis, as well as showing a cohort of patients that progressed towards 
gastric metaplasia also demonstrated small numbers of patients that had 
spontaneous regression of gastric atrophy (118). These observations have been 
validated more recently, and have been extended to include the dynamics of 
progression towards intestinal metaplasia and dysplasia as summarised in Table 1-3. 
These data suggest that both progression and regression of these pathologies is 
possible, but that over time there is an overall progression to the more severe end 
of the spectrum in untreated individuals. An important caveat to these observations 
is that they are subject to potential sampling bias due to the combination of patchy 
pre-malignant gastric pathology, and the small size of endoscopic biopsies.  
 
Table 1-3: Progression and regression of pre-malignant gastric pathology (119) 
Progression Rate/100 
person-years 
Regression Rate/100 
person-years 
Non atrophic Gastritis → 
Multifocal atrophic 
gastritis 
7.5 Multifocal atrophic 
gastritis → Non atrophic 
gastritis 
1.7 
Multifocal atrophic 
gastritis → Intes\nal 
metaplasia 
6.7 Intestinal metaplasia → 
Multifocal Atrophic 
gastritis 
4.4 
IM → Dysplasia 3.2 Dysplasia → IM 5.7 
 
The earliest reports of Helicobacter pylori eradication as a means of triggering the 
regression of gastric atrophy were made in the late 1990s. Several studies used 
serial biopsies after eradication therapy to attempt to define whether this was an 
efficacious method of reversing gastric atrophy. Early studies produced conflicting 
results, ranging from the observation of partial resolution of atrophy and 
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widespread improvement in other gastric pathology (120) to no change in gastric 
atrophy (121-123). 
To address some of the shortcomings in the design of early studies a larger scale 
trial comparing Helicobacter pylori eradication with omeprazole, amoxicillin and 
clarithromycin against placebo was performed. 552 patients from Shandong 
province in China, which is an area of high gastric cancer incidence, were recruited. 
All had an initial gastroscopy and biopsy that confirmed Helicobacter pylori infection 
on the basis of both histology and rapid urease testing, and patients were 
randomised to receive either eradication therapy or placebo. Patients were 
followed up over 5 years with further endoscopy and biopsy (124).  
At the start of the study period no differences were observed in inflammation, 
atrophy or intestinal metaplasia between treatment and placebo groups. At five 
years there was a significant reduction in severity and activity of inflammation in 
the treatment group, which was not observed in the placebo group. Intestinal 
metaplasia did not progress in the treatment group, whilst progression was seen in 
the placebo group, but gastric atrophy did not change significantly. Overall this 
study suggests that gastric atrophy is not reversible in this population, however it 
cannot address whether atrophy could be reversible under different conditions, 
particularly in other populations with less extreme cancer risk. Neither can it 
address whether atrophy could regress over a longer period than the five years of 
follow up. Most recently in 2010 a study following up a cohort of 300 patients with 
atrophic body gastritis 192 of whom were Helicobacter pylori positive at the start of 
the study has been reported. In this study patients were followed up for a mean of 
5.2 years and 14% of the Helicobacter eradicated group showed regression of 
atrophy. This study was able to define additional factors that made regression of 
atrophy more likely including more severe inflammation, “mild” atrophy and the 
absence of associated intestinal metaplasia (125). 
All of these studies are compromised by flaws in study design, one with no control 
group to compare against spontaneous resolution of atrophy (120), and many with 
relatively small numbers of patients recruited into them. There is also a degree of 
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heterogeneity between these studies both in terms of the eradication therapy used, 
with a variety of different proton pump inhibitors and antibiotics being employed, 
as well as bismuth based eradication protocols (125) and in terms of study 
populations, with Far Eastern and Western populations being studied 
independently. There also remains a question over the duration of follow up that 
these studies have so far reported. The morphological changes of the Correa 
sequence are known to develop over several decades, it is logical therefore that any 
reversal of these changes could also occur over a prolonged timescale. In support of 
this a cohort study of a Finnish population that had undergone Helicobacter pylori 
eradication has recently reported after a mean 10.1 years follow up. This study does 
not directly report on atrophy, but does demonstrate that the risk of gastric cancer 
remained elevated in this population for the first six years after eradication of 
Helicobacter pylori, before falling to population risk (126). It would be interesting to 
know whether this risk was associated with regression of a specific pre-malignant 
pathology or not. 
Overall the human data suggest that gastric atrophy is a reversible lesion in some 
instances, Helicobacter pylori eradication is adequate therapy to achieve this in a 
minority of cases, and there remains a potential therapeutic niche that could 
address more effective resolution of atrophy beyond eradication of Helicobacter. 
There is also compelling animal data that supports the concept that gastric atrophy 
may be reversible, for example in C57BL/6 mice infected with Helicobacter felis, 
gastric atrophy could be reversed up until the 12
th
 month of life, with animals 
treated beyond that stage having delayed pathological progression, but no 
resolution of atrophy (80). 
1.2.3.2.3 Metaplasia 
A proportion of patients with gastric atrophy develop intestinal type metaplasia of 
the gastric mucosa over time. This histopathological lesion is typified by the 
replacement of oxyntic glands with glands that are morphologically similar to the 
intestinal crypt. Metaplasia can be classified either as type I, where the tissue 
architecture is similar to that of a normal small intestinal crypt, type II, an 
intermediate phenotype, or type III, characterised by tortuous crypts and a loss of 
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cellular differentiation. In type III intestinal metaplasia Paneth cells become harder 
to define and columnar cells predominate over goblet cells. An alternative 
classification of metaplasia classifies it according to relative similarity to small 
intestinal or colonic mucosa. Immunohistochemical staining of metaplastic glands of 
the gastric mucosa demonstrate the expression of several usually intestine specific 
markers, including Villin, MUC2 and LI-Cadherin. Different patterns of intestinal 
metaplasia confer different degrees of risk of carcinogenesis. Type III is considered 
to have greater transformational potential than type II, which in turn is more likely 
to transform than type I.  
The molecular mechanisms that regulate intestinal metaplasia of the stomach are 
beginning to be dissected. Recently published data link the homeobox transcription 
factor CDX2 to intestinal metaplasia. CDX2 is essential for intestinal differentiation 
and has been shown to interact with bone morphogenetic proteins, members of the 
TGF-β growth factor family that are involved in several cellular functions, including 
organogenesis. In adult mice, CDX2 is expressed only in intestinal epithelial cells. 
CDX2 null mice are non-viable. Mice hemizygous for CDX2 are viable but develop 
spontaneous colonic and small intestinal adenomas over the first 6 months of life. 
Adenomas in these animals do not express CDX2, suggesting a role for this 
transcription factor in the maintenance of normal intestinal structure in these 
animals (127). In mice that express CDX2 under the control of the Foxa3 promoter 
sequence, CDX2 is constitutively expressed in the gastric mucosa. These animals 
develop spontaneous intestinal metaplasia of the gastric mucosa, demonstrating 
the importance of this transcription factor in the onset of this condition (128). More 
recently it has also been shown that the activation of CDX2 in the gastric mucosa is 
a self-perpetuating event. CDX2 binds to its own promoter site in the context of 
intestinal metaplasia and further up regulates its own activity (129). 
Helicobacter pylori is rarely found in direct association with intestinal metaplasia, 
presumably because the environmental niche that Helicobacter usually occupies has 
already been disrupted by the establishment of gastric atrophy. Consistent with this 
finding, meta-analyses of the effect of Helicobacter pylori eradication on patients 
with established intestinal metaplasia have failed to show a trend towards 
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resolution of the condition (odds ratio 0.891 CI 0.663-1.253)(130). Interestingly a 
recent report has suggested that short term Cox-2 inhibition with celecoxib may 
offer a treatment that can induce regression of intestinal metaplasia in patients that 
had received Helicobacter pylori eradication several years previously (131). This 
study investigated 33 patients all of whom were being followed up 3 years after 
eradication of Helicobacter, and all of whom had histologically proven intestinal 
metaplasia. An 8 week course of celecoxib was administered to all patients with 8 of 
33 patients having complete regression of their intestinal metaplasia. Clearly this is 
a pilot study that only shows resolution of the morphological changes of intestinal 
metaplasia, but represents a potentially important therapy if the morphological 
changes persist and are accompanied by a reduction in cancer risk.  
1.2.3.2.4 Dysplasia and cancer 
A recent study of pre-malignant gastric lesions in an asymptomatic population has 
reported 7.1% of the population as having intestinal metaplasia, with approximately 
20% of those individuals having concurrent dysplastic changes in the gastric mucosa 
(132). The importance of this lesion is demonstrated by the significantly increased 
risk of gastric cancer that it confers. A population based study in a high risk 
population has reported a relative risk of gastric cancer of 104.2, with wide 95% 
confidence intervals of 9.7–999 in patients with moderate or severe dysplasia (133). 
More recent studies of risk of gastric cancer and dysplasia have focussed on the 
potential for sampling error. This is particularly relevant in the context of 
endoscopic therapy for low grade dysplastic lesions of the stomach. A recent report 
(134) of histological findings following endoscopic resection of lesions biopsied and 
thought to represent only low grade dysplasia demonstrated that 4% of 236 lesions 
contained invasive carcinoma, while a further 30.1% contained foci of high grade 
dysplasia. 
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1.2.4 Risk factors for gastric cancer development 
 
The development of gastric cancer is just one of several potential outcomes of 
chronic gastric colonisation with Helicobacter pylori. Several environmental, host 
and bacteriological factors alter the risk of progressing along the Correa sequence 
rather than developing benign gastric pathology or clearing the initial Helicobacter 
infection. Figure 1-6 summarises these risks graphically. 
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1.2.4.1 Bacterial virulence factors 
One of the hypotheses that attempts to explain the difference in gastric 
adenocarcinoma incidence between populations worldwide is that individual strains 
of Helicobacter pylori have different degrees of pathogenicity. In support of this 
hypothesis, a number of differences have been demonstrated between strains of 
Helicobacter pylori cultured from different populations. Amongst the most 
significant differences is the presence or absence of the Cag pathogenicity island, a 
group of genes that allows intra-cytosolic injection of bacterial components into 
epithelial cells. This group of genes is present in 60% of H. pylori strains isolated in 
Western populations, but is almost universal in strains isolated from the Far East 
(135). Similarly, there is heterogeneity in the sequence of the ubiquitously 
expressed VacA cytotoxin (136), and the adhesion molecules SabA (137) and BabA 
(138, 139) that alter the interaction of Helicobacter pylori with gastric mucosa. Each 
of these bacterial virulence factors has the potential to generically increase the 
pathogenicity of Helicobacter pylori infection, increasing the risk of developing both 
benign and malignant disease. More recently, DupA has become the first 
Helicobacter pylori virulence factor recognised to potentially influence the type of 
pathology induced by chronic Helicobacter pylori infection (140). 
1.2.4.1.1 The cag pathogenicity island 
The cag pathogenicity island is a group of 31 genes, most of which encode a type IV 
bacterial secretion system. This construct acts to facilitate the transfer of bacterial 
proteins directly into a host eukaryotic cell, allowing transfer of the Helicobacter 
protein CagA, which is also encoded within the Cag pathogenicity island (cagPAI), 
and peptidoglycan, into the cell. Meta-analysis of the effect of CagA seropositivity 
on risk of gastric cancer (clinically used as a surrogate for infection with a CagA and 
cagPAI positive strain of H. pylori) demonstrated a relative risk of 1.64 (95% CI 1.21 
– 2.24) over infection with CagA negative strains (141).  
CagA binds to and activates SHP-2, CSK and CRK, all of which have Src-homology 
domains. These interactions have a number of cellular effects including RAS MAPK 
pathway and NF-κB classical pathway activation as well as stabilisation of β-catenin, 
interruption of tight junctions and cytoskeletal remodelling. In-vitro, this can be 
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observed by the addition of CagA to AGS gastric cell line culture, which results in cell 
scattering and a change in cellular morphology (142, 143). In-vivo, transgenic 
expression of CagA results in spontaneous gastric hyperplasia and carcinogenesis 
(144). Epidemiological studies suggest that, in Western populations, there is a 
positive correlation between atrophic gastritis and gastric adenocarcinoma and 
CagA positive strains of Helicobacter pylori (145-147). Similar data do not exist for 
Asian populations due to the almost ubiquitous nature of CagA positivity. 
CagA also has a number of different isoforms which are differentially distributed 
geographically. The CagA molecule has a variable region in its C-terminal portion 
that is made up of several EPIYA (glutamic acid-proline-isoleucine-tyrosine-alanine)) 
motifs. The sequence surrounding the EPIYA motif defines each segment as either 
EPIYA-A, -B, -C or-D. EPIYA A and B motifs are universally expressed in Western 
isolates of CagA positive H. pylori. EPIYA-C is expressed in 1, 2 or 3 repeats in 
Western isolates of CagA, and confers increasing pathogenicity with increasing 
numbers of motifs (148). EPIYA –D is present only in isolates from the Far East.  
EPIYA–D containing isoforms of CagA have greater Shp2 binding activity than 
others. When mice expressing Western and East Asian CagA subtypes are 
compared, greater susceptibility to carcinogenesis is observed in the mice 
expressing the East Asian variant (149).  
1.2.4.1.2 VacA 
VacA is a ubiquitously expressed cytotoxin, but it demonstrates genetic 
heterogeneity with a differential global distribution. There are two regions of 
heterogeneity within the VacA gene; one in the signalling domain, giving genotypes 
s1 and s2, the other in the midpoint of the gene, giving genotypes m1 and m2 (150). 
Genotype s1 has a strong association with both benign and malignant gastric 
disease. In a Western population, the relative risk for gastric cancer associated with 
this allele is 8.28 (95% CI 2.75–24.95) (136). In East Asian Helicobacter strains, this 
genotype is almost ubiquitous, and there are no data available on any association 
with different pathology in such populations.   
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1.2.4.1.3 DupA 
DupA is a homolog of the type IV secretory system protein vir. In a study examining 
samples from a total of 5008 patients, it was found to be expressed in 25.1% of 
cases, and its expression was positively correlated with increased risk of peptic ulcer 
disease. DupA positivity conferred a 3.1 (95% CI 1.7-5.7) fold relative risk of 
duodenal ulcer, but its presence was negatively correlated with gastric cancer risk, 
conferring a relative risk of 0.42 (95% CI 0.2-0.9) in this study (140). 
1.2.4.1.4 Other bacterial virulence factors 
In addition to cag PAI and VacA, there are other proposed virulence factors that act 
on bacterial adherence to epithelial cells, including BabA (138), a blood group 
antigen binding adhesin, which has a reported polymorphism described as BabA2. 
In a Chinese population, infection with a BabA2 positive organism conferred relative 
risks of 7.5 (95% CI: 2.3-24.3) and 7.4 (95% CI: 2.2-25.3) for developing gastric 
atrophy and gastric metaplasia when compared with BaBA2 negative infections 
(139). The sialic acid binding adhesion SabA is also considered to be a putative 
virulence factor for Helicobacter pylori as it has a role in bacterial adhesion, and 
there is genetic heterogeneity of the gene encoding it that is distributed in a similar 
geographical pattern to gastric cancer cases, however the effect of these 
polymorphisms on cancer or other pathological risk has yet to be demonstrated 
(137, 151).  
1.2.4.2 Environmental risk factors 
Environmental risk factors for gastric cancer include both alterations in an 
individual’s gastric environment and risk factors which affect the gastric mucosa less 
directly. Risk factors may also be separated into those influenced by an individual’s 
behaviour, and those that are a consequence of preexisting pathology. The most 
important environmental factors that are determined by the individual are tobacco 
use and diet, whilst both bacterial and viral infections may also serve to alter the 
gastric environment and increase the risk of carcinogenesis. 
A recent meta-analysis of the effect of cigarette smoking on gastric cancer 
demonstrated a relative risk of 1.48 (95% CI 1.28-1.71) for those that have ever 
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smoked, in comparison to non-smokers. In the current smoking population, the 
observed risk is higher, estimated at 1.57 (95% CI 1.24-2.01) (152). 
High dietary salt consumption is also associated with an increased risk of developing 
gastric cancer. Of 42 case control studies examining the association between gastric 
cancer and salt intake, 31 have found a positive correlation. The other studies found 
no correlation. There have also been 11 cohort studies which investigated the use 
of table salt and salty foods. Again these support the hypothesis that high salt 
consumption is associated with an increased rate of gastric cancer, and report 
relative risks ranging from 2.3 (95% CI 1.5-3.4) to 5.4 (95% CI 1.8-16.3). A dose 
dependent increase in risk has also been reported in some studies (153). 
Animal studies have also confirmed an association between gastric cancer and salt 
intake. The incidence and size of gastric tumours in rats treated with the chemical 
carcinogen MNNG was increased if the animals were subsequently fed a high salt 
diet (32). Similarly, there was an increase in the incidence of gastric pathology in 
C57BL/6 mice that were infected with Helicobacter pylori and subsequently fed a 
high salt diet in comparison to their low salt counterparts (92, 154). 
Other dietary factors have also been considered as potential risk factors for 
developing gastric cancer. N-Nitrosamines are nitrogenous compounds found in red 
meat, as well as processed meat and fish. Between 45 and 75% of the total 
exposure of an individual is generated through acid catalysed thionitrosation of 
dietary haem iron. The European Prospective Investigation into Cancer and 
Nutrition (EPIC-EURGAST study) found that there was a positive correlation 
between endogenously produced nitrosamines and gastric cancer (relative risk 1.42, 
95% CI 1.14-1.78) (155). Conversely, there is now evidence for a protective effect 
conferred by consumption of certain vegetables. Animal and human studies have 
shown that sulforophanes, compounds found in broccoli shoots, are able to 
interrupt the interaction of Helicobacter with gastric mucosa. In the mouse, this has 
also been shown to be associated with a reduction in gastric mucosal pathology 
(156). However the EPIC-EURGAST study, which also looked at vegetable intake, 
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failed to show a link between dietary vegetable intake and intestinal type gastric 
cancer (157). 
1.2.4.3 Intrinsic risk factors for developing gastric cancer 
The gastric mucosa is constantly renewed from tissue resident stem cells with 
relatively high basal proliferation rates and equal rates of programmed cell death. 
There are hence significant opportunities for acquisition and perpetuation of 
mutations, enhancing the intrinsic risk of carcinogenesis. An increasing number of 
host genetic factors are now recognised to influence an individual’s risk of 
developing gastric cancer. Best characterised amongst these are polymorphisms in 
immunomodulatory genes that have been shown to confer altered susceptibility to 
gastric cancer in various populations.  
1.2.4.3.1 IL1 family 
Polymorphisms in the promoter regions of IL-1B and the IL-1 receptor were the first 
recognised to confer an increased risk of any form of carcinogenesis (158, 159). 
Three diallelic single nucleotide polymorphisms are recognised in the IL1B promoter 
and gene. IL1B-511T, where wild-type C is replaced with T at position -511 in the 
promoter, IL1B -31C, where the wild-type T is replaced with C, also in the promoter 
sequence, and IL1B +3954T, a C-T transition 3954 base pairs from the 
transcriptional start site of the gene. All three of these polymorphisms were 
recognised in the original case control study, and have been examined in several 
subsequent studies that have recently been subjected to meta-analysis.  
Both promoter polymorphisms were first shown to confer an enhanced risk of 
gastric carcinogenesis in case control studies of Scottish and Polish populations. 
IL1B-511T conferred a homozygote relative risk in these populations of 2.6 (95%CI 
1.7-3.9) and a heterozygote risk of 1.8 (95% CI 1.3-2.4), whilst homozygous and 
heterozygous IL1B-31C conferred relative risks of 2.5 (95% CI 1.6-3.8) and 1.8 (95% 
CI 1.3-2.4) respectively.  
The IL1B+3954T polymorphism tended to protect against gastric carcinogenesis in 
Scottish and Polish populations, with homozygosity conferring a relative risk of 
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carcinogenesis of 0.6, however this risk reduction did not meet statistical 
significance in this population. 
Subsequent studies have examined these polymorphisms in several different 
populations, and have recently been collated into a meta-analysis (160). This meta-
analysis considered data from 40 studies that have investigated the IL1B-511T 
polymorphism, 32 studies that have looked at the IL1B-31C polymorphism and 17 
studies that have investigated the IL1B+3954 polymorphism. These studies have 
examined both Caucasian populations, as in the original report, and a number of 
high risk Asian populations. The full data collated from these studies do not support 
the generalised attribution of additional risk of gastric cancer due to the IL1B-511T 
polymorphism, however when subdivided to investigate histological types of gastric 
cancer a dichotomy between studies performed in Asian and non-Asian populations 
is revealed. In Asian populations the IL1B-511T polymorphism is associated with a 
significant reduction in relative risk of intestinal type gastric cancer (combined OR 
0.69 for homozygotes and 0.78 for heterozygotes), whilst in non-Asian populations 
the relative risk is elevated (combined OR 1.49 for homozygotes, 1.42 for carriers).  
The effect of the IL1B-31C polymorphism is similarly divergent between 
populations, with no significant overall alteration in gastric cancer risk, but with a 
significant reduction in cancer risk in studies of Asian populations (OR 0.82 for C/C 
homozygotes and 0.86 for C/T heterozygotes). In non-Asian populations this 
polymorphism had no statistically significant effect on cancer risk. Meta-analysis of 
data from studies that investigated the IL1B+3954T polymorphism has failed to 
show a pattern of homozygous polymorphism having little or no effect on cancer 
risk, but of heterozygote polymorphism conferring an increased risk of gastric 
cancer (OR=1.26). 
These findings demonstrate the complexity of genetic influence on gastric 
carcinogenesis. It remains unclear what factors interact to generate such divergent 
effects of the same polymorphism in different populations, but hypothetically this 
could either be a haplotype effect, or interaction with any of the other defined 
gastric cancer risk factors that segregate between Asian and non-Asian populations. 
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Overall these observations demonstrate the complexity of polymorphisms 
associated with cancer risk. It is perhaps unsurprising that polymorphisms that 
confer an alteration in one population have a different effect in another in a disease 
where there is great heterogeneity between populations in disease incidence. It 
seems probable that there are biological, rather than methodological effects that 
account for the differences observed between populations. These effects may 
either be attributable to the interaction with other risk factors that segregate 
between populations (e.g. Helicobacter pylori virulence factors), or due to a 
haplotype effect. It is plausible that Asian populations that have the described 
polymorphism share a haplotype that is different to that seen in non-Asian 
populations with the same polymorphism, the integration of a defined SNP within 
an as yet undefined haplotype context may be essential for alteration of cancer risk. 
More consistent are the findings associated with polymorphisms in the gene 
encoding the IL-1 receptor IL1RN. This gene has a penta-allelic polymorphism of an 
86 base pair tandem repeat within the second intron of the gene. Allele 2 (IL1RN*2) 
of this polymorphism is associated with an enhanced chronic inflammatory 
phenotype and in the same original study as defined IL1B polymorphisms in 
association with gastric cancer was shown to confer a statistically significantly 
elevated relative risk of 3.7(95%CI 2.4-5.7) in homozygous form, compared to 
IL1RN*1 homozygosity. Meta-analysis of 39 subsequent studies has confirmed 
increased risk of gastric cancer associated with this allele in both Asian and non-
Asian populations (160). 
Whilst the epidemiological data relating to polymorphisms of the interleukin 1 
family demonstrate a complex relationship between host and environment that 
subtly modulates cancer risk, animal studies of IL1 are more dramatic. When human 
IL1B was highly expressed under the control of the H
+
/K
+
 ATPase β subunit 
promoter, 15% of male mice developed spontaneous tumours at 14 months of age. 
In addition when these animals were infected with Helicobacter felis, disease 
severity was markedly increased in the IL1B overexpressing group (161). 
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1.2.4.3.2 TNF-α 
Another key inflammatory mediator in which promoter sequence polymorphisms 
have been associated with gastric carcinogenesis is TNF-α. Two polymorphisms 
have been studied, TNFA-238A and TNFA-308A. Meta-analysis of 9 studies 
examining risk associated with TNFA-238A failed to demonstrate a significant 
difference in cancer risk when all data were compiled, whilst carrier status for 
TNFA-308A conferred an increased risk of distal gastric cancer in non-Asian 
populations (160). 
1.2.4.3.3 IL-10 
Three polymorphisms of the promoter sequence of IL10 are recognised: IL10-
1082G, IL10-819T and IL10-592A. IL10-819T has been studied in 2 Asian and 3 non-
Asian populations. Overall no significant effect on cancer risk can be attributed to 
this polymorphism, or to IL10-592A following 3 studies in Asian populations and 5 in 
non-Asian populations. IL10-1082G has however been shown to confer differential 
risks in Asian (OR of gastric carcinogenesis 1.57) and non-Asian (OR 0.80) 
populations (160). 
1.2.4.3.4 Toll Like Receptors 
The Toll like receptors are highly conserved pattern recognition molecules that are 
expressed by both immune and epithelial cells, they are specialised to detect 
specific antigenic moieties. The two Toll like receptors (TLR) in which 
polymorphisms that influence risk of gastric pathology have been demonstrated are 
TLR4 and TLR9. TLR4 recognises lipopolysaccharide, and is expressed on the surface 
of both epithelial and immune cells (162), whilst TLR9 is predominantly expressed in 
immune cells, specifically B cells, dendritic cells and monocytes. In these cell types it 
is localised to the endosomal surface, and detects unmethylated CpG nucleotide 
from endocytosed bacteria (162).  
Case control studies have shown that the TLR4-896A>G polymorphism is associated 
with both an increased risk of gastric cancer (OR = 2.3; 95% CI = 1.6-3.4) and 
increased risk of achlorhydria and gastric atrophy in a Caucasian population (163). 
The TLR9-1237T/C polymorphism has been the focus of significant interest, because 
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it is predicted in-silico to insert an additional NF-κB binding site into the TLR9 
promoter (164). This polymorphism has been investigated by case control studies in 
several Caucasian populations, including Polish, American (165) and Scottish 
populations. The studies in Polish and American populations failed to demonstrate a 
link between this polymorphism and gastric cancer, however in the Scottish 
population first degree relatives of patients with gastric cancer were studied and 
assessed for achlorhydria and gastric atrophy on endoscopic biopsy. In this study a 
3.9 (95% CI 1.7-8.6) fold increased risk of gastric atrophy was observed in patients 
that are heterozygous at this locus compared to those that are homozygous for the 
T allele (164).  
1.2.4.3.5 Matrix metalloproteinases 
There are now a number of reports of differential risk of gastric cancer in individuals 
with polymorphisms in the promoter regions of both MMP7 and MMP9. These 
enzymes have critical roles in extra cellular matrix remodelling, and MMP9 has been 
implicated in gastric cancer cell invasion assays in-vitro (166). MMP7-181AG and 
MMP7-181GG both confer an increased relative risk of gastric cancer with a 
combined odds ratio of 1.9 (95% CI 1.43-2.51), whilst polymorphisms in the MMP9 
promoter are linked with a 3.4 (95% CI 1.29-9.17) fold increased risk of lymph node 
metastasis (167). 
1.2.5  Animal models of gastric carcinogenesis 
Several different species have been used to establish animal models of gastric 
carcinogenesis. As with all non-human models of human disease each model system 
has both advantages and compromises. Initial methods of inducing gastric cancer 
used direct chemical carcinogens, but more sophisticated models utilising infection 
with Helicobacter species and transgenic mice have more recently been established. 
1.2.5.1 Chemical carcinogen induced cancer models. 
The first reliable model of chemical induced gastric carcinogenesis was reported in 
male Wistar rats in 1967 (168). N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) was 
administered to 13 animals continuously in drinking water over a period of up to 1 
year. Of the 13 rats investigated, 9 developed gastric adenocarcinomas, with 4 
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showing serosal invasion. The other animals also had evidence of changes in the 
gastric mucosa, described as “early epithelial growth”, but it is not clear from the 
reported data whether these changes were similar to the metaplastic changes seen 
in association with human cancers (168). 
Similar models using N-nitroso compounds to induce gastric cancer have been 
established in Mongolian gerbils (Meriones unguiculatus), and a number of different 
strains of laboratory mice. In Mongolian gerbils, both MNNG and N methyl-N-
nitrosourea (MNU) have been shown to induce gastric adenocarcinomas over the 
course of 1 year. In one study, MNU induced gastric adenocarcinomas in 2 of 12 
gerbils, whilst MNNG induced tumours in 7 of 11 gerbils over the same time scale, 
and no control animals developed tumours (169). BALB/c mice were the first murine 
strain to be reported as susceptible to MNU induced gastric carcinogenesis. These 
animals were administered MNU by weekly oral gavage on ten occasions, starting at 
a post natal age of 6 weeks. By 20 weeks after birth 2 of 19 mice developed gastric 
adenocarcinomas, by 30 weeks this had risen to 12 of 14 mice and at 40 weeks all 
13 mice had developed gastric tumours (170). Another study looked at the effect of 
administering MNU in the drinking water of BALB/c mice. The authors 
demonstrated that at high concentration (240ppm), MNU in drinking water induced 
tumours in 17 of 22 mice after 12 months, and at an MNU dose of 120ppm, 10 of 28 
mice developed tumours (171).  
C3H mice, another inbred strain, have also been shown to be susceptible to MNU 
induced gastric carcinogenesis. In mice administered 120ppm MNU, 12.5% of mice 
developed an adenocarcinoma by 30 weeks, rising to ≥40% at 42 and 54 weeks 
(172). C57BL/6 mice have also been subjected to MNU in drinking water, but using a 
different protocol: mice were given 200ppm MNU in drinking water over a ten week 
period, followed by normal drinking water ad libitum, before being culled at 52 
weeks. 7/15 mice developed gastric adenocarcinomas over the course of this 
experiment (173). Because of the heterogeneity of experimental protocols 
published for induction of gastric cancer in mouse models, a further study 
compared several strains of mice treated with one experimental procedure 
(administration of 120ppm MNU in drinking water to 7 week old male mice for 18 
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weeks, before culling at 52 weeks). This study demonstrated BALB/c mice to be 
more susceptible than other strains to MNU induced carcinogenesis, with 59.6% of 
mice developing tumours. C57BL/6 mice developed tumours in 30% of mice as did 
CBA and C3H mice. DBA/2 and outbred ICR mice developed tumours in only 20% of 
animals (174). 
1.2.5.2 Models of Helicobacter induced gastric cancer 
There are at least 15 Helicobacter species that naturally colonise the gastric mucosa 
of a variety of mammals (see Table 1-4), however only H. pylori in man, H. mustalae 
in ferrets and H. aurati in the Syrian hamster have been shown to cause malignant 
gastric pathology in nature. Therefore to establish experimental models, it has been 
necessary to investigate alternative strategies for inducing pathology in common 
laboratory animals. 
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An ideal model of gastric carcinogenesis would utilise H. pylori as the pathogenic 
organism and would induce a similar spectrum of disease to that seen in man over 
an accelerated time course. H. pylori is able to colonise the gastric mucosa of both 
Mongolian gerbils and mice, but its pathogenicity is variable. Following inoculation 
of 5 week old gerbils with H. pylori strain TN2GF4, animals were culled at 62 weeks, 
by which time 10 of 27 animals developed adenocarcinoma of the stomach (176). 
Another study utilising H. pylori ATCC-43504 showed that 2/5 animals developed 
adenocarcinomas 18 months after infection, however it was also noted that all mice 
Table 1-4: Naturally occurring Helicobacter sp. Infections and their hosts. 
Helicobacter species Natural host  Natural host cancers  
H. suis Pig, macaque, mandrill monkey   
H. felis Dog, cat, rabbit, cheetah, mouse  
H. bizzozeronii Dog, cat  
H. salomonis Dog, cat, rabbit  
"Candidatus 
Helicobacter 
heilmannii" 
Dog, cat, wild felidae, nonhuman 
primates 
 
H. baculiformis Cat   
H. cynogastricus Dog   
"Candidatus 
Helicobacter bovis" 
Cattle   
H. mustelae Ferret  Gastric 
adenocarcinoma and 
gastric MALT 
lymphoma 
H. aurati Syrian hamster  Gastric 
adenocarcinoma 
H. nemestrinae
a
 Macaque   
H. acinonychis Cheetah, tiger   
H. cetorum Whales, dolphins   
H. muridarum Mice   
H. pylori Man Gastric 
adenocarcinoma and 
gastric MALT 
lymphoma 
Data from Haesebrouck F et al, Clinical Microbiology Reviews 2009 (175) 
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in this group had developed dysplasia of the gastric mucosa over the same 
timescale (177). In contrast, Elfvin et al failed to demonstrate adenocarcinoma 
development in groups of five male Mongolian gerbils infected for 18 months with 
either TN2GF4 or SS1 strains of H. pylori (178). Independently, Sun et al infected 
Mongolian gerbils with H. pylori ATCC 43504 for periods of up to 94 weeks, and 
whilst intestinal metaplasia was observed, this was a relatively rare event, with only 
2 out of 22 animals demonstrating this pathology and none developing gastric 
adenocarcinomas (179). The heterogeneity of the results from these four studies 
demonstrate that whilst Mongolian gerbils infected with Helicobacter pylori may be 
an interesting model for studying gastric carcinogenesis, the observed pathology is 
not reliably reproducible. There are several factors that may influence the reliability 
of this model, including the outbred nature of Mongolian gerbils, strain specific 
features of Helicobacter and the differences in commensal microbiota between 
laboratories. Overall these conspire to make this model system difficult to establish 
in an experimental laboratory. 
Wild-type mice infected with the Sydney strain of Helicobacter pylori develop 
gastritis and, over the course of 8 months, gastric body atrophy. This occurs in 
C57BL/6 and BALB/c mice, but does not progress to gastric cancer (180). An 
alternative Helicobacter strain, H. felis, has been shown to induce gastric cancer in 
the C57BL/6 mouse when infected for up to 15 months (181). It has been reported 
that more severe pathology is observed in female than male mice in this model. 
Intestinal metaplasia was not observed in either sex, but gastric atrophy was 
established by 8 weeks post infection in females, and was not observed until 52 
weeks in males (182). This contrasts with human disease in which males are more 
susceptible, and it should also be noted that the severity of pathology induced in 
both male and female mice in this study was less than observed in some reports of 
this model in other institutions. 
1.2.5.3 Spontaneous gastric cancer 
A number of transgenic mice have been produced that develop spontaneous 
tumours. Best characterised amongst these is the INS-Gas mouse. This mouse 
expresses a human gastrin minigene under the control of the insulin promoter. It 
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constitutively expresses gastrin in β-cells of the pancreatic islets. As these cells are 
of neuroendocrine origin, they are able to process preprogastrin fully, resulting in 
an animal that constitutively overexpresses amidated gastrin. These animals are 
born with increased numbers of parietal cells and at birth hypersecrete acid, but 
over the first 5 months of life the number of parietal cells falls to equal the number 
seen in wild-type animals. Over longer periods, profound gastric atrophy occurs, 
without administration of an extrinsic carcinogen, or infection with Helicobacter 
and a small proportion of these animals (reported as 13%) develop spontaneous 
gastric cancers (93). The pathology observed in this mouse is accelerated by 
Helicobacter infection. When INS-Gas mice were infected with H. felis, the rate of 
gastric cancers rose from 13% at 7 months post infection to 85% post infection (93), 
similarly when INS-Gas mice are subjected to H. pylori infection, they develop 
significantly more severe inflammation and dysplasia than uninfected controls (92). 
However in this context there are also marked sex differences with males being 
more severely affected than female mice. 
In addition to the INS-Gas mouse, other less well characterised transgenic mice 
have been shown to develop spontaneous gastric cancers. The CEA/SV40 T L5496 
mouse expresses the SV40 T proto-oncogene under the control of a truncated CEA 
promoter. These mice were developed in an attempt to study the CEA promoter, 
from a panel of transgenic animals with different CEA promoter constructs. This one 
is found to cause gastric tumours in all mice, with dysplasia being evident as early as 
37 days postnatal and mice becoming moribund by 100 -130 days postnatal (183).  
Mice transgenically deficient for mutT homolog-1 (MTH1) are unable to process 
oxygen free radicals that are implicated in DNA damage. These animals are 
susceptible to a number of spontaneous tumours including gastric tumours which 
develop over approximately 18 months. 13 of 93 MTH1 null mice developed gastric 
tumours, compared with 4 of 90 littermate controls (184).  
Trefoil factor 1 deficient mice show marked alterations in the structure of both 
antral and corpus mucosa from birth. By five months of age all mice have 
adenomatous changes in the gastric mucosa, with 30% having established 
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adenocarcinomas (185). Other transgenic animals that demonstrate spontaneous 
gastric cancer include the IL-1β overexpressing mouse described in section 1.2.4.3.1 
above and the gp130
757F/F 
mouse. In this model the IL6 co-receptor gp130 is 
mutated such that IL-6 mediated activation of SHP2 and subsequent ERK 
phosphorylation are impaired, but STAT3 responses are retained. In this context 
gastric antral adenomas spontaneously develop over the first 6-8 weeks of life and 
subsequently grow and spread to include the gastric fundus by 48 weeks of age 
(186, 187). This may have relevance to Helicobacter pylori mediated disease as the 
EPIYA status of CagA has been shown to influence gp130 mediated switching 
between SHP2/ERK and JAK/STAT signalling cascades in-vitro (188). 
1.2.5.4 Larger animal models of gastric cancer 
Models of gastric carcinogenesis have also been established in larger animals 
including Rhesus monkeys. Arguably this is one of the best models of human 
disease, with pathology being established over 5 years, clearly the closest duration 
to the human disease, and being in a species that is phylogenetically closer to 
humans than any other model. Studies using this model have demonstrated gastritis 
in monkeys infected with H. pylori for 5 years, and when H. pylori infection was 
coupled with MNNG administration, metaplasia developed over three years, with 
dysplastic lesions occurring after 5 years (189). Due to the size of these animals, it is 
possible to perform endoscopy during the course of an experiment, and hence 
observe the progression of pathology in an individual, but the extreme cost and 
specialist skills required for animal husbandry make this model unsuitable for 
general usage.  
Other large animal models of Helicobacter including dogs (190), cats (191) and 
gnotobiotic (192) or conventionally housed (193) piglets infected with Helicobacter 
pylori have been found to be of some use in studying chronic gastritis, but have not 
been shown to develop gastric adenocarcinomas. 
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1.3 Nuclear Factor κB 
Members of the Nuclear Factor κB (NF-κB) family were first described as 
transcription factors in B lymphocytes in 1986 (194). Since then, these proteins have 
been shown to be widely expressed, and conserved across both vertebrates and 
invertebrates (195, 196).  
Transcription is mediated by the binding of dimers of NF-κB proteins to specific 
promoter sequences. Signalling is controlled by a combination of sequestration of 
NF-κB proteins in the cytoplasm where they are unable to influence transcription, 
and competitive occupation of DNA binding sites by transcriptionally inactive 
dimers. 
The conventional model of NF-κB signalling proposes two main arms of the pathway 
which share some similar features, but which are triggered independently and 
activate different target genes (197). Classical pathway NF-κB signalling is triggered 
by Th1 cytokines and is typified by the action of p65:NF-κB1 heterodimers, whilst 
alternative pathway signalling is triggered by ligand binding to BAFF and CD40, and 
is signalled through the adaptor protein NIK. The best characterised dimers of the 
alternative pathway consist of RelB:NF-κB2 heterodimers. 
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Figure 1-7: Schematic drawings of A: classical, and B: alternative, pathway NF-κB signalling 
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Both NF-κB pathways are associated with multiple downstream effectors. Signalling 
through either pathway can hence influence multiple different cellular functions 
and can have effects that at first appear contradictory. For example, both pro- and 
anti-apoptotic effects, and proliferative (198) and senescence (199) signals have 
been attributed to classical pathway NF-κB signalling. Because of the wide variation 
in outcomes of pathway activation observed, it is difficult to extrapolate the effects 
of NF-κB signalling from one context to another. 
1.3.1 Pathway activation 
Transcription is activated by dimers of NF-κB proteins. Regulation of this process is 
achieved principally through the inhibitors of κB (IκB) proteins. These proteins bind 
to cytoplasmic dimers of NF-κB proteins, inhibiting nuclear translocation and hence 
transcriptional activity. The IκB proteins have ubiquitination sites that can be 
targeted by specific E2 ligases, once they have been phosphorylated. This results in 
the targeting of these proteins for proteasomal degradation. Phosphorylation of IκB 
proteins is mediated through the inhibitor of κB kinases (IKK); the kinase activity of 
IKK proteins is closely controlled by upstream signalling events. This provides a 
mechanism by which a dimer can initially be held in the cytoplasm, and 
subsequently be released, allowing nuclear translocation (200). 
1.3.1.1 NF-κB proteins 
There are five recognised NF-κB proteins, all of which share a C-terminal Rel 
homology domain. This domain consists of a dimerisation site as well as sequence 
specific DNA binding sites and a nuclear translocation site. RelA, RelB and c-Rel also 
have N-terminal transcriptional activation sites that facilitate gene activation. NF-
κB1 and NF-κB2 have Rel homology domains, but do not have transcriptional 
activation domains (196).  
NF-κB1 is produced as a 105kDa protein (NF-κB1 p105) which has a C-terminal Rel 
homology domain and N-terminal ankyrin repeat domain. The ankyrin repeat 
domain acts as an intrinsic inhibitor of its nuclear translocation domain and hence 
functions as an inhibitor of κB protein. Before activation, the ankyrin repeat domain 
is cleaved, generating functional NF-κB1 p50. Similarly NF-κB2 is produced as a 
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100kDa precursor protein (NF-κB2 p100) with a C-terminal Rel homology domain 
and an inhibitory N-terminal ankyrin repeat domain. On activation, the ankyrin 
repeat domain is cleaved, leaving a functional 52kDa protein (NF-κB2 p52). The 
processing of NF-κB1 and NF-κB2 differs in that NF-κB1 is constitutively processed 
and the predominant intracellular form is p50, whilst NF-κB2 is only enzymatically 
cleaved from p100 to p52 under specific signalling conditions. All of the NF-κB 
proteins are able to both homo- and hetero- dimerise, and the various dimers 
generated represent the essence of different parts of the pathway (Table 1-5). 
Homodimerisation of both p50 and p52 results in the formation of dimers that lack 
a transcription activation domain. These dimers have been shown to have an 
important negative regulatory function, competing for DNA binding sites with 
transcriptionally active dimers and thereby modulating the effects of the signalling 
pathway (201). 
Table 1-5: The principal dimers responsible for NF-κB mediated signalling 
Monomer 1  Monomer 2  Role  
RelA  NF-κB1 Principal classical pathway dimer 
RelB NF-κB2 Principal alternative pathway dimer  
c-Rel  NF-κB1 Secondary classical pathway dimer  
NF-κB1 p50 NF-κB1 p50 Inhibitory dimer of the classical pathway  
NF-κB2 p52 NF-κB2 p52 Inhibitory dimer of the alternative pathway  
1.3.1.2  Inhibitors of κB  
The inhibitors of κB proteins have structurally similar N-terminal ankyrin repeat 
domains that inhibit the nuclear translocation signal of NF-κB protein dimers. They 
also have various ubiquitination domains, through which their proteasomal 
degradation is signalled. IκBα and IκBβ share a C-terminal domain rich in negatively 
charged residues which is essential for intranuclear modulation of transcriptional 
activity. The best characterised of these proteins is IκBα, which forms a cytoplasmic 
complex with RelA:p50 dimers in a resting cell. On activation by ligand binding, TNF 
receptor 1 trimerises and recruits TRADD and RIP1 into a complex at the cell 
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surface. This complex then recruits and activates the inhibitor of κB kinase complex 
(see Figure 1-7 A). 
The inhibitor of κB kinase (IKK) family consists of IKK α, β and γ. IKKα and IKKβ have 
kinase activity and can phosphorylate their targets, whilst IKKγ (also known as 
NEMO) is a scaffold protein that is essential for the kinase activity of the other 
complex members. The activated IKK complex then phosphorylates IκBα at serine 
residues 32 and 36, utilising the kinase activity of IKKβ. Phospho-IκBα is then 
ubiquitinated by an E3 ligase and targeted for proteasomal degradation. This 
releases the RelA:p50 dimer, allowing it to translocate to the nucleus, where it 
becomes transcriptionally active (197).  
The alternative pathway is also under kinetic control of the IKK complex (see Figure 
1-7 B). The principal dimer of the alternative pathway is NF-κB2 p100:RelB. This 
pathway is triggered by CD40L and BAFF at the cell surface. The IKK complex is 
activated by the adaptor protein NIK which interacts with these cell surface 
receptors. In this context, IKKα phosphorylates the N-terminus of NF-κB2 p100 
which is then ubiquitinated. This leads to only partial degradation of NF-κB2, leaving 
the active NF-κB2 p52 molecule. The NF-κB2 p52:RelB dimer then translocates to 
the nucleus, where it is transcriptionally active. Unlike classical pathway signalling, 
the alternative pathway takes several hours to activate, because NIK is highly 
unstable and must be synthesised before pathway activation can occur (197, 200). 
1.3.1.3 The downstream effectors of NF-κB signalling 
NF-κB signalling can influence the expression of multiple target genes; evidence for 
approximately 500 distinct targets have been collated by the Gilmore Laboratory at 
Boston University (202). This array of targets has diverse functions, but can be 
usefully considered in four groups (203). The first of these is the inflammatory 
mediators, including cytokines such as TNF-α (204), IL-1β (205) and IL-6 (206), 
cytokine receptors including TNF receptors (207), other mediators of inflammation 
including cell adhesion molecules like VCAM-1 (208) and pattern recognition 
proteins including TLR9 (209). The up-regulation of these genes reflects an 
important role for NF-κB signalling not only in the maintenance of the inflammatory 
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response, but also in establishing a positive feedback loop whereby NF-κB activation 
leads to further stimulation of NF-κB through production of Th1 cytokines and their 
receptors.  
To balance this pro-inflammatory phenotype, and particularly the positive 
regulation of NF-κB signalling, the second group of NF-κB targets are those that 
inhibit further NF-κB activity. Amongst these are the inhibitors of κB, and TNF-AIP3, 
which encodes a zinc finger protein which inhibits NF-κB activation (210). 
The third group of genes under the control of NF-κB mediated transcription are 
those that mediate apoptosis. These include both pro- and anti-apoptotic proteins 
including Fas (211) and Fas ligand (212), that each enhance apoptosis, and BclxL 
(213, 214), Bcl-2 (215) and the inhibitors of apoptosis c-IAP1 (216), c-IAP2 (217) and 
x-IAP(218). This reflects the complex interaction between NF-κB signalling and 
apoptosis. 
The last group of NF-κB targets to consider are genes that encode proteins that 
influence cell cycle progression, including cyclins (219) and cyclin dependent kinases 
(220, 221) both of which promote cell cycle progression. In addition to these the 
cyclin dependent kinase inhibitor p21
waf1 
(208), which mediates p53 cell cycle arrest 
signals, and p53 are also under transcriptional control of NF-κB and inhibit cell cycle 
progression. 
This diverse range of potential targets requires a high degree of specificity in NF-κB 
signalling. The classical and alternative pathways as described above do not fully 
delineate the nuanced control of transcription along these pathways. At all stages of 
signal transduction, further specificity is achieved through a variety of mechanisms 
(203). Different stimuli activate a spectrum of upstream activators, the balance of 
which determines the specific IKK proteins to be activated. In turn, the balance of 
IKK activation affects the stoichiometry of activated NF-κB dimers. Post 
transcriptional modifications of the NF-κB proteins also affect the affinity of these 
dimers for DNA binding sites. Several acetylation and phosphorylation sites are 
known for each of the NF-κB proteins, processing of which can either enhance or 
suppress DNA binding. DNA binding may also be affected by the modification of 
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histone proteins (203). These modifications can vary the availability of specific NF-
κB binding sites, thereby impacting which specific promoters are targeted. The 
efficiency of transcriptional activation may also be affected. This can be achieved 
through the recruitment of co-factors into the NF-κB complex, for example the IκB 
protein Bcl-3. This protein is classified upon structural criteria as an inhibitor 
1protein, but it acts as a transcriptional enhancer in the context NF-κB dimers 
containing NF-κB1 or NF-κB2 (222). Finally, other promoter bound transcription 
factors may interact with NF-κB dimers impacting the effect on transcription (203).  
1.3.2 Pathophysiological insights from mouse models of NF-κB 
Table 1-6: and Table 1-7 summarise the published data from mouse models of 
abrogated NF-κB signalling. The studied mice include animals with each of the NF-κB 
family members constitutively deleted, with each of the principal IKK proteins 
deleted from the germline and a variety of mice with tissue specific abrogation of 
one of the IKK proteins. In addition to animals with abrogated NF-κB signalling, mice 
with deletion of the C-terminal fragment of p105 and p100 have been generated. 
These animals have constitutively processed, and hence active, p50 and p52 
respectively.  
The constitutive abrogation of IKK proteins provided some insight into the function 
of these proteins during embryogenesis, but due to the devastating nature of their 
phenotypes, they have limitations as models of disease in which to investigate 
pathway dysregulation. To counter this, mice with floxed ikka, ikkb and ikkg have 
been generated. These animals have been crossed with animals expressing Cre 
recombinase under the control of tissue-specific promoters, enabling the study of 
tissue-specific deletion of these proteins. 
Collectively, these models have demonstrated the importance of NF-κB signalling in 
several areas, including immune system homeostasis and epithelial development. 
There is evidence for an important role for classical pathway NF-κB signalling in 
hepatic embryogenesis, as evidenced by a number of models that result in 
embryonic death due to hepatocellular apoptosis (223-226). There is also 
accumulating evidence demonstrating the importance of NF-κB signalling in 
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epithelial homeostasis (227-229). The combination of epithelial and inflammatory 
phenotypes seen in these animals forces consideration of the effect of NF-κB 
signalling on inflammation related cancer models. Classical pathway NF-κB signalling 
has been shown to influence outcomes in a number of models of inflammation 
associated cancer (74-76, 230) but the same models have yet to be used in mice 
with abrogated alternative pathway signalling. 
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Table 1-6: Table of mice with abrogated NF-κB signalling 
Mice with abrogated inhibitor of κB complex function 
Gene Promoter Tissue Specificity Phenotype Refs 
Ikk-α N/A Constitutive Dies at birth, limb malformation, thickened skin (231-233) 
Ikk-β N/A Constitutive Dies embryonic day 13: hepatic apoptosis (223) 
Ikk-γ N/A Constitutive Dies embryonic day 10-11: hepatic apoptosis 
Heterozygote females model incontinentia pigmenti 
(225, 234) 
Ikk-α Keratin-14 Keratinocyte Impaired epidermal development and lipid processing, abnormal tight junction function (228) 
Ikk-β Keratin-5 Keratinocyte Skin hyperplasia and dysplasia, leading to squamous cell carcinoma by 15 weeks  (230) 
Ikk-γ Keratin-14 Keratinocyte Incontinentia pigmenti like epidermal inflammation (235) 
Ikk-α Alfp Hepatocyte Resistant to LPS induced hepatocyte apoptosis (224) 
Ikk-β Alfp Hepatocyte Resistant to LPS induced hepatocyte apoptosis 
Reduction in number of tumours in model of hepatocellular carcinoma 
(76, 224) 
Ikk-γ Alfp Hepatocyte LPS induced hepatocyte apoptosis and liver failure (224) 
Ikk-α and 
Ikk-β 
Alfp Hepatocyte LPS induced hepatocyte apoptosis and liver failure (224) 
Ikk-β Cd19 B-cells Absence of mature B-cells in adult mice; backed up by Kaisho’s chimera work in Ikk-α (236) 
Ikk-γ Cd19 B-cells Absence of mature B-cells in adult mice (236) 
Ikk-β Lck /Cd4 T-cells Loss of natural killer T-cells and T regulatory cells (237, 238) 
Ikk-γ Lck T-cells Loss of peripheral T-cells, reduced numbers of CD8+ T-cells (237) 
Ikk-β Lysm Myeloid cells Reduced expression of several cytokines 
Reduction in tumour size in colitis associated cancer 
 
(74, 239) 
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Table 1-6 continued: Table of mice with abrogated NF-κB signalling 
Gene Promoter Tissue Specificity Phenotype Refs 
Ikk-β Villin Enterocytes Increased sensitivity to radiation induced apoptosis 
Reduction in tumour number in colitis associated cancer 
Increased susceptibility to Clostridium difficile toxin damage 
Increased intestinal permeability in response to thermal injury 
Differential responses to models of acute and chronic colitis 
Exacerbation of local inflammation in response to intestinal ischaemia reperfusion, but 
blunting of systemic inflammatory response 
(74, 227, 
240-243) 
Ikk-γ Villin Enterocytes Spontaneous colitis in both SPF and bacteria free conditions (229) 
Ikk-β Foxa3 Stomach Increased apoptosis in response to ionising radiation 
More rapid progression towards cancer in response to Helicobacter infection 
(75) 
Ikk-β Camk2a 
and Nestin 
Neurons Reduction in infarct size in a mouse model of ischaemic stroke (244) 
Ikk-β Mck Myocytes No reported unstressed phenotype, and no difference in insulin sensitivity (245) 
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 Table 1-7: Mice with abrogated NF-κB protein function 
Gene Promoter Tissue Specificity Phenotype Refs 
RelA N/A Constitutive Embryonic lethal due to hepatic apoptosis at E15-16 (226) 
NF-κB1 N/A Constitutive Multiple immunological defects 
Increased colonic epithelial proliferation 
Increased intestinal epithelial sensitivity to radiation induced apoptosis 
Inability to clear Trichuris muris infection and subsequent severe colitis 
Resistant to hepatoma formation in response to DEN and Wy-14,643 
(246-
249) 
NF-κB2 N/A Constitutive Abnormal splenic architecture and B-cell function 
Inability to clear Trichuris muris infection 
(250, 
251) 
c-Rel N/A Constitutive Defective B and T cell proliferation 
Normal clearance of Trichuris muris 
(251, 
252) 
RelB N/A Constitutive Absence of dendritic cells and thymic UEA-1+ medullary epithelial cells 
Mixed inflammatory cell infiltrates in lymphoid, lung and hepatic tissues 
(253, 
254) 
p105-Δc N/A Constitutive Lymphocytic infiltration in lungs and liver, increased sensitivity to opportunistic infection (255) 
p100-Δc N/A Constitutive Massive gastric hyperplasia, enlarged lymph nodes and enhanced cytokine production in T-
cells 
(256) 
c-rel-Δc N/A Constitutive Enlarged spleen, bone marrow hypoplasia, lymphoid hyperplasia in spleen, stomach, liver and 
lung 
(257) 
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1.3.2.1  NF-κB in immune system development and regulation 
Both classical and alternative pathway NF-κB signalling defects have profound 
effects on the immune system. Mice with constitutive deletion of NF-κB1 have 
normal splenic and lymph node architecture, with normal lymphocyte lineages. 
However these animals have defective responses to infection, being unable to clear 
intracellular Listeria monocytogenes, probably due to aberrant macrophage 
function. Similarly, these animals are more susceptible to Staphylococcus 
pneumoniae, Haemophilus influenzae and Escherichia coli infections (246). NF-κB2 
null mice have structural defects in the spleen and lymph nodes with irregular B-cell 
areas and an absence of perifollicular and mantle zones. In association with this, 
fewer B-cells were observed, but B-cell maturation was maintained. In keeping with 
this observation, these mice have impaired production of antigen specific 
antibodies (250). c-Rel null mice have impairment of proliferation of both T and B 
cell lineages, and subsequently also demonstrate impaired antigen specific antibody 
production. However the spleen and lymph nodes of these animals are structurally 
normal (252).  
Deletion of IKK-α in mice has been achieved by a number of independent groups 
(231-233). Heterozygous deletion of this gene results in reduced levels of IKK-α 
protein, but no overt phenotype (231). Mice that are homozygous for this deletion 
survive to birth, but are not viable postnatally, due to a profound cutaneous and 
bone morphogenetic phenotype. Because of this, it has been difficult to study the 
immune system of this animal in-vivo. However, chimeric bone marrow studies have 
been performed, transplanting IKK-α null bone marrow into wild-type animals. In 
this model, B-cells fail to develop, in a similar manner to that observed in NF-κB2 
null mice (258). Ex-vivo studies of foetal macrophages from IKK-α null mice 
demonstrate enhanced macrophage function (259).  
Constitutive deletion of either IKK-β or IKK-γ is embryonic lethal, due to hepatic 
apoptosis. The immune system in these animals has not therefore been 
investigated, but targeted deletion of IKK-β has been achieved in myeloid cells, and 
specific deletion of both IKK-β and IKK-γ has been achieved in both B- and T-cells. B-
lineage targeting was achieved by expressing Cre under the control of CD19 
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promoter, T-cells have been targeted with a cre-recombinase expressed on the lck 
promoter, and the LysM promoter has been used to target myeloid cells. 
Mice with deletion of either IKK-β or IKK-γ in B-cells fail to produce mature B-cells 
(236). Conditional deletion of IKK-γ or expression of a kinase inactivated form of 
IKK-β in thymocytes results in failure of T-cell maturation. Intriguingly, the complete 
deletion of IKK-β in this lineage results in normal maturation, suggesting that the 
kinase inhibited form of IKK-β acts in a dominant negative fashion in this model 
(237). 
1.3.2.2  The role of NF-κB in hepatic development 
Heterozygous deletion of IKK-β does not result in any significant phenotype. 
However, of 87 pups born from heterozygote crosses, 31 were wild-type and 56 
were heterozygous, but no homozygous mice survived to birth. Further analysis 
demonstrates that homozygous ikkb null mice die at embryonic day 13 (223) due to 
massive hepatocyte apoptosis, a phenotype that is shared by mice with constitutive 
deletion of RelA. IKK-β null MEFs are more susceptible to TNF-α mediated apoptosis 
than wild-type (223), and when IKK-β haploinsufficient mice are crossed with TNF 
receptor 1 knockout mice, IKK-β / TNFR1 double knockout mice survive to birth. This 
suggests that the hepatocyte apoptosis observed may be mediated through TNFR1 
mediated signalling. 
Deletion of IKK-γ (or NEMO) also results in early embryonic (E10-11) mortality. 
Again, this occurs due to massive hepatocyte apoptosis. These mice also have 
impaired activation of NF-κB, demonstrating that whilst NEMO does not have a 
defined enzymatic role in NF-κB activation, its scaffold protein function is essential 
for the activation of NF-κB (225). 
Mice with hepatocyte specific IKK-α deletion have been studied in association with 
mice with hepatocyte specific NEMO and IKK-β deletions. Mice with hepatocyte 
specific NEMO deletion undergo hepatocyte apoptosis and develop liver failure. 
Initially, it was hypothesised that a similar phenotype would be observed in mice 
with hepatocyte specific IKK-β deletions, mimicking the pattern observed in mice 
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with constitutive deletions, but this was not the case. Mice with hepatocyte specific 
deletion of both IKK-α and IKK-β are resistant to LPS induced liver damage, 
demonstrating the close interplay between, but absence of redundancy for, these 
kinases (224).  
1.3.2.3 The effect of NF-κB signalling on gastrointestinal epithelial function 
A number of the transgenic mice with abrogated NF-κB signalling have a defined 
gastrointestinal phenotype. Mice with constitutive deletion of NF-κB1 demonstrate 
increased colonic proliferation. They have longer colonic crypts in comparison to 
wild-type animals (31 cells per hemicrypt c.f. 22) and significantly longer 
proliferating zones, as shown by proliferating cell nuclear antigen (PCNA) and 
Bromodeoxyuridine (BrdU) immunohistochemistry (248). Mice with enterocyte 
specific deletion of IKK-γ develop microscopic foci of colitis within the first couple of 
weeks of postnatal life. These areas are associated with breakdown of mucosal 
integrity and translocation of bacteria into the lamina propria of the intestine, 
resulting in recruitment of neutrophils, dendritic cells and CD4+ T cells. Over time, 
this colitis progresses to affect the entire colon. This phenotype is recapitulated in 
mice with the intestine specific double knockout of IKK-α and IKK-β. This suggests 
that it is a truly NF-κB signalling derived effect of NEMO, rather than an effect of 
disturbing the IKK complex stoichiometry, and furthermore reveals a degree of 
redundancy within the IKK complex. Deletion of IKK-β in the intestine results in 
markedly reduced classical pathway NF-κB activity, whilst deletion of IKK-γ results in 
the complete abrogation of this signalling, presumably accounting for the more 
severe phenotype that is observed in animals with deletion of IKK-γ (229). 
p100-Δc mice were generated by the targeted disruption of the NF-κB2 gene. A stop 
codon and the SV40 promoter were inserted at codon 451. This generates a 
constitutively active gene that produces truncated NF-κB2 which is functionally 
similar to the p52 protein. Animals with this transgene have a shortened life 
expectancy, with 50% dying by postnatal day 25. This early mortality was associated 
with markedly abnormal gastric morphology and histology. Stomachs of 2 week old 
mice were significantly smaller than wild-type animals, with a reduction in luminal 
contents and thickened antral mucosa and hyperkeratosis in the forestomach (256). 
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Unfortunately, cellular differentiation and corpus specific changes have not been 
published in connection with this model. 
In addition to the baseline phenotypes described above, a number of animal models 
with abrogated NF-κB signalling show altered responses to a variety of 
gastrointestinal stimuli. Mice with abrogated classical pathway signalling through 
either intestinal epithelial cell specific deletion of IKKβ (227) or constitutive deletion 
of NF-κB1 (247) demonstrate increased susceptibility to γ-irradiation induced 
intestinal epithelial apoptosis. In mice with intestinal epithelial cell specific IKKβ 
deletion, this is observed in the colon, and is associated with an up-regulation of 
phosphorylated p53. In addition, unlike wild-type mice, radiation induced apoptosis 
could not be rescued by pre-treatment with lipopolysaccharide (227). In NF-κB1 null 
mice, increased apoptosis and lethality was observed: the LD50 at 7 days for wild-
type mice was a dose of 13.12Gy, whilst for NF-κB1 null mice, the required dose was 
7.75Gy (247). Similarly, abrogation of intestinal epithelial cell IKK β results in 
significantly worse pathology in response to instillation of Clostridium difficile toxin 
A than is seen in wild-type mice. These animals had increased mucosal fluid 
secretion and also had significantly more epithelial cell apoptosis than their 
littermate controls (240). 
Classical pathway NF-κB signalling does not, however, universally protect the 
gastrointestinal mucosa from injury. In mice with intestinal epithelial cell specific 
deletion of IKKβ, acute dextran sodium sulphate induced colitis is exacerbated, but 
when these animals are crossed with IL10 null mice that develop spontaneous 
colitis (when housed in normal animal house conditions), the colitis that develops is 
unchanged. If animals with myeloid specific IKKβ deletion are crossed with the IL10 
knockout mouse, the colitis that is induced is ameliorated (242). These observations 
suggest a protective role for intestinal epithelial NF-κB signalling in acute colitis, but 
a role in the perseverance of chronic colitis for myeloid derived classical pathway 
NF-κB signalling.  
NF-κB deletion also has an impact on gut helminth infestations. Deletion of both NF-
κB1 and NF-κB2 leads to persistence of infestation with Trichuris muris, whilst wild-
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type mice and c-Rel null mice effectively clear such an acute infestation (251). The 
underlying cause for the failure to clear Trichuris in both NF-κB1 and NF-κB2 null 
mice is a defective Th2 response to the infection, however the defect in this 
response is more profound in NF-κB1 null than NF-κB2 null mice, as anti-IL-12 
antibody therapy can restore a normal Th2 response and induce helminth expulsion 
in the NF-κB2 null mouse, whilst similar therapy fails in NF-κB1 null animals (251). 
A further model of gastrointestinal disease that has been studied in these animals is 
an intestinal ischaemia-reperfusion model. Mice with intestine specific IKK-β 
deletion underwent laparotomy during which the superior mesenteric artery was 
clamped for 30 minutes before being released. Animals were administered fluid 
resuscitation and allowed to recover before being culled at 4 hours. In this model, 
wild-type animals developed a marked Th1 type inflammatory response as typified 
by elevated TNF-α transcription; they also developed multiple organ dysfunction, 
typified by massive inflammatory infiltrate into the lungs. In mice with intestine 
specific IKK-β deletion, the TNF-α response was significantly attenuated and 
pulmonary pathology was markedly less severe. However, in the intestine, wild-type 
animals developed only mild oedema, whilst in mice with intestine specific IKK-β 
deletion, there was severe epithelial sloughing and higher apoptotic indices (243). 
These data demonstrate both the role of local NF-κB signalling in rescuing the 
gastrointestinal phenotype, and also the contribution of systemic effects of such 
signalling to the multiple organ dysfunction syndrome. 
1.3.2.4 The cutaneous effects of abrogating NF-κB signalling 
Heterozygous deletion of ikka results in reduced levels of IKK-α protein, but no 
overt phenotype (231). Mice that are homozygous for this deletion survive to birth, 
but are not viable beyond that point. They have obvious bone and skin phenotypes 
with failure of normal limb development and thickened skin (231-233). 
The effect of keratinocyte specific deletion of IKK-α is to impair epidermal 
development through a paracrine mechanism. Expression of desmoglein-3, and 
claudin-23 and occludin are all decreased. The protein products of these genes are 
crucial for tight junction and epidermal lipid processing function (228). These 
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studies have not been extended to investigate the effect of conditional deletion of 
IKK-α on gastrointestinal tract permeability, but this is an area of potential future 
interest. 
From the perspective of human disease, one of the most important phenotypes 
demonstrated by any of the mice is analogous with the rare genetic disease in 
humans, incontinentia pigmenti. This condition produces a typical dermatological 
phenotype with pigmentation along Blaschko's lines, and is associated with multiple 
congenital abnormalities. In humans it is an X-linked disorder caused by mutations 
in IKK-γ. Mice both heterozygote for constitutive IKK-γ deletion (234), and mice with 
keratinocyte specific IKK-γ deletion (235) express a cutaneous phenotype very 
similar to that of the human disease. In humans the other important manifestations 
of this disease include proliferative retinopathy, which is recapitulated by the 
phenotype of female mice with heterozygote deletion of IKK-γ (260); and dental 
problems, analogies of which have yet to be reported in this model system. 
1.3.2.5 Neurological sequelae of NF-κB deletion 
In neural tissue, IKK-β deletion has been achieved by crossing mice with floxed ikκB 
with those expressing cre recombinase either on a Camk2a-promoter for neurone 
specific deletion, or on the nestin promoter to target both neuronal and glial cells. 
In both cases, these animals suffered less neuronal cell death following an 
ischaemia-reperfusion event than wild-type animals (244).  
1.3.2.6 The effect of abrogated NF-κB signalling in animal models of 
malignancy 
Over the past five years, molecular evidence has linked particularly classical 
pathway NF-κB signalling with carcinogenesis. These associations have been made 
in some of the tumours most clearly recognised as associated with chronic 
inflammation, including colitis associated cancer (74) and hepatocellular carcinoma 
(76). However the effects of specific NF-κB proteins, and in particular the role of the 
alternative pathway has yet to be assessed. 
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1.3.2.6.1 Colitis associated cancer 
In humans, inflammatory bowel disease affecting the colon is associated with an 
increased risk of developing colorectal cancer. This disease has been modelled in 
the mouse using a chemically induced colitis triggered by exposure to dextran 
sulphate sodium (DSS), along with administration of a carcinogen (azoxymethane). 
Greten et al studied this model in two strains of transgenic mice (74). In both mice, 
a Cre-Lox recombinase system was used to delete IKKβ in a single tissue type. One 
colony had the Cre enzyme expressed on a villin promoter, resulting in the 
abrogation of classical pathway NF-κB signalling in intestinal epithelial cells only. 
The other used a LysM promoter, leading to specific abrogation of signalling in 
myeloid cells.  
When subjected to the colitis associated cancer model, both strains of mice with 
abrogated NF-κB signalling developed fewer tumours than their wild-type controls. 
However those mice that had interrupted NF-κB signalling in their intestinal 
epithelial cells also had an increased rate of intestinal apoptosis. This implies that 
NF-κB signalling in the intestinal mucosa provides an anti-apoptotic, pro-survival 
signal, resulting in an increased risk of carcinogenesis, whilst NF-κB signalling in 
myeloid cells is important for stimulating the growth of already mutated cells, but 
does not directly affect the survival of mutated epithelial cells. 
1.3.2.6.2 Hepatocellular carcinoma 
At a similar time, a study investigating the importance of NF-κB in hepatocellular 
cancer was published. This study utilised Mdr2 transgenic mice, that develop 
spontaneous cholestasis and hepatocellular carcinomas. These mice were crossed 
with mice transgenic for an IκBα (76, 261) super repressor gene, which could be 
deactivated by feeding mice a tetracycline containing diet. When mice were 
maintained under normal conditions for 7 months, no difference was seen in 
inflammation between those with functional and non-functional NF-κB; however 
between 7 and 10 months, 7/9 mice fed a tetracycline containing diet developed 
hepatocellular carcinomas, in contrast to none of the mice with interrupted NF-κB 
signalling. Histological evaluation of these mice showed a marked increase in 
hepatocyte apoptosis in mice with abrogated NF-κB signalling, in comparison to 
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those with functional NF-κB (76). This appears to concur with the evidence from the 
colitis associated model of colon cancer described above.  
A further model of hepatocellular carcinoma, using DEN and Wy14,643, both known 
causes of hepatocellular cancer has been evaluated in p50-null mice. A reduced 
number of tumours were seen, but no differences in proliferation or apoptosis were 
observed (249).  
1.3.2.6.3 Gastric neoplasia 
There is evidence that NF-κB signalling is activated by Helicobacter infection. 
Classical pathway NF-κB signalling is up-regulated both by Helicobacter pylori in-
vitro (262, 263) and in Mongolian gerbils (264) and mice infected with Helicobacter 
pylori in-vivo (265). A transgenic mouse expressing a LacZ reporter gene on the NF-
κB p105 promoter and retaining functional κB sites has been generated. When this 
mouse was infected with Helicobacter pylori, there was a rapid increase in nuclear 
β-galactosidase expression (a surrogate for NF-κB signal activation). This early 
increase in NF-κB signalling was not seen with Helicobacter felis, but a later onset 
elevation in NF-κB was observed (265). There is also evidence that Helicobacter 
pylori can up-regulate the alternative pathway of NF-κB signalling in-vitro. This is a 
Cag PAI independent event. Additionally, increased NF-κB2 activity has been 
observed in inflammatory cells infiltrating Helicobacter infected human gastric 
tissues (266) .  
The most convincing evidence for an association of classical pathway NF-κB 
signalling with Helicobacter induced gastric pathology has come from studies using 
a mouse expressing cre-recombinase on a FoxA3 promoter, where cre expression is 
limited to the gastric mucosa, in association with a floxed ikkb gene. These animals 
were infected with Helicobacter felis. After infection for 6-12 months, animals with 
tissue specific deletion of ikkb showed increased gastric epithelial apoptosis, 
increased cellular proliferation and more advanced metaplastic progression (75). 
Together these studies provide good evidence that classical pathway NF-κB 
signalling plays a role in regulating susceptibility towards developing epithelial 
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malignancy. However, to date, the role of alternative pathway signalling in the 
development of epithelial malignancy has not been addressed. 
1.4 Hypothesis 
Helicobacter infection induces pathological changes in the stomach that can 
progress to gastric carcinogenesis. Moreover the NF-κB family of transcription 
factors is involved in regulating the mucosal and inflammatory response to 
Helicobacter infection. In view of the known association between NF-κB signalling 
and the development of inflammation associated cancers, we therefore hypothesise 
that: 
Individual members of the NF-κB family specifically regulate the consequences 
(especially apoptosis and inflammation) of Helicobacter infection, thus modulating 
susceptibility towards gastric carcinogenesis. 
 
1.5 Aims 
1. To assess whether individual members of the NF-κB family regulate 
epithelial cell turnover in untreated gastric mucosa 
2. To determine whether individual members of the NF-κB family regulate the 
consequences of γ-irradiation in the gastric mucosa 
3. To investigate whether specific members of the NF-κB family influence the 
consequences of acute gastric injury 
4. To investigate whether specific members of the NF-κB family regulate the 
long term sequelae of Helicobacter infection, particularly the onset of pre-
malignant pathology 
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2 Materials and Methods 
Unless otherwise stated reagents were sourced from Sigma-Aldrich (Gillingham, 
UK). 
2.1 Animals 
2.1.1 C57BL/6 wild-type mice 
In-bred, wild-type C57BL/6 mice were purchased from Charles River Laboratories 
(Margate, UK), and were maintained for acclimatisation under standard animal 
house conditions for a minimum of 1 week prior to being used in experimental 
procedures. 
2.1.2 NF-κB1 null mice 
These animals were generated by Sha and Baltimore in 1995 (246); they were 
donated to our laboratory by Dr Jorge Caamano of the University of Birmingham, 
UK. Targeted disruption of the NF-κB1 gene was achieved by insertion of a PGK-neo 
cassette into Exon 6 of the NF-κB1 gene. Exon 6 encodes the Rel homology domain 
of NF-κB1, and disruption of this region was shown to result in the formation of a 
functionally inactive protein incapable of either dimerisation with other NF-κB 
proteins or binding to DNA. Homozygosity for this transgenic alteration effectively 
inhibits the production of NF-κB1 p105 and p50. The same gene encodes IKK-γ, 
through an alternative promoter site, but the disruption of exon 6 does not alter 
the transcription of IKK-γ (246). Homozygously null mice survive to maturity and are 
fertile; therefore a null colony on a C57BL/6 genetic background was maintained 
under standard animal house conditions.  
2.1.2.1 Genotyping 
To verify the genotype of these animals, standard PCR was performed on DNA 
samples extracted from tail-tip samples. Tail tips were digested by proteinase K 
digestion in buffer containing 10 mM Tris, 400 mM NaCl, 100 mM EDTA, 0.6 % SDS, 
pH 7.5 incubated at 55°C for 12 hours. DNA was extracted in saturated 6M sodium 
chloride solution and subsequently precipitated in chilled 100% ethanol. PCR 
reactions were performed in a Hybaid Omnigene (Thermo, Loughborough, UK) 
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thermalcycler. PCR conditions are summarised in Table 2-1. Wild-type alleles 
produced a 120bp product, whilst NF-κB1 null alleles generated a 200bp PCR 
product, therefore genotype was verified by standard agarose electrophoresis using 
2% agarose gel made with 40mM Tris, 20mM acetic acid, and 1mM EDTA buffer 
(TAE). DNA visualisation was achieved by incorporation of 1:10000 GelRed 
(Cambridge BioScience, Cambridge, UK) in the gel. Gels were imaged with a 
ChemiDoc XRS imager (BioRad, Hemel Hempstead, UK). 
Table 2-1: Conditions for genotyping of NF-κB1 null mice 
Constituent Volume (for 1 
reaction) 
Temperature 
(°C) 
Time 
(seconds) 
Cycles 
Reddy Mix 
(Thermo, 
Loughborough, 
UK) 
22.5 µL 94 90 1 
Primer Mix 1.5 µL 94 30 
35 Template DNA 1 µL 68 30 
 72 30 
72 120 1 
Primers 
Common GCA AAC CTG GGA ATA CTT CAT GTG ACT AAG 
Wild-Type ATA GGC AAG GTC AGA ATG CAC CAG AAG TCC 
Mutant AAA TGT GTC AGT TTC ATA GCC TGA AGA ACG 
 
 
  
Figure 2-1: Representative image of agarose gel 
following electrophoresis of PCR product from NF-κB1 
genotyping. Lane 1 PCR product generated from 
template DNA extracted from NF-κB1 null mouse. Lane 2
PCR product generated from template DNA extracted 
from wild-type mouse. Lane 3 PCR product generated 
from template DNA extracted from NF-κB1 heterozygote 
mouse. L represents DNA ladder positions in base pairs 
300 
200 
100 
2 1 L 3 
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2.1.3 NF-κB2 null mice 
These animals were generated (250) and donated by Dr Jorge Caamano, University 
of Birmingham, UK. Exon 4 of the NF-κB2 gene was targeted by insertion of a PGK-
neo cassette. Disrupting exon 4 effectively interrupted the production of both p100 
and p52 (250). Homozygously null mice survive to maturity and are fertile; 
therefore a null colony on a C57BL/6 genetic background was maintained under 
standard animal house conditions. 
2.1.3.1 Genotyping 
To verify the genotype of these animals, standard PCR was performed using a 
Hybaid Omnigene thermalcycler. PCR conditions are summarised in Table 2-2. Wild-
type alleles produced a 230bp product, whilst NF-κB2 null alleles generated a 120bp 
PCR product, therefore genotype was verified by standard agarose electrophoresis 
in 2% agarose gel with TAE buffer. 
 Table 2-2: Conditions for genotyping of NF-κB2 null mice 
Constituent Volume (for 1 
reaction) 
Temperature 
(°C) 
Time 
(seconds) 
Cycles 
Reddy Mix 22.5 µL 95 60 1 
Primer Mix 1.5 µL 95 60 
35 Template DNA 1 µL 55 90 
 72 90 
72 120 1 
Primers 
Common GCC TGG ATG GCA TCC CCG 
Wild-Type GTT TGG GCT GTT CCA CAA 
Mutant CCA GAC TGC CTT GGG AAA 
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2.1.4 c-Rel null mice 
These animals were generated by targeted replacement of c-Rel exons 4-9 with a 
PGK-neo cassette. This construct effectively disrupted c-Rel production (252). 
Animals on the C57BL/6 genetic background are fertile and have an unaltered 
lifespan in standard animal house conditions, hence a null colony was maintained. 
Animals were again donated by Dr. Jorge Caamano of the University of Birmingham. 
2.1.4.1 Genotyping 
To verify the genotype of these animals, standard PCR was performed using a 
Hybaid Omnigene thermalcycler. PCR conditions are summarised in Table 2-3. Wild-
type alleles producede a 389bp product, whilst c-Rel null alleles generated a 281bp 
PCR product, therefore genotypes were verified by standard agarose 
electrophoresis in 2% agarose gel with TAE buffer. 
  
Figure 2-2: Representative image of agarose gel following 
electrophoresis of PCR product from NF-κB2 genotyping. Lane 1 PCR 
product generated from template DNA extracted from wild-type 
mouse. Lane 2 PCR product generated from template DNA extracted 
from NF-κB2 null mouse. L represents DNA ladder positions in base 
pairs 
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Table 2-3: Conditions for genotyping of c-Rel null mice 
Constituent Volume (for 1 
reaction) 
Temperature 
(°C) 
Time 
(seconds) 
Cycles 
Reddy Mix 22.5 µL 94 60 1 
Primer Mix 1.5 µL 94 30 
35 Template DNA 1 µL 56 30 
 72 30 
72 120 1 
Primers 
Common AG TGG GGT TAC AGG TGC TCA 
Wild-Type TTG CCAATA GGC TTA GTC AAA TA 
Mutant CTC TCG TGG GAT CAT TGT TTT TC 
 
 
2.2 Animal procedures 
All animal procedures were performed under a UK Home Office project licence as 
stipulated in Animals (Scientific Procedures) Act 1986. The author is a UK Home 
Office personal licensee and performed the described experiments either 
independently or under the tutelage of a suitably experienced licensee. Most 
experiments were carried out in the University of Liverpool Biomedical Services 
Unit; where this was not the case procedures were performed in an alternative 
room listed on the University of Liverpool certificate of designation for animal 
procedures. 
  
Figure 2-3: Representative image of agarose gel following 
electrophoresis of PCR product from c-Rel genotyping. Lane 1 PCR 
product generated from template DNA extracted from wild-type 
mouse. Lane 2 PCR product generated from template DNA extracted 
from c-Rel null mouse. L represents DNA ladder positions in base 
pairs. 
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2.2.1 Standard housing 
Animals were housed in the University of Liverpool Biomedical Services Unit. Unless 
otherwise stated mice were housed in standard conditions with temperature 
maintained between 18-21°C, humidity 55+/-10%, a 12 hour light dark cycle and tap 
water and standard CRM (P) rodent chow (SDS diet, Braintree, UK) were available 
ad libitum.  
2.2.2 Whole body γ-irradiation 
Animals were exposed to 12Gy γ irradiation in a single fraction administered from a 
Caesium-137 source in a GammaCell closed source irradiator. Animals were 
subsequently returned to standard housing conditions before being culled either 6 
or 48 hours post procedure using a schedule 1 approved method.  
2.2.3 Induction of gastric ulceration with ethanol 
Animals were fasted by removal of chow for 16 hours pre-procedure. Drinking 
water remained available ad libitum throughout. Following the fast, animals were 
administered 100μl 100% ethanol by oral gavage. 1 hour following this procedure 
animals were culled using a schedule 1 approved method. 
2.2.4 Induction of Helicobacter felis infection 
Helicobacter felis infection of mice was studied at 2 separate time points after 
gastric colonisation. Groups of at least 6 mice were colonised by oral gavage with 
Helicobacter felis cell suspension and were culled at either 6 or 48 weeks post 
procedure using a schedule 1 approved method.  
2.2.4.1 Bacterial culture 
Helicobacter felis (ATCC 49179) was cultured on chocolate agar plates in a 
controlled microaerophilic environment at 37°C for 72 hours. At least 1 plate was 
inoculated per mouse per culture. Previous experience with H. felis in our 
laboratory has demonstrated waning pathogenicity of the organism in proportion 
to the number of in-vitro passages through which the organism has passed 
(unpublished data), therefore H. felis for inoculation of mice was used only up to 
passage 7 from the original stocks supplied by ATCC. 
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Following culture on solid media, bacteria were harvested and suspended in 
tryptone soy broth and optical density was assessed at 550nm. Cell suspensions 
were deemed adequate for administration to animals once OD550 >1.0 was 
achieved. This corresponds to a concentration of >1*10
9
 organisms per mL. 
2.2.4.2 Animal infection 
Bacterial cell suspensions were immediately transferred to the animal facility for 
administration by oral gavage within 30 minutes of harvest from solid media. 
Animals were administered 500μL cell suspension on 3 separate occasions over the 
course of 1 week. Successful bacterial colonisation was confirmed by microscopy of 
gastric tissue sections on completion of the experiment. 
2.2.4.3 Long term animal husbandry 
In addition to the standard conditions described above, animals that were 
maintained under a licenced procedure for greater than 2 months were also 
subjected to more rigorous checks. Colonisation with Helicobacter felis was verified 
by examination of sentinel animals culled 6 weeks after infection. Body weights 
were recorded pre-procedure and at least monthly throughout the experiment. If 
individual animals were shown to be losing weight the frequency of checks was 
increased and animals losing greater than 20% body mass were culled using a 
schedule 1 approved method and were subjected to post-mortem examination by a 
veterinary pathologist. 
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2.3 Necrosectomy 
Generally standard dissection techniques were employed. On excision of the 
stomach for histopathological assessment ligatures were tied around the 
oesophagus and duodenum before removal. Stomachs were subsequently inflated 
with 1mL of 4% formalin in phosphate buffered saline (PBS see Table 2-4) and were 
then submerged into the same solution. 
Table 2-4: Constituents of PBS 
Constituent Concentration (mmol/L) 
 NaCl  137 
 KCl  2.7 
 Na2HPO4  8.1 
 KH2PO4  1.76 
 pH  7.4 
2.4 Histological techniques 
2.4.1 Tissue cut up and processing 
Following a minimum of 12 hours fixation in 4% formalin in PBS, inflated stomachs 
were briefly rinsed in 70% ethanol before being cut into corpus, antrum and central 
sections as shown in Figure 2-4 (267). After cutting, tissue samples were placed into 
plastic histology cassettes and transferred through graded alcohols and 3 changes 
of 100% xylene before being impregnated with paraffin wax. Wax impregnated 
samples were then embedded into tissue moulds for sectioning. Microtome 
sections were taken at 4μm thickness for all staining techniques used. 
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2.4.2 Haematoxylin and Eosin staining 
Samples for haematoxylin and eosin staining were placed onto plain glass slides and 
baked at 60°C for 60 minutes before staining. Sections were de-waxed in 2 changes 
of xylene and subsequently re-hydrated in graded ethanols and tap water. 
Once in aqueous phase, sections were placed in Gill No1 haematoxylin solution for 
2 minutes 30 seconds to ensure that they were fully saturated with stain. Following 
this haematoxylin was washed out and “blued” in running tap water for 10 minutes. 
Sections were then transferred to eosin Y solution for 2 minutes 30 seconds, again 
saturating sections with stain. Following this, excess eosin was washed out in 
running tap water for approximately 30 seconds, before being dehydrated in 2 
changes of 95% ethanol, before being transferred to 100% ethanol and 
subsequently xylene to clear before coverslipping under DPX mounting media. 
2.4.3 Immunohistochemical staining 
All immunohistochemical staining processes had similar pre-treatment prior to 
primary antibody administration. Sections were placed on APES coated slides and 
were air dried at 37°C in a fan assisted drying oven overnight. Prior to staining, 
samples were dewaxed in 2 changes of xylene and rehydrated in graded ethanol. 
 
 
2 
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C 
B 
A 
Figure 2-4: schematic drawing of cut-up of murine stomach. Transections made in number order. 
Forestomach was discarded. A section retained as antral section, C section as corpus whilst B section 
wass retained and embedded for use if needed. 
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Endogenous peroxidase activity was inhibited by incubation for 4 minutes in 1% 
H2O2 in methanol (this stage was omitted for samples to be stained with 
fluorophore conjugated secondary antibodies). After washing in distilled water, 
samples were transferred to 100mM sodium citrate solution pH6.0, and were 
microwaved in this solution for 20 minutes at 650W to complete heat induced 
antigen retrieval. 
After antigen retrieval, sections were allowed to cool at room temperature before 
being transferred to 50mM Tris buffered saline (150mM NaCl) with 0.1% Tween20 
solution. Sections were then surrounded with hydrophobic PAP pen and sections 
were incubated for 1 hour with 100μl block solution consisting of 10% goat serum 
in TBS with 0.1% Tween20. Following block solution incubation, primary antibodies 
were applied at the concentrations shown in Table 2-5. Sections were incubated 
with primary antibody overnight at 4°C without agitation. 
Following primary antibody incubations, sections were washed three times in 
TBS/0.1% Tween20 solution for 5 minutes each time. After this, secondary 
antibodies were applied and different staining protocols used different protocols as 
described below. 
Table 2-5: Primary antibodies used for immunohistochemistry 
Antigen Source Catalogue 
number 
Species 
raised in 
Working 
concentration 
Cleaved Caspase 3 R & D 
Systems  
AF835 Rabbit 1:900 
Ki67 Dako M7249 Rat 1:40 
CD3 AbCam ab5690 Rabbit 1:100 
CD20 SantaCruz sc-7735 Goat 1:100 
2.4.3.1 Secondary antibody and chromagen application using Envision+ kit 
Sections stained with primary antibodies raised in rabbit (ie cleaved caspase 3) 
were visualised with the anti-rabbit Envision+ (Dako, Ely, UK) kit. This kit relies upon 
an HRP conjugated antibody polymer construct which binds to primary antibody 
and amplifies the signal in a single stage process. Therefore, once primary antibody 
had been washed off sections, polymer solution was applied and incubated at room 
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temperature for 30 to 40 minutes. Following this step, sections were again washed 
in TBS with 0.1% Tween20 solution on three occasions, each for 5 minutes. 
Samples were then incubated for 5 minutes in proprietary liquid DAB chromagen 
solution as supplied in the Envision kit, before being washed in TBS to stop further 
chromagen precipitation. Following chromagen precipitation, sections were 
transferred to Gill No. 1 haematoxylin and incubated for 90 seconds, before being 
washed in tap water for 10 minutes to wash out and blue the counterstain. Samples 
were then dehydrated in graded ethanols, before being transferred to xylene to 
clear before coverslipping under DPX mounting media. 
2.4.3.2 Secondary antibody and chromagen application using streptavidin 
/ biotin based assay 
Sections stained for Ki67 were not suitable for use with an Envision+ detection kit. 
Sections were therefore incubated with a biotinylated anti-Rat secondary antibody 
raised in rabbit (E0468, Dako, Ely, UK), diluted 1:200 in block solution for 30 
minutes. 
These sections were then washed 3 times in TBS with 0.1% Tween20 for 5 minutes 
on each occasion. Subsequently, sections were incubated with Vectastain ABC Kit 
(Vector Laboratories, Peterborough, UK) solution made to the proprietor’s 
instructions for 30 minutes, before again being washed 3 times in TBS with 0.1% 
Tween 20 for 5 minutes on each occasion. The ABC solution conjugates multiple 
horseradish peroxidase molecules to each biotinylated secondary antibody moiety, 
thereby amplifying the primary antibody signal for chromagen detection. DAB 
tablets were dissolved in 5mL TBS with 0.05% H2O2, and this solution was applied to 
sections for 5 minutes before the reaction was halted by washing once with TBS. 
After chromagen precipitation, sections were transferred to Gill’s No. 1 
haematoxylin and incubated for 90 seconds. Following this, sections were washed 
in tap water for 10 minutes to wash out and blue stain. Samples were then 
dehydrated in graded ethanols, before being transferred to xylene to clear before 
coverslipping under DPX mounting media. 
103 
2.4.3.3 Fluorophore conjugated secondary antibodies 
CD3 and CD20 stained sections were co-stained and marked with secondary 
antibodies directly conjugated to green (AlexaFluor 488) and red (AlexaFluor 594) 
fluorophores. After washing off excess primary antibody, slides were incubated in 
the dark at room temperature with mixed secondary antibodies for 1 hour. 
Secondary antibody solution consisted of 10% donkey serum in TBS 0.1% Tween20, 
fluorophore conjugated antibodies were added to a final concentration of 1:400, 
using AlexaFluor 488 conjugated donkey anti-rabbit IgG (H+L) and AlexaFluor 594 
conjugated donkey anti-goat IgG (H+L) (both sourced from Invitrogen, Paisley, UK, 
Catalogue numbers A-21206 and A-11058 respectively). Following secondary 
antibody incubation, slides were kept in the dark throughout. Secondary antibodies 
were washed off with 3 changes of TBS, each for five minutes, before being 
coverslipped under DAPI containing Vectashield mounting medium for fluorescence 
(Vector Laboratories, Peterborough, UK). Coverslips were secured with clear nail 
polish and sections were visualised using standard fluorescence microscopy. 
2.4.4 Immunocytochemical staining 
Immunocytochemical staining was carried out on primary cultures of gastric glands 
(see section 2.7) and was limited to immunocytochemical staining for cleaved 
caspase 3. Samples were first fixed by incubation in 2% paraformaldehyde in PBS 
solution at room temperature for 30 minutes. This solution was removed and 
samples were rinsed three times in PBS to ensure no residual paraformaldehyde 
remained. 
Fixed samples were incubated for 1 hour at room temperature in blocking solution 
consisting of PBS supplemented with 10% goat serum, 1% BSA and 0.1% Triton 
X100 on a rocker platform set at 100 RPM, before being incubated overnight with 
anti-cleaved caspase 3 antibody (AF835, R&D systems) diluted 1:900 in block 
solution at 4°C, again on a rocking platform at 100 RPM to ensure constant 
coverage of samples. 
Following primary antibody incubation samples were washed three times for 5 
minutes each, in wash solution (PBS supplemented with 1% BSA and 0.1% Triton 
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X100) before secondary antibodies were applied. From this stage onwards all 
procedures were carried out in dark conditions. Secondary antibody (1:200 FITC 
conjugated goat anti-rabbit antibody, Cat No: 111-095-144, Stratech Scientific Ltd, 
Newmarket, UK) incubations were carried out for 40 minutes at room temperature 
on a rocking platform. Following secondary antibody incubation, a further 2 
washes, each for 5 minutes were carried out using wash buffer. A final wash for 10 
minutes was completed using PBS to remove any excess protein and surfactant. 
Coverslips were removed from 12 well plates and mounted onto standard glass 
slides using DAPI containing Vectashield mounting medium for fluorescence (Vector 
Laboratories, Peterborough, UK). Coverslips were secured in place using clear nail 
varnish and were visualised using standard fluorescence microscopy. 
2.5 Protein sample collection 
Protein samples were acquired from mechanical scrapes of gastric mucosa. 
Following cull by a schedule 1 approved method, murine stomachs were removed 
using conventional dissection techniques. An incision was made along the greater 
curve and stomachs were rinsed in PBS to remove gastric contents. Mucosal 
scrapes were then performed by scraping between two glass microscope slides to 
mechanically separate the gastric mucosa from the serosal surface of the stomach. 
The subsequent mucosal sample was separated into two components, half for cell 
fractionation, and half for whole cell lysis. 
2.5.1 Whole cell lysates 
Mucosal scrape samples were placed into 1mL of RIPA buffer (see Table 2-6) on ice, 
and were briefly disrupted by mechanical homogenisation. Samples were allowed 
to stand on ice for 20 minutes to allow complete cell lysis before being spun at 
maximum speed in a refrigerated centrifuge for 20 minutes at 4°C to separate 
protein lysate from membranes and other non-proteinaceous material. Protein 
lysates were stored at -80°C until needed. 
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Table 2-6: Constituents of complete RIPA buffer 
Constituent Concentration 
Tris  50mM 
NaCl  150 mM 
SDS  0.1 % 
Na.Deoxycholate  0.5 % 
Triton X 100 1% 
β-mercaptoethanol 0.075% 
Protease Inhibitor Cocktail Set III 
(Merck Chemicals, Nottingham, UK) 
1:100 
2.5.2 Cell fractionation 
Cell fractionation was carried out using an osmolar gradient method adapted from 
that published by Castle et al (268). Mucosal scrape samples were placed into tubes 
containing 1mL of hypotonic lysate buffer (Table 2-7), and were briefly 
homogenised with a mechanical homogeniser at low speed setting. Lysates were 
placed on ice for 10 minutes before being spun in a centrifuge chilled to 4°C at 230g 
for 5 minutes. The supernatant was removed into a clean tube and stored as the 
cytoplasmic fraction at -80°C until needed. 
The pellet was resuspended in nuclear fractionation buffer (Table 2-8). This was 
placed in a layer over 3mL nuclear separation buffer (Table 2-9) and the samples 
were spun at 4°C and 2800g for 10 minutes. The supernatant was discarded and the 
pellet, which consisted of the nuclei was resuspended in 250μl of RIPA buffer.  
To ensure complete nuclear lysis, samples were sonicated for 10 seconds prior to 
centrifugation for a further 10 minutes at 4°C and maximum speed. The 
supernatant was taken as the nuclear lysate and was again frozen at -80°C until 
needed.  
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Table 2-7: Constituents of hypotonic lysate buffer 
Constituent Concentration 
HEPES 10mM 
MgCl2 1.5mM 
KCl 10mM 
DTT 0.5mM 
Protease Inhibitor Cocktail Set III 1:100 
 
Table 2-8: Constituents of nuclear fractionation buffer 
Constituent Concentration 
Sucrose  0.25mM 
MgCl2 10mM 
Protease Inhibitor Cocktail Set III 1:100 
 
Table 2-9: Constituents of nuclear separation buffer 
Constituent Concentration 
Sucrose  0.88mM 
MgCl2 0.5mM 
Protease Inhibitor Cocktail Set III 1:100 
2.5.3 Protein sample quantification 
Protein samples were quantified by Bio-Rad Protein assay. This assay relies upon a 
colorimetric change in acidic Coomassie blue dye on binding to proteins. Assays 
were performed in duplicate in 96 well plates. Protein standards were generated by 
serial dilution of 1mg/mL bovine serum albumin solution. At least 5 concentrations 
of BSA were used for standard curve generation. 10μl of standard curve and sample 
proteins were added to a 96 well plate before 200μl diluted protein assay solution 
was added. After brief shaking, absorbance was measured at 595nm in a Tecan 
SUNRISE plate reader. Standard curve values were plotted against concentration. 
The linear component of this curve was used to generate a line of best fit. An 
acceptable line of best fit was defined as having an R
2
 value of 0.65 or greater; in all 
assays this was achieved. The equation for the line of best fit was subsequently 
used to estimate the concentrations of protein samples. If sample concentrations 
fell outside of the range of linear correlation between absorbance and 
concentration samples were diluted by a known factor to shift them into this range 
before repeating the assay. 
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2.6 RNA sample collection 
2.6.1 Sample collection and initial storage 
Animals were culled using a schedule 1 approved method and stomachs were 
removed as described previously. Following excision, stomachs were cut along the 
greater curve and rinsed briefly in PBS to remove debris and begin to neutralise 
gastric acid. Using a clean scalpel blade a full thickness strip of gastric corpus, 1mm 
by 5mm in length was removed. This was cut into 1mm cubes and transferred into 
an Eppendorf tube containing at least 0.75mL of RNAlater (Applied Biosystems, 
Warrington) RNA and tissue storage solution. The time from cull to submersion in 
storage solution was always less than 5 minutes and typically less than 3 minutes. 
Samples, were stored for 12 to 24 hours at 4-7°C to allow RNALater to impregnate 
tissue, before being transferred to -20°C for long term storage. 
2.6.2 RNA extraction 
RNA was extracted from tissue using the High Pure RNA Tissue Kit (Roche, Burgess 
Hill, UK) according to the manufacturer’s instructions. This kit comprised a tissue 
lysis buffer containing the chaotropic salt guanidine hydrochloride. Tissues were 
lysed in this buffer using a mechanical tissue homogeniser. Following this, nucleic 
acids were bound to a glass fleece filter column and contaminating salts and 
proteins were washed away. DNA was digested on the column using DNAse I, and 
fragments were subsequently washed through the column. Finally RNA samples 
were eluted in TE buffer or RNAse free water. These samples were quantified by 
absorbance spectrophotometry at 260nm and 280nm, using the 260nm value to 
enter into Beer’s law to calculate a concentration of RNA. Sample quality was 
determined by the A260/280 ratio, with a ration >1.7 being considered acceptable 
RNA quality for subsequent use in assays. 
2.6.3 Reverse transcription 
1μg of RNA was revered transcribed using the Transcriptor reverse transcriptase kit 
(Roche, Burgess Hill, UK). This kit was optimised for use with RNA extracted using 
the High Pure RNA kit; 1μg of template RNA was incubated in the presence of 
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OligoDT primers to allow non-specific reverse transcription of mRNAs. The 
subsequent reaction mixture was used as template cDNA for quantitative PCR 
assays.  
2.7 Primary cultures of gastric glands 
Primary cultures of gastric glands were derived from adult mice aged 10 to 12 
weeks using a protocol originally described by Pagliocca et al (269). All animals for 
these procedures were maintained in standard animal house conditions prior to 
culling using a schedule 1 approved method.  
2.7.1 Digestion process 
Following cull, ligatures were tied around the distal oesophagus and 1
st
 part of the 
duodenum before stomachs were removed. The majority of the forestomach was 
removed and stomachs were inverted such that the mucosal surface was on the 
outer aspect. A further suture was tied around the orifice where the forestomach 
had been removed to form an inverted, sealed stomach. This was briefly rinsed in 
Hank’s balanced salt solution (HBSS) on ice and was inflated with collagenase A 
solution, before being transferred into a large volume of HBSS for short term 
storage.  
Once ready to digest and liberate gastric glands, stomachs were placed into 100mL 
conical flasks and incubated with 1mM dithiothreitol in HBSS in a shaker water bath 
set at 37°C and 100 RPM in an atmosphere of 95% oxygen, 5% carbon dioxide. This 
incubation lasted no longer than 10 minutes and was continuously evaluated to 
note when the mucus layer became dissociated from the stomach. 
Once the mucus layer had been dissociated, samples were washed 3 times in 
warmed HBSS and were further digested in collagenase A solution. Again this 
digestion took place in a shaker waterbath at 37°C set at 100 RPM and in an 
atmosphere of 95% oxygen, 5% carbon dioxide. Once digestion of the stromal tissue 
and release of glands into the solution was evident, complete mechanical 
breakdown of the tissues was completed using gentle mechanical agitation. Glands 
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suspended in collagenase solution were placed on ice to settle for 45 minutes prior 
to plating into 12 well tissue culture plates (Appleton Woods, Selly Oak, UK).  
12 well plates were prepared with sterile 19mm diameter glass coverslips in their 
base. Prior to inoculation with gastric glands, each well was filled with 1.5mL 
complete media (Table 2-10). 
Table 2-10: Constituents of complete media for primary cultures 
Constituent Volume in 562.5mL 
DMEM / F12 HAM mix 500mL 
Foetal Calf Serum 50mL 
L-glutamate 6.25mL 
Antibiotic Antimycotic mixture 5mL 
2.7.2 Tissue Culture conditions 
Following digestion, glands were cultured at 37°C in a humidified atmosphere with 
5% supplemental carbon dioxide. After 24 hours, glands were washed 3 times in 
complete media and returned to the incubator. 48 hours after initial plating, media 
was replaced once more, either with standard media, or with cytokine containing 
media. Treatments were maintained at 37°C in 5% carbon dioxide with humidity for 
a further 48 hours before fixation. 
2.8 Histological / cytological scoring methods 
A number of different histological scoring techniques were employed to quantify 
pathological findings in different settings. In all cases samples were scored by the 
author and scoring was performed whilst blinded to treatment and genotype of the 
slide being scored. To ensure accurate scoring both inter- and intra-observer 
variability were assessed during the training process for scoring, examples of which 
are shown in Figure 2-5 and Figure 2-6 respectively. 
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Figure 2-5: Intraobserver variability. Left hand panel demonstrates percentage of apoptotic cells scored for a 
group of 6 mice on two separate occasions (using identical slides and microscopy equipment). Right hand 
panel represents the same data on a cell positional basis. No statistical differences were defined by 2-way, 
independent samples Students t-test (percentage data) or modified median test (cell positional data) 
Figure 2-6: Interobserver variability. Left hand panel demonstrates percentage of apoptotic cells scored for a 
group of 6 mice by two separate observers (using identical slides and microscopy equipment). Right hand 
panel represents the same data on a cell positional basis. No statistical differences were defined by 2-way, 
independent samples Students t-test (percentage data) or modified median test (cell positional data) 
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2.8.1 Non-parametric scoring 
Initial histological scoring of mice following Helicobacter felis infections was 
performed using a modification of the visual analogue scale defined by Rogers et al 
(270). This scoring system provides a rapid method for scoring inflammation, gastric 
parietal cell loss and mucosal thickening in the corpus. In the antrum it can be used 
to assess mucosal thickening and inflammation as well as Helicobacter colonisation. 
In our studies it has provided a rapid assessment of mucosal atrophy, which has 
subsequently been corroborated by more quantitative methods. This scoring 
system has also been used as the principal method of quantifying gastric 
inflammation and Helicobacter colonisation, variables which are not otherwise 
quantifiable by the histological scoring systems in use in our laboratories. Data from 
these scoring systems were considered to be discrete ordinal variables and were 
tested using the Kruskal-Wallis one-way analysis of variance on ranks test, and 
where appropriate Dunn’s post-hoc method was used to define specific differences. 
Data are represented by dot plot with median values. 
 
 
112 
Table 2-11: Summary of non-parametric scoring scale for murine gastric pathology following Helicobacter infection 
Score Inflammation Oxyntic gland atrophy Mucosal thickening Helicobacter felis colonisation 
0 
No different to untreated 
wild-type mice 
No different to untreated 
wild-type mice 
No different to untreated 
wild-type mice 
No Helicobacter type organisms 
seen 
1 
Patchy infiltration of 
mixed leukocytes in 
mucosa and/or 
submucosa. Add 0.5 for 
significant granulocytes 
<25% parietal cell loss ∼1.5× normal length 
Light colonisation of a few gastric 
glands 
2 
Multifocal-to-coalescing 
leukocyte infiltration not 
extending below 
submucosa 
25-50% parietal cell loss ∼2× normal length 
Either light colonisation of the 
majority of gastric glands, or 
heavy colonisation of the minority 
of glands 
3 
Marked increase in 
leukocytes with lymphoid 
follicles ± extension into 
tunica muscularis 
50-75% parietal cell loss ∼3× normal length 
Heavy colonisation of the majority 
of antral glands seen in a single 
circumference 
4 
Effacing transmural 
inflammation 
>75% parietal cell loss ≥4× normal length  
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2.8.2 Cell positional scoring 
To quantify apoptosis and mitosis in the gastric antrum and corpus of untreated and 
irradiated mice a cell positional scoring system was employed. This system is based 
upon the validated cell positional scoring systems initially established in small 
intestine (271, 272) , but also validated in gastric tissues (65, 267).  
This scoring system relies upon the observation of well oriented gastric glands and 
the morphology of each cell forming the epithelial monolayer is assessed and 
scored as apoptotic, mitotic or normal. In the antrum 20 hemi-glands per animal 
were scored, whilst in the corpus 40 hemi-glands were scored per animal. 
Following scoring, apoptotic and mitotic indices were plotted in both percentage 
terms and against cell position as shown in Figure 2-7. Statistical differences in 
apoptotic index were tested by 1-way or 2-way ANOVA, depending upon treatment 
groups. Differences in cell positional plots were assessed by modified median test 
as previously described (273). 
Figure 2-7: Cell positional scoring. 
A is a representative curve of 
apoptosis scoring from an 
irradiated antrum. B demonstrates 
schematically the location of cell 
positions and presence of 
apoptotic and mitotic cells. C is a 
representative photograph of a 
gastric antral gland original 
magnification *40, in which both 
apoptotic and mitotic lesions can 
be seen. 
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2.8.3  “Graticule” scoring 
Haematoxylin and eosin sections of gastric corpus were scored using a grid system 
to quantify mucosal thickness and parietal cell numbers. Similarly Ki67 stained 
sections were scored by this method to obtain proliferation indices. 10 areas per 
mouse were randomly selected for scoring. These areas were located on the lesser 
curve with exclusion of areas directly abutting the forestomach. 
A 10mmx10mm eyepiece graticule divided into 1mm squares was used with a x40 
objective lens (therefore each square corresponds to 25µm
2
). This graticule was 
rotated to cross the tissue section with the base of one square at the level of the 
basement membrane. A score for the number of parietal cells per box in the grid 
was then recorded (Figure 2-8). This generated both an estimate of the thickness of 
the tissue (number of boxes recorded x25µm) and an assessment of the number of 
parietal cells according to depth of tissue from the basement membrane of cells 
located at the base of the gland. All parietal cells fully within a box, plus those 
where greater than 50% of the cell was within the box were counted in that column. 
This scoring method was particularly useful in mice subjected to chronic infection as 
cell positional scoring was not feasible due to the degree of tissue architectural 
damage induced by chronic infection. 
Absolute numbers of cells scored were calculated and plotted as means; statistical 
differences were tested by 1-way or 2-way ANOVA and Holm-Sidak post hoc 
analysis. Scores were also plotted against graticule position, defined as a set 
distance in μm from the basement membrane of cells at the base of the gland. As 
these values were pooled for graticule squares, they were considered as discrete 
ordinal variables rather than continuous variables. Therefore differences were 
tested using the non-parametric Kruskall-Wallis test at each graticule position. 
When differences between groups were defined Dunn’s post hoc analysis was 
employed. 
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2.8.4 High power field scoring of apoptosis 
Apoptotic events are rare within the gastric corpus, therefore sections 
immunostained for cleaved-caspase 3 were scored by examining 10 high powered 
fields (*63 objective) and tabulating the number of apoptotic cells seen per field. 
Means were generated and statistical analysis was carried out by 2-way ANOVA and 
Holm-Sidak post-hoc analysis. 
2.8.5 Scoring of primary cultures 
Primary cultures of gastric glands generate discrete glandular units in culture. Units 
suitable for scoring were defined as having a minimum of 20 cells and, at the upper 
size limit, the nuclei of all cells within the gland being visible within a single *40 
objective field. Gland size was defined by counting the number of nuclei visible 
within each gland on visualisation of the DAPI channel. The number of apoptotic 
cells seen was defined by counting the number of cells with cleaved caspase-3 
positive immunostaining using the FITC channel. 
Data were tabulated and expressed as percentage of cells apoptotic. Statistical 
analysis was carried out using 2-way ANOVA and Holm-Sidak post-hoc analysis. 
Following statistical analysis data were presented graphically as bar charts 
normalised to untreated glands from mice of the same genotype. Scores were taken 
from 10 glands from each treatment group per animal, and scores from 5 animals 
per group were generated. 
  
Figure 2-8: Representative micrograph of gastric 
corpus mucosa with overlaid grid (not to scale), to 
represent graticule method of scoring. 
The number of parietal cells per square were 
scored beginning at the base of a gland. The 
entire column of the grid was scored until the 
mucosal surface was reached. To generate a value 
for thickness of the mucosa, boxes with no 
parietal cells were scored as 0. 
 
116 
2.9 Western blotting 
2.9.1 Polyacrylamide gel electrophoresis 
Polyacrylamide gels were cast using a 10% acrylamide, pH 8.8 resolving gel and a 5% 
acrylamide, pH 6.8 stacking gel as described in Table 2-10. Electrophoresis was 
performed in a tank containing running buffer comprising of 25mM Tris base and 
200mM glycine with 0.1% sodium dodecyl sulphate. Prior to loading, protein 
samples were denatured at 95°C for 2 minutes in Laemmli buffer (Table 2-13). 
Electrophoresis was started at 60 volts until the bromophenol blue was aligned with 
the intersection between stacking and running gels. At this stage the voltage was 
increased to 120 volts until the bromophenol blue was seen at the lower edge of 
the gel. 
Table 2-12: Constituents of polyacrylamide gels (volumes sufficient for 2 gels) 
Running Gel Stacking Gel 
Constituent Volume Constituent Volume 
Water 8.4 ml  Water 6.17 ml  
30% acrylamide 6.6 ml  30% acrylamide 1.33 ml  
1.5M TRIS buffer (pH 8.8) 5 ml 1.5M TRIS buffer (pH 8.8) 2.5 ml  
10% SDS 200 μl  10% SDS 100 μl  
10% APS 100 μl  10% APS 50 μl  
TEMED 10 μl  TEMED 10 μl  
 
Table 2-13: Constituents of Laemmli buffer (final concentrations) 
Constituent Quantity  
Tris HCl 63 mM   
Glycerol 10%  
SDS 2%  
Bromophenol Blue 0.0025%   
pH 6.8  
2.9.2 Protein transfer 
Following gel electrophoresis, proteins were immobilised onto nitrocellulose 
membranes (Whatman Protran, 0.45μm pore size, Fisher Scientific, Loughborough) 
by electrophoretic transfer using transfer buffer consisting of 25mM Tris base, 
200mM glycine and 20% methanol. Electrophoresis was performed at 100 volts for 
1 hour. 
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2.9.3 Immunoblotting 
Membranes were placed in sealed 50mL universal containers with 10mL blocking 
buffer consisting of 5% dried skimmed milk in PBS with 0.1% Tween20. Containers 
were laid on a roller and were allowed to incubate for 1 hour at room temperature. 
Following this the blocking solution was discarded and replaced with 5mL of 
primary antibody solution. Primary antibodies were incubated at concentrations 
shown in Table 2-14 on a roller overnight at 4°C. 
After incubation, primary antibody solution was discarded and the membranes 
were washed 3 times in an excess of PBS-Tween20, each wash being carried out on 
a roller at room temperature for 5 minutes. 
Following washing, secondary antibodies (Goat anti-mouse and goat anti-rabbit HRP 
conjugated, both sourced from Thermo, both used at 1:1000 concentration) were 
applied in a volume of 5mL and incubations were continued on a roller at room 
temperature for a further hour. Secondary antibodies were washed off using the 
same protocol as followed primary antibody washes.  
Bound antibodies were visualised by chemiluminescence using SuperSignal ECL kit 
(Thermo, Loughborough, UK). Images were taken using a ChemiDoc XRS imager 
(BioRad, Hemel Hempstead, UK). 
 
Table 2-14: Primary antibodies used for Western blotting 
Antigen Source Catalogue 
number 
Species 
raised in 
Working 
concentration 
RelA SantaCruz SC-109 Rabbit 1:100 
RelB SantaCruz SC-226 Rabbit 1:50 
c-Rel SantaCruz SC-71 Rabbit 1:200 
NF-κB1 AbCam ab7971 Rabbit 1:200 
NF-κB2 AbCam Ab7972 Rabbit 1:200 
Panactin Millipore MAB1501 Mouse 1:2000 
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2.10 DNA binding ELISA 
The DNA binding ELISA technique was carried out in accordance with instructions 
supplied in the TRANS-AM NF-κB family kit as supplied by Active Motif (Belgium). 
Proprietary 96 well plates were supplied with oligonucleotides specific to NF-κB 
binding sequences adherent to them. Nuclear extracts were incubated for 1 hour at 
room temperature in these plates, before being exposed to polyclonal primary 
antibodies raised in rabbit and targeted to specific NF-κB proteins. Primary 
antibodies with reported activity in the murine system were available for RelA, RelB, 
NF-κB1 and NF-κB2, but not cRel. Adherence of primary antibody was visualised 
through a horseradish peroxidase conjugated anti-rabbit secondary antibody. 
Horseradish peroxidase activity was quantified by incubation with 3,3′,5,5′-
tetramethylbenzidine (TMB) chromogen, which when oxidised generates a blue 
colour. To stabilise the plate and stop further TMB oxidation, the plate was treated 
with a stop solution containing strong acid. This induced a further colour change to 
yellow; quantification of this was achieved by detection of absorbance at 450nM 
using a BioChron Anthos plate reader. Assays were carried out in duplicate, with 
three animals per group.  
2.11 Quantitative (real time)-PCR 
Real time PCR (RT-PCR) was carried out using a LightCycler 480 instrument (Roche, 
Burgess Hill, UK). 14 μl reactions were used thoughout and all assays were designed 
for use with using a primer and probe technique. Probes were from the Universal 
Probe Library (Roche, Burgess Hill, UK) and when incorporated into a PCR product 
the 5’ conjugated fluorescein molecule emits light of 518nm wavelength.  
2.11.1 Assay Design 
RT-PCR assays were designed through the Roche Universal Probes Library Assay 
Design Centre. This online tool aids in-silico assay design. PCR targets were defined 
by their Ensembl number to ensure accurate target selection and the on-line tool 
was set up to design PCR reactions spanning at least one intron, and predicted to 
function under standard PCR conditions (Table 2-16). The primers and probes used 
in these assays are listed in Table 2-15. 
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Primers and probes were aliquoted into plates prior to PCR assays in a volume of 
5μL so that final primer concentration in a 14μL reaction was 400nM and final probe 
concentration was 200nM. As 21 targets were selected, each plate was arranged 
such that assays were completed in triplicate on a single plate, resulting in 63 filled 
wells per 96 well plate. Plates containing primers and probes were briefly 
centrifuged before being frozen for future use. Primers and probes frozen in plates 
were considered to be stable for at least 28 days (as advised by Roche, UK). 
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Table 2-15: summary of RT-PCR reactions 
Target L Primer R Primer Probe Amplicon Intron 
IFN-γ ENSMUSG00000055170 ATC-TGG-AGG-AAC-TGG-CAA-AA TTC-AAG-ACT-TCA-AAG-AGT-CTG-AGG-TA #21 89 83 
IL-1β ENSMUSG00000027398 TTG-ACG-GAC-CCC-AAA-AGA-T GAA-GCT-GGA-TGC-TCT-CAT-CTG #26 75 1541 
TNF-α ENSMUSG00000024401 TCT-TCT-CAT-TCC-TGC-TTG-TGG GGT-CTG-GGC-CAT-AGA-ACT-GA #49 128 514 
IL4 ENSMUSG00000000869 CAT-CGG-CAT-TTT-GAA-CGA-G CGA-GCT-CAC-TCT-CTG-TGG-TG #2 104 4367 
IL14  ENSMUSG00000053841 GAG-AAG-CTG-GCT-GCA-CTG-T TCA-TCT-GCT-TCT-GCG-AGT-TC #11 73 2549 
IL6 ENSMUSG00000025746 GCT-ACC-AAA-CTG-GAT-ATA-ATC-AGG-A CCA-GGT-AGC-TAT-GGT-ACT-CCA-GAA #6 78 3056 
IL17 ENSMUSG00000025929 CAG-GGA-GAG-CTT-CAT-CTG-TGT GCT-GAG-CTT-TGA-GGG-ATG-AT #74 94 1106 
Fas ENSMUSG00000024778 TGC-AGA-CAT-GCT-GTG-GAT-CT CTT-AAC-TGT-GAG-CCA-GCA-AGC #34 60 16377 
FasL ENSMUSG00000000817 ACC-GGT-GGT-ATT-TTT-CAT-GG AGG-CTT-TGG-TTG-GTG-AAC-TC #21 117 791 
c-IAP1 ENSMUSG00000057367 GAA-GAA-AAT-GCT-GAC-CCT-ACA-GA CAT-GAC-GAC-ATC-TTC-CGA-AC #80 72 4393 
c-IAP2  ENSMUSG00000032000 GGG-GAC-GAT-TTA-AAG-GTA-TCG TCG-GTT-TTA-CTG-CTA-GGC-TGA #5 139 11412 
XIAP  ENSMUSG00000025860 GCT-TGC-AAG-AGC-TGG-ATT-TT TGG-CTT-CCA-ATC-CGT-GAG #25 88 1334 
p53 ENSMUSG00000059552 ATG-CCC-ATG-CTA-CAG-AGG-AG AGA-CTG-GCC-CTT-CTT-GGT-CT #78 74 585 
Bcl-2 ENSMUSG00000057329 GTA-CCT-GAA-CCG-GCA-TCT-G GGG-GCC-ATA-TAG-TTC-CAC-AA #75 76 168904 
Bcl-xL  ENSMUSG00000007659 TGA-CCA-CCT-AGA-GCC-TTG-GA TGT-TCC-CGT-AGA-GAT-CCA-CAA #2 68 47142 
TFF2 ENSMUSG00000024028 TAG-AGG-GCG-AGA-AAC-CTT-CC TTC-TTT-CTG-TTG-TGG-GGT-GTC #1 61 906 
TFF3 ENSMUSG00000024029 CTG-GGA-TAG-CTG-CAG-ATT-ACG CAT-TTG-CCG-GCA-CCA-TAC #94 60 1980 
flaA GenBank: Y11601.2 GTT-TCT-GGG-GCC-AAT-GTA-AG GCC-TTT-GGC-AAA-ACC-AAT-AG #120 60 N/A 
TNF-AIP3 ENSMUSG00000019850 GCT-CAA-CTG-GTG-TCG-TGA-AG ATG-AGG-CAG-TTT-CCA-TCA-CC #21 69 3142 
NIK ENSMUSG00000020941 CTG-CAA-CCT-GAC-GGC-CTA CTC-CGT-GCC-AGG-AAT-GTA-GT #100 60 2632 
GAPDH ENSMUSG00000057666 GGG-TTC-CTA-TAA-ATA-CGG-ACT-GC CCA-TTT-TGT-CTA-CGG-GAC-GA #52 112 240 
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2.11.2 RT-PCR conditions 
All assays were performed using LightCycler 480 Probes Master mix (Roche, Burgess 
Hill, UK) and primers and probes as described in assay design above. Assays were 
designed to function with annealing temperature 60°C and hence functioned under 
standard PCR conditions as described in Table 2-16. As primers and probes were 
already laid out in plates in a pattern with 63 assays per 96 well plate, providing 
assays in triplicate for each PCR, a working mix of PCR grade water cDNA and 
proprietary master mix was generated for use across a single PCR plate. Its 
constituents are described in Table 2-17. 
 
 
 
 
Table 2-17: Master mix constituents for 14μL Real-Time PCR assays 
Constituent Volume per 
reaction 
Master Mix 
volume for 1 plate 
LightCycler480 Probes Master 7 μL 441 μL 
PCR grade water 1.68 μL 106 μL 
Template cDNA 0.31 μL 20 μL 
Primer and probe mix (in plate) 5 μL N/A 
2.11.3 Real-Time PCR Data analysis. 
Crossing point data were derived from Roche LightCycler software release 1.5.0, the 
maximal second derivative mathematical model was used to derive crossing point 
data set at high confidence. This algorithm is superior to threshold values as it 
excludes any bias derived from human selection of threshold levels. Prior to data 
collection standard curves were generated for all PCR assays using cDNA derived 
from a single Helicobacter infected wild-type mouse. These curves were used to 
define the efficiency of each PCR assay. 
Crossing point data and efficiency values were transferred to GenEx 5.3.4 (MultiD 
Software). Prior to statistical analysis, crossing point data were transformed by 
normalisation to GAPDH, and were represented as relative quantities compared to 
Table 2-16: Cycling conditions for real-time PCR assays 
Cycle Temperature (°C) Duration (seconds) Cycles 
Pre-incubation 95 600 1 
Amplification 95 10 45 
60 30 
72 1 
Cooling 40 30 1 
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untreated wild-type mice, samples were then scaled to Log2, transforming 
exponentially distributed data into normally distributed data and representing fold 
increases. These values were subjected to statistical analysis by 2-way ANOVA and 
Holm-Sidak post hoc analysis.  
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3 The impact of NF-κB signalling on gastric epithelial cell 
turnover 
Early human studies examining apoptotic and proliferative indices during the 
sequence of pre-malignant gastric pathology demonstrated higher apoptosis and 
proliferation indices at stages up to the development of complete intestinal 
metaplasia, at which point apoptotic indices fell sharply (274). Subsequent human 
studies have confirmed the observation that apoptotic indices are increased in 
gastritis and early metaplastic changes, but are reduced in the more advanced 
stages of gastric neoplasia (275). Once adenocarcinoma has been established, there 
appears to be a clear divergence in apoptotic and proliferative indices. Several 
studies have reported increased proliferation indices in human gastric cancers on 
the basis of Ki67 immunohistochemistry, and have also correlated these differences 
with poorer prognosis (276-278). In studies of established gastric adenocarcinoma, 
apoptotic indices have been observed to be reduced, with lower apoptotic indices 
being found in more poorly differentiated tumours (279).  
These findings are compatible with the complex mechanistic roles for gastric 
epithelial cell apoptosis that have been proposed during gastric carcinogenesis. Pro-
carcinogenic gastric epithelial apoptosis has been described in mouse models by 
Houghton and Wang, whereby Helicobacter induced stem-cell zone apoptosis leads 
to the recruitment of bone marrow derived pluripotent stem-cells. This results in 
the clonal repopulation of glandular units, which subsequently appear to have 
greater malignant potential than glands which are derived from native gastric stem 
cells (79). This is counterintuitive to the established carcinogenesis hypothesis 
based on Vogelstein’s work in colorectal cancer (280). This hypothesis proposes that 
evasion of apoptosis leads to the retention of mutations in stem cells, leading to 
progression along a carcinogenesis pathway. Whilst this hypothesis was established 
in colon cancer, similar mechanisms have been proposed in several other epithelial 
tumours types, including gastric adenocarcinoma (281). Together these concepts 
suggest that apoptosis in the gastric epithelium could have at least a biphasic effect 
upon gastric carcinogenesis. Apoptosis in the gastric epithelial stem cell zone during 
early gastric carcinogenesis may lead to the recruitment of bone marrow derived 
124 
stem cells, increasing the risk of pre-malignant change. Conversely, later stage 
apoptosis may function as a mechanism to delete cells that have acquired 
mutations, impeding progression towards carcinoma. This model correlates well 
with the earlier work examining apoptotic indices in human gastric tumours and 
premalignant tissue. 
Proliferation in the gastric mucosa has been shown to be linked to alternative 
pathway NF-κB signalling through studies involving mice that express a 
constitutively activated, truncated form of NF-κB2 p100. Over 90% of these animals 
die in the first few weeks of postnatal life and have massive gastric epithelial 
hyperplasia, associated with increased epithelial proliferation markers (256). These 
observations demonstrate a role for NF-κB signalling in the regulation of gastric 
epithelial cell proliferation, but the specific roles of other NF-κB proteins in 
regulating gastric epithelial homeostasis have yet to be investigated. 
Abrogation of classical pathway NF-κB signalling has however previously been 
shown to enhance γ-irradiation induced apoptosis in the intestine of mice with 
constitutive deletions of NF-κB1 (227, 247), and similar effects have also been 
shown in the stomachs of mice with gastric epithelial specific deletion of IKK-β (75). 
Therefore we have investigated the gastric mucosal structure and cell turnover in 
wild-type animals and those with specific germline deletions of NF-κB1, NF-κB2 and 
c-Rel both at baseline and after the induction of acute epithelial apoptosis by 12Gy 
whole-body γ-irradiation. 
3.1 Impact of abrogating NF-κB signalling upon gastric 
morphology and cell turnover 
To investigate the impact of NF-κB signalling on gastric epithelial structure and cell 
turnover, groups of adult (10-12 weeks post-natal) male and female mice were 
assessed, each group consisting of six animals. Haematoxylin and eosin (H&E) 
sections of both corpus and antrum were generated, and gland length and cell 
turnover were assessed by cell positional scoring of morphologically normal, 
apoptotic and mitotic cells as described in section 2.8.2. 
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3.1.1 Untreated mice with NF-κB deletions have altered gastric gland 
lengths 
In the gastric antrum, NF-κB1 null mice and NF-κB2 null mice were demonstrated to 
have elongated gastric glands. C57BL/6 mice had a mean number of 20.1 cells per 
half gland, whilst NF-κB2 null mice had a mean of 23.7 cells per half gland. NF-κB1 
null mice had a mean antral gland length of 26.9 cells which was significantly longer 
than the antral glands of both C57BL/6 and NF-κB2 null mice (1-way ANOVA and 
Holm-Sidak post-hoc test p<0.05) (Figure 3-1 upper panels and Figure 3-2 A and C). 
When separated by gender, the trend towards antral gland elongation was clear in 
both male and female NF-κB1 null mice, whilst it was only apparent in male NF-κB2 
null animals. The antral glands of c-Rel null mice were however of a similar length to 
wild-type animals. 
In the corpus, there were no significant differences in gland length between the 
different strains of mice when both male and female mice were considered 
together (Figure 3-1 lower panel and Figure 3-2 B). If genders were separated 
however, a significant elongation of the corpus glands of female NF-κB1 null mice 
became apparent. A similar trend was also seen in male mice, but this difference 
was small in magnitude and did not reach statistical significance (Figure 3-2 C). 
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Figure 3-1: Representative photomicrographs of antrum (upper panels) and corpus (lower panels) of 
untreated mice of each genotype 
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Figure 3-2: Number of cells per half gland in untreated animals. A: gastric antral glands separated by 
genotype. B: gastric corpus glands separated by genotype. C: Gastric antral glands separated by gender. D: 
Gastric corpus glands separated by gender.  
Statistical differences assessed by one way ANOVA (A and C) or 2-way ANOVA (B and D) and Holm-Sidak post-
hoc tests ** denotes significantly different (p<0.05) to both C57BL/6 and all other groups * signifies 
significantly different to C57BL/6 (p<0.05). n=6 male and 6 female per genotype. 
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3.1.2 Untreated mice with abrogated NF-κB signalling have increased 
cell turnover in both corpus and antrum 
Histological scoring of apoptosis and mitosis was achieved by assessing cells using 
morphological criteria from standard H+E sections. Representative images of gastric 
glands with mitotic and apoptotic events are shown in Figure 3-3. 
 
  
Figure 3-3: Representative images of mitotic and apoptotic events in the gastric epithelium. Solid black arrows 
annotate mitotic events, open white arrows mark apoptotic events. 
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3.1.3 Mitotic indices are elevated in untreated mice with abrogated 
NF-κB signalling 
In the antrum of wild-type C57BL/6 mice, 0.74% of cells were mitotic by 
morphological criteria. In comparison, NF-κB1 null mice had 2.3 fold higher 
proliferation scores with 1.7% of observed cells being mitotic. The percentage of 
mitotic cells in the antrum of untreated NF-κB2 null or c-Rel null mice was not 
significantly different to wild-type. When plotted on a cell positional basis, wild-type 
C57BL/6 animals demonstrated maximal numbers of apoptotic cells in the antrum 
at cell position 6, with mitotic events being observed between cell positions 2 and 
14. NF-κB2 null and c-Rel null mice showed no differences in these distributions by 
modified median test, whilst NF-κB1 null mice showed both an expansion, and a 
shift, in their proliferating zone with peak amounts of cell proliferation occurring at 
cell position 13 and proliferation being observed between cell positions 3 and 29. By 
modified median testing there were increased amounts of mitosis in the antrum of 
NF-κB1 null mice compared with wild-type mice between cell positions 11 and 21 
(Figure 3-4 A and C). 
In the corpus a similar pattern was observed. Wild-type C57BL/6 mice had a mitotic 
index of 0.31%, NF-κB1 null mice demonstrated 3.0 times more mitosis than this, 
whilst NF-κB2 and c-Rel null mice had similar amounts of corpus mitosis to wild-type 
mice. The cell position of maximal cell proliferation in the corpus of C57BL/6 mice 
was 14, with proliferation being observed between positions 8 and 31. NF-κB2 null 
and c-Rel null mice had no significant differences in the distribution of mitosis 
compared to wild-type mice. NF-κB1 null mice exhibited gastric corpus mitosis in a 
similar cell positional distribution to wild-type mice, with peak mitosis being 
observed at cell position 18 and dividing cells being seen between positions 10 and 
32. However, significantly more mitotic bodies were seen in NF-κB1 null mice than 
wild-type animals between cell positions 15 and 24 (Figure 3-4 B and D). 
Separating these data by gender revealed elevated mitotic indices in both the 
antrum and corpus of both male and female NF-κB1 null mice in comparison to 
wild-type controls. Other genotypes had similar quantities and distributions of 
mitosis to wild-type animals. When examined on a cell positional basis, significantly 
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elevated mitotic indices were observed in the antrum of female NF-κB1 null mice 
compared with C57BL/6 mice between cell positions 11 and 22. Cell positional 
differences were however not seen between any of the male groups in the antrum. 
In the corpus, significantly higher mitotic indices were observed in NF-κB1 null mice 
than wild-type animals between cell positions 17 and 24 in males and cell positions 
18 and 24 in females. Other groups had similar mitotic cell distributions to wild-type 
mice (Figure 3-5 A-F).   
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Figure 3-4: Mitosis in untreated animals, n=12 (6 male and 6 female) per group. A: gastric antral mitotic 
indices separated by genotype, B: gastric corpus mitotic indices separated by genotype, C: cell positional plot 
of mitotic scores in the gastric antrum, D: cell positional plot of mitotic scores in the gastric corpus. Statistical 
differences assessed by one way ANOVA and Holm-Sidak post-hoc tests in A and B, * signifies significantly 
different to C57BL/6. Statistical differences assessed by modified median test in C and D. Arrow denotes cell 
positions over which there was a significant difference from wild-type. Colour of arrow denotes comparison 
genotype. 
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Distribution of mitotic cells in the corpus of untreated female mice
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Figure 3-5: Mitosis in untreated animals separated by gender n=6 per group. A: gastric antral mitotic indices 
compared by genotype and gender, B: gastric corpus mitotic indices compared by genotype and gender, C: 
cell positional plot of mitosis in the gastric antrum of male mice, D: cell positional plot of mitosis in the gastric 
corpus of male mice, E: cell positional plot of mitosis in the gastric antrum of female mice, F: cell positional 
plot of mitosis in the gastric corpus of female mice. Statistical differences defined as in Figure 3-4. 
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3.1.4 Apoptotic indices are elevated in untreated mice with abrogated 
NF-κB signalling 
Untreated wild-type mice showed predictably low epithelial apoptotic indices in the 
stomach; in the antrum 0.12% of cells were morphologically apoptotic, whilst in the 
corpus 0.075% of cells had features of apoptosis (Figure 3-6 A and B). These events 
were distributed at very low frequency from cell position 4 to 20 in the antrum and 
8 to 26 in the corpus (Figure 3-6 C and D). NF-κB2 null and c-Rel null mice had 
similar levels and distributions of apoptotic cells as wild-type mice in both the 
antrum and corpus. In NF-κB1 null mice however higher apoptosis scores were 
observed. In the antrum of untreated NF-κB1 null mice there was a 3.5 fold increase 
in apoptotic cells compared to wild-type (0.41%), whilst in the corpus a 2.5 fold 
increase (0.19%) was observed. In the antrum this difference reached statistical 
significance, whilst in the corpus it fell short of a test of 95% confidence. No 
significant differences were observed in apoptotic index at specific cell positions 
between any of these groups. When these data were separated into different 
genders, the observed difference in number of apoptotic cells in the antrum was 
recapitulated in both male and female mice, with male NF-κB1 null mice having a 
2.7 fold increase in apoptosis scores, and females demonstrating a 4.8 fold increase 
(Figure 3-6 E and F). No significant differences in cell positional distributions were 
observed in individual genders (data not shown).  
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Figure 3-6: Apoptosis in untreated animals. A: gastric antral apoptotic indices separated by genotype. B: 
gastric corpus apoptotic indices separated by genotype. C: cell positional plot of apoptosis scores in the 
gastric antrum. D: cell positional plot of apoptosis scores in the gastric corpus. E: gastric antral apoptotic 
indices separated by both gender and genotype. F: gastric corpus apoptotic indices separated by both gender 
and genotype. In A-D n=12 per group (6 male and 6 female mice), in E and F n=6 mice per group. Statistical 
differences as defined in Figure 3-4. 
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3.1.5 NF-κB signalling in untreated animals with abrogated NF-κB 
signalling 
To investigate the mechanisms responsible for the changes in cell turnover 
observed in the gastric mucosae of mice with deletions of specific NF-κB family 
members, the DNA binding activity of specific NF-κB proteins in gastric mucosal 
samples was assayed. Nuclear lysates from gastric mucosal scrape samples were 
assayed using a proprietary DNA binding ELISA assay. Groups of three mice of each 
genotype were studied, and total protein was equalised by Bradford assay prior to 
conducting these assays. This assay is capable of assessing DNA binding activity of 
RelA, RelB, NF-κB1 and NF-κB2 in murine samples, but not c-Rel. 
This assay demonstrated no significant differences in DNA binding activity of any 
NF-κB proteins in any of the transgenic animals compared to control (Figure 3-7). 
These data were surprising, as it was expected that transgenic mice with deletions 
of specific pathway members would have lower DNA binding for these proteins 
than wild-type mice. These data therefore imply either non-specificity of the DNA 
binding ELISA technique, or that baseline NF-κB activity in the gastric mucosa of 
these animals was below the threshold of detection for this assay. The latter 
hypothesis is supported by the observation that classical pathway assays detect 
substantially higher levels of NF-κB DNA binding in the positive control assay than in 
our test assays. 
To assess whether there were any differences in the abundance of total NF-κB 
protein Western blotting for specific NF-κB proteins was therefore undertaken. All 
antibodies detected appropriately sized bands in wild-type mice; however c-Rel and 
NF-κB2 antibodies also detected proteins of these molecular weights in mice that 
had deletions at these loci, reflecting potential problems with the specificity of 
commercially available antibodies against NF-κB proteins. With this major caveat 
there were no statistically significant differences in protein quantification between 
untreated animals of different genotype by Western blotting and band 
densitometry (Figure 3-8 and Figure 3-9). 
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Figure 3-7: NF-κB protein DNA binding assays in untreated mice. A: Relative RelA DNA binding in nuclear 
lysates generated from gastric mucosal scrapes from mice of listed genotypes. B: Relative NF-κB1 DNA 
binding in nuclear lysates generated from gastric mucosal scrapes from mice of listed genotypes. C: Relative 
RelB DNA binding in nuclear lysates generated from gastric mucosal scrapes from mice of listed genotypes. D: 
Relative NF-κB2 DNA binding in nuclear lysates generated from gastric mucosal scrapes from mice of listed 
genotypes. n=3 mice per group. Statistical differences assessed by 1-way ANOVA on raw data – no significant 
differences were observed. 
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Figure 3-8: Representative images of Western blotting of protein extracts from the stomach of untreated 
mice probed with antibodies raised against targets defined to left of blot images. Lanes 1-3 protein extracts 
from C57BL/6 mice, lanes 4+5, NF-κB1 null mice, lanes 6-8 NF-κB2 null, lanes 9-11 c-Rel null mice. 
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Figure 3-9: Western blot band densitometry quantifying relative protein expression in wild-type and NF-κB 
null mice. A: RelA densitometry, B: RelB, C: c-Rel, D: NF-κB1 open bars p105, hatched bars p50, E: NF-κB2 
open bars p100, hatched bars p52 
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3.1.6 Cytokine and apoptosis mediating gene expression in untreated 
mice with abrogated NF-κB signalling 
To further investigate the mechanisms responsible for the differential proliferation 
and apoptosis observed in mice with altered NF-κB signalling, quantitative PCR 
assays were undertaken. These assays were targeted to quantify Th1 and Th2 
cytokines as well as a variety of apoptosis mediating genes. Transcripts of genes 
that influence positive and negative feedback into NF-κB signalling were also 
assessed, as were Trefoil factors 2 and 3 reflecting gastrointestinal mucosal 
remodelling. Assays were undertaken using RNA samples derived from corpus 
mucosa of adult (10-12 weeks post-natal) female mice with 3 animals in each group. 
Expression data were generated by comparing standard crossing point data to PCR 
efficiency curves using GenEx software. Statistical analysis was carried out using 
standardised expression data and 1-way ANOVAs with Holm-Sidak post-hoc testing. 
Compared to wild-type mice the most noticeable differences were observed in NF-
κB1 null mice. These animals had a 2.3 fold up-regulation in interferon-γ (Figure 
3-10 C), a 2.0 fold increase in IL1-β (Figure 3-10 B) gene expression and a 29.3 fold 
increase in TNF-α (Figure 3-10 A) expression. The Th2 differentiating factor IL-4 
(Figure 3-11 C) was also up-regulated in NF-κB1 null mice by a factor of 8.6 
compared to wild-type mice. No differences in IL-14 or IL-6 expression were 
observed in these, or any other genotype of mouse (Figure 3-11 A and B). 
The Fas/FasL axis of NF-κB1 null mice was also altered, with a 1.9 fold increase in 
Fas expression (Figure 3-12 A) and 4.8 fold increase in FasL expression (Figure 3-12 
B). This could explain the pro-apoptotic phenotype of these animals, however there 
was also a small (1.5-2.2 fold) but significant up-regulation of several conventionally 
anti-apoptotic transcripts, including c-IAP1, xIAP and BclxL (Figure 3-12 C, E and H). In 
addition to these the G1 checkpoint guardian p53 was also up-regulated in these 
animals by a factor of 1.8 (Figure 3-12 F). No differences were observed in the 
expression of cIAP2 or Bcl-2 in any of the groups (Figure 3-12 D and G). 
NF-κB2 null mice also showed a 1.8 fold increase in FasL expression (Figure 3-12 B), 
whilst c-Rel null mice demonstrated no significant differences in the abundance of 
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transcripts of either cytokines or apoptosis modulating genes compared to wild-
type mice. However all groups of NF-κB deficient mice demonstrated suppressed 
TNF-AIP3 signalling (Figure 3-13 A) with 1.7 fold reductions in TNF-AIP3 transcript 
abundance being observed in mice with classical pathway deletions and a 2.8 fold 
reduction in transcripts being detected in NF-κB2 null mice. No differences were 
observed in the relative abundance of transcripts of NIK (Figure 3-13 B) in un-
stimulated mice. 
The final difference that was observed in these animals was that there was a 2.8 
fold up-regulation of TFF-2 (Figure 3-13 C) in NF-κB1 null mice. It is unclear from 
these data whether this was a consequence of altered NF-κB signalling, or whether 
it reflects the altered mucosal structure observed in NF-κB1 null animals. 
Differences were not observed in the abundance of TFF-3 transcripts (Figure 3-13 
D). 
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Figure 3-10: Relative quantification of Th1 cytokine 
transcripts in the gastric corpus of untreated mice. A: 
relative expression of TNF-α. B: relative expression 
of IL-1β. C: relative expression of Interferon-γ. 
 * denotes significant difference in expression 
compared with wild-type. p<0.05 by 1-way ANOVA 
and Holm-Sidak post-hoc test, n=3 mice per group. 
 
Figure 3-11: Relative quantification of other cytokine 
transcripts in the gastric corpus of untreated mice. A: 
relative expression of IL-6. B: relative expression of 
IL-14. C: relative expression of IL-4. 
 * denotes significant difference in expression 
compared with wild-type. p<0.05 by 1-way ANOVA 
and Holm-Sidak post-hoc test, n=3 mice per group. 
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  Relative expression of Fas in untreated mice
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Figure 3-12: Relative quantification of apoptosis modulating gene transcripts in the gastric corpus of 
untreated mice. A: relative expression of Fas. B: relative expression of FasL. C: relative expression of c-IAP1. 
D: relative expression of c-IAP2. E: relative expression of xIAP. F: relative expression of p53. G: relative 
expression of Bcl-2. H: relative expression of Bcl-xL. 
 * denotes significant difference in expression compared with wild-type. p<0.05 by 1-way ANOVA and Holm-
Sidak post-hoc test, n=3 mice per group. 
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Figure 3-13: Relative quantification of NF-κB modulating transcripts (A and B) and trefoil factors (C and D) in 
the gastric corpus of untreated mice. A: relative expression of TNF-AIP3. B: relative expression of NIK. C: 
relative expression of TFF-2. D: relative expression of TFF-3. 
 * denotes significant difference in expression compared with wild-type. p<0.05 by 1-way ANOVA and Holm-
Sidak post-hoc test, n=3 mice per group. 
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3.2 The impact of NF-κB deletion on γ-irradiation induced 
changes in gastric epithelial structure and cell turnover 
Having observed the differences in gastric epithelial structure and cell turnover in 
untreated mice with NF-κB1 deletion, we hypothesised that deletion of this NF-κB 
protein would also have a role in the regulation of induced apoptosis. Unlike in the 
intestine where several chemical means of inducing epithelial apoptosis have been 
established, only γ-irradiation has been established as a reliable method to induce 
gastric epithelial apoptosis. Previous studies have established that a dose of 12Gy 
whole body γ-irradiation induces gastric epithelial apoptosis in the proliferating 
zone of C57BL/6 mice (267). In these studies maximal gastric epithelial apoptosis 
was observed after 48 hours, but apoptosis was observed as early as 6 hours after 
irradiation, hence mice of each genotype were subjected to 12Gy γ-irradiation and 
culled at either 6 or 48 hours post procedure. Six mice were included in each group, 
and both male and female mice were studied. H&E sections of both corpus and 
antrum were stained and cell turnover was assessed by cell positional scoring of 
apoptosis and when relevant mitosis.  
3.2.1 Irradiated NF-κB1 null mice continue to have elongated gastric 
glands 
6 hours after irradiation, NF-κB1 null mice continued to have elongated antral 
glands, with a mean gland length of 26.0 cells compared to 21.7 cells in wild-type 
mice (Figure 3-14a). When separated by genotype and gender it became apparent 
that this difference was due predominantly to elongated gastric glands in male NF-
κB1 null mice. This group had an average gland length of 27.9 cells, whilst male 
wild-type animals had an average gland length of 20.4 cells (Figure 3-14c). A similar 
pattern of gland elongation was observed in the antrum of female NF-κB1 null mice, 
but this did not reach statistical significance (Figure 3-14c). Antral gland length 
remained increased in NF-κB1 null mice 48 hours after γ-irradiation. At this point 
the antral gland length of c-Rel null mice was also significantly longer than wild-type 
mice, but significantly shorter than NF-κB1 null mice (Figure 3-15a). When these 
data were separated by gender, significantly longer glands were observed in the 
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antrum of both male and female NF-κB1 null mice, but only in male c-Rel null mice 
(Figure 3-15c). In the gastric corpus there were no significant differences in gland 
length between any genotypes either 6 or 48 hours post irradiation (Figure 3-14b 
and d and Figure 3-15b and d). 
  
Figure 3-14: Gastric gland length of animals 6 hours after γ-irradiation. A: gastric antral gland length by 
genotype. B: Gastric corpus gland length separated by genotype. C: Gastric antral gland length separated by 
genotype and gender. D: Gastric corpus gland length separated by genotype and gender. Statistical analyses 
as defined in Figure 3-2, n=12 mice (6 male and 6 female) for A and B, n=6 animals per group in C and D. 
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Figure 3-15: Gastric gland length of animals 48 hours after γ-irradiation. A: gastric antral gland length by 
genotype. B: Gastric corpus gland length separated by genotype. C: Gastric antral gland length separated by
genotype and gender. D: Gastric corpus gland length separated by genotype and gender. Statistical analyses 
as defined in Figure 3-2, n=12 mice (6 male and 6 female) for A and B, n=6 animals per group in C and D. 
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3.2.2 γ-irradiation induces gastric epithelial apoptosis in the 
proliferative zone 
Mitosis was entirely suppressed in the gastric antrum and corpus of all mouse 
genotypes both 6 and 48 hours after 12Gy γ-irradiation (data not shown). Gastric 
epithelial cell apoptosis was increased at both 6 and 48 hours post γ-irradiation in 
all groups of mice, and in both corpus and antrum (Table 3-1 and Table 3-2, Figure 
3-16 A and B, Figure 3-18 A and B).  
In the antrum of wild-type C57BL/6 mice, maximum frequency of apoptosis were 
observed at cell position 6, with apoptotic bodies being observed between cell 
positions 2 and 17 six hours after irradiation (Figure 3-16 C). In the corpus of these 
animals, maximum frequency of apoptosis were seen at cell positions 17 and 18, 
with apoptosis being observed between cell positions 8 and 27. These positions 
correlate with the proliferative zones of gastric antral and corpus glands as defined 
in section 3.1.3 above. 48 hours after γ-irradiation, apoptosis persisted in both the 
corpus and antrum of wild-type animals and was increased compared to animals 
culled 6 hours after irradiation. Apoptosis scores in the corpus increased by 2 fold 
and in the antrum by 1.4 fold. In these animals apoptosis was seen at similar cell 
positions to the earlier time point. No significant differences in the cell positional 
distribution of apoptosis was observed between C57BL/6 mice culled at 6 or 48 
hours post irradiation (Table 3-1 and Table 3-2). 
As predicted from the observations performed in untreated animals, deletion of NF-
κB1 resulted in more gastric epithelial apoptosis than similarly treated wild-type 
mice. Six hours after γ-irradiation, NF-κB1 null mice had a 1.3 fold elevation in 
apoptosis in comparison to wild-type mice in the antrum, with significant 
differences being observed compared to C57BL/6 mice between cell positions 9 and 
16 (Figure 3-16 A and C). In the corpus, a similar difference was observed, with a 4.4 
fold increase in apoptotic cells compared to C57BL/6 mice. This was associated with 
increased apoptosis between cell positions 9 and 24. In the corpus, there was also a 
significant increase in the number of apoptotic events observed in NF-κB2 null (2.0 
fold increase) and c-Rel null (2.2 fold increase) mice compared to wild-type, 
148 
although these differences were significantly smaller than those observed in NF-κB1 
null mice, and were not associated with corroborative statistically significant 
differences in cell positional distributions. 
48 hours after γ irradiation, animals with transgenic deletion of NF-κB1 continued to 
have elevated apoptosis scores in the corpus in comparison to irradiated wild-type 
mice, with a 2.96 fold increase in apoptosis. These animals demonstrated 
significantly increased apoptotic scores at cell positions 10-18. No differences in 
antral apoptosis were however observed between C57BL/6 and NF-κB1 null mice 48 
hours after 12Gy γ-irradiation. Comparisons between wild-type and NF-κB2 or c-Rel 
null mice at the 48 hour time point demonstrated no significant differences in either 
the antrum or corpus. 
These studies were performed in groups of 6 male and female animals. In most 
cases the same pattern was observed in both male and female mice, but in some 
cases statistical significance was only reached when male and female groups were 
pooled. When comparing groups of different gender, but the same genotype and 
treatment statistically significant differences in opposite vectors were not observed, 
nor were statistically significant differences in both cell positional and fold changes 
observed between these groups (Table 3-1, Table 3-2, Figure 3-16 and Figure 3-18). 
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Table 3-1: Summary of statistical differences in apoptosis in the gastric antrum in response to γ 
irradiation 
Group 1 Group 2 
Fold difference Cell positions 
C ♂ ♀ C ♂ ♀ 
Untreated C57BL/6 6 hours C57BL/6 
29.7 19.38 48.22 3-13 5-10 4-11 
Untreated NF-κB1 null 6 hours NF-κB1 null 
11.0 9.89 12.40 2-14 3-14 3-11 
Untreated NF-κB2 null 6 hours NF-κB2 null 
23.4 14.42 41.27 3-13 4-10 3-11 
Untreated c-Rel null 6 hours c-Rel null 
26.1 14.60 83.55 3-12 3-10 3-12 
6 hours C57BL/6 6 hours NF-κB1 null 
1.29 1.37 1.23 9-16 9-16 NSD 
6 hours C57BL/6 6 hours NF-κB2 null 
0.89 0.75 1.01 NSD NSD NSD 
6 hours C57BL/6 6 hours c-Rel null 
0.80 0.82 0.78 NSD NSD NSD 
Untreated C57BL/6 48 hours C57BL/6 
40.9 33.42 52.55 2-16 3-15 3-12 
Untreated NF-κB1 null 48 hours NF-κB1 null 
8.31 8.04 8.54 4-19 5-20 5-13 
Untreated NF-κB2 null 48 hours NF-κB2 null 
34.1 20.06 62.00 2-14 3-9 3-14 
Untreated c-Rel null 48 hours c-Rel null 
39.6 15.45 160.8 3-16 4-15 3-14 
6 hours C57BL/6 48 hours C57BL/6 
1.38 1.72 1.09 NSD NSD NSD 
6 hours NF-κB1 null 48 hours NF-κB1 null 
0.75 0.81 0.69 3-6 NSD 3-5 
6 hours NF-κB2 null 48 hours NF-κB2 null 
1.46 1.39 1.50 NSD NSD NSD 
6 hours c-Rel null 48 hours c-Rel null 
1.52 1.06 1.93 9-12 9-13 NSD 
48 hours C57BL/6 48 hours NF-κB1 null 
0.71 0.65 0.78 10-18 NSD NSD 
48 hours C57BL/6 48 hours NF-κB2 null 
0.95 0.61 1.39 NSD NSD NSD 
48 hours C57BL/6 48 hours c-Rel null 
0.88 0.50 1.37 NSD NSD NSD 
C: Combined male and female genotypes n=12. When genders separated n=6 per group 
NSD: No statistically significant difference at any cell position 
Figures in red represent statistically significant differences 
Shaded cells reflect concordance in statistical differences in fold changes and cell positional data 
Differences in fold change tested by ANOVA and Holm Sidak post-hoc test 
Differences in cell positional distributions tested by modified median test 
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Table 3-2: Summary of statistical differences in apoptosis in the gastric corpus in response to γ 
irradiation 
Group 1 Group 2 
Fold difference Cell positions 
C ♂ ♀ C ♂ ♀ 
Untreated C57BL/6 6 hours C57BL/6 
6.01 8.44 5.16 14-24 NSD 16-21 
Untreated NF-κB1 null 6 hours NF-κB1 null 
10.5 9.34 11.7 9-25 9-24 11-23 
Untreated NF-κB2 null 6 hours NF-κB2 null 
8.17 27.4 3.90 11-27 8-27 15-22 
Untreated c-Rel null 6 hours c-Rel null 
9.96 8.40 14.3 11-25 15-23 12-21 
6 hours C57BL/6 6 hours NF-κB1 null 
4.43 5.41 3.86 9-25 10-26 13-21 
6 hours C57BL/6 6 hours NF-κB2 null 
1.98 3.28 1.22 NSD 19-26 NSD 
6 hours C57BL/6 6 hours c-Rel null 
2.22 3.28 1.59 NSD NSD NSD 
Untreated C57BL/6 48 hours C57BL/6 
12.0 31.3 5.18 9-24 9-22 NSD 
Untreated NF-κB1 null 48 hours NF-κB1 null 
14.1 11.9 16.6 7-25 10-25 7-21 
Untreated NF-κB2 null 48 hours NF-κB2 null 
9.77 34.0 4.38 8-24 8-21 17-21 
Untreated c-Rel null 48 hours c-Rel null 
7.01 5.66 10.5 12-25 16-24 13-20 
6 hours C57BL/6 48 hours C57BL/6 
2.00 3.71 1.00 NSD 13-20 NSD 
6 hours NF-κB1 null 48 hours NF-κB1 null 
1.34 1.28 1.42 NSD NSD 8-12 
6 hours NF-κB2 null 48 hours NF-κB2 null 
1.20 1.24 1.12 NSD 22-24 NSD 
6 hours c-Rel null 48 hours c-Rel null 
0.70 0.67 0.73 NSD NSD NSD 
48 hours C57BL/6 48 hours NF-κB1 null 
2.96 1.86 5.46 9-21 NSD 8-20 
48 hours C57BL/6 48 hours NF-κB2 null 
1.18 1.10 1.36 NSD NSD NSD 
48 hours C57BL/6 48 hours c-Rel null 
0.78 0.60 1.16 NSD NSD NSD 
C: Combined male and female genotypes n=12. When genders separated n=6 per group 
NSD: No statistically significant difference at any cell position 
Figures in red represent statistically significant differences 
Shaded cells reflect concordance in statistical differences in fold changes and cell positional data 
Differences in fold change tested by ANOVA and Holm Sidak post-hoc test 
Differences in cell positional distributions tested by modified median test 
Underlined figure signify significantly higher scores than C57BL/6 mice, but scores that are 
significantly lower than those observed in NF-κB1 null animals 
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Figure 3-16: Gastric epithelial apoptosis in animals 6 hours after 12Gy γ-irradiation, n=12 mice (6 male, 6 
female) per group. A: gastric antral apoptotic indices separated by genotype, B: gastric corpus apoptotic 
indices separated by genotype, C: cell positional plot of apoptosis scores in the gastric antrum, D: cell 
positional plot of apoptosis scores in the gastric corpus. Statistical differences defined as in Figure 3-4. 
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Figure 3-17: Gastric epithelial apoptosis in irradiated animals 6 hours after 12Gy γ-irradiation and separated 
by gender, n=6 mice per group. A: gastric antral apoptotic indices by genotype and gender, B: gastric corpus 
apoptotic indices by genotype and gender, C: cell positional plot of apoptosis in the gastric antrum of male 
mice, D: cell positional plot of apoptosis in the gastric corpus of male mice, E: cell positional plot of apoptosis 
in the gastric antrum of female mice, F: cell positional plot of apoptosis in the gastric corpus of female mice. 
Statistical differences defined as in Figure 3-4. 
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Figure 3-18: Gastric epithelial apoptosis in animals 48 hours after 12Gy γ-irradiation, n=12 mice (6 male and 6 
female) per group. A: gastric antral apoptotic indices separated by genotype, B: gastric corpus apoptotic 
indices separated by genotype, C: cell positional plot of apoptosis scores in the gastric antrum, D: cell 
positional plot of apoptosis scores in the gastric corpus. Statistical differences defined as in Figure 3-4. 
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Figure 3-19: Gastric epithelial apoptosis in irradiated animals 48 hours after 12Gy γ-irradiation and separated 
by gender, n=6 mice per group. A: gastric antral apoptotic indices by genotype and gender, B: gastric corpus 
apoptotic indices by genotype and gender, C: cell positional plot of apoptosis in the gastric antrum of male 
mice, D: cell positional plot of apoptosis in the gastric corpus of male mice, E: cell positional plot of apoptosis 
in the gastric antrum of female mice, F: cell positional plot of apoptosis in the gastric corpus of female mice. 
Statistical differences defined as in Figure 3-4. 
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3.2.3 DNA binding of NF-κB sub-units in irradiated mice  
To analyse the effect of γ-irradiation on NF-κB signalling, DNA binding ELISAs were 
performed. Groups of three adult (10-12 week old) female mice were subjected to 
12Gy whole body γ-irradiation. Animals were culled 6 hours following the 
procedure and tissues were taken for cellular fractionation and protein extraction. 
As described in section 3.1.5 above, assays were available for DNA binding activity 
of RelA, RelB, NF-κB1 and NF-κB2, but not c-Rel. 
In wild-type mice, irradiation resulted in a significant (1.7 fold) reduction in NF-κB2 
DNA binding compared to untreated mice (Figure 3-20 D), but no significant 
changes were demonstrated in other assayed NF-κB family members (Figure 3-20 A-
C). 
In irradiated NF-κB1 null mice a 2.1 fold increase in NF-κB2 DNA binding was 
observed (Figure 3-20 D), whilst in NF-κB2 null animals a 1.2 fold decrease in RelA 
DNA binding was observed (Figure 3-20 A). There was also a statistically significant 
reduction in the NF-κB2 DNA binding result observed in NF-κB2 null mice (Figure 
3-20 D), though this resulted from a ratio of two low readings and may therefore 
reflect variations in essentially negative results. 
To compare the effects of different genotypes on the DNA binding activity of 
different NF-κB proteins, data have been plotted normalised to the DNA binding 
activity of wild-type mice. These data demonstrate no statistically significant 
differences in the DNA binding activity of RelA, RelB or NF-κB1 (Figure 3-20 E-G), but 
do demonstrate that NF-κB2 null mice have significantly less NF-κB2 DNA binding 
than other groups, as expected, and that NF-κB1 null mice have enhanced NF-κB2 
DNA binding in comparison to wild-type mice (Figure 3-20 H). The absence of any 
differences in NF-κB1 DNA binding again raises the possibility that NF-κB1 activity 
was below the level of detection for this assay.  
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Figure 3-20: NF-κB protein DNA binding assays in irradiated mice, n=3 female mice per group. A: Relative RelA 
DNA binding in nuclear lysates generated from gastric mucosal scrapes from mice of listed genotype. B: 
Relative NF-κB1 DNA binding in nuclear lysates generated from gastric mucosal scrapes from mice of listed 
genotype. C: Relative RelB DNA binding in nuclear lysates generated from gastric mucosal scrapes from mice 
of listed genotype. D: Relative NF-κB2 DNA binding in nuclear lysates generated from gastric mucosal scrapes 
from mice of listed genotype. E: Relative RelA DNA binding between untreated and irradiated mice. F: 
Relative NF-κB1 DNA binding between untreated and irradiated mice. G: Relative RelB DNA binding between 
untreated and irradiated mice. H: Relative NF-κB2 DNA binding between untreated and irradiated mice. A-D: 
Statistical differences assessed by 1-way ANOVA on raw data – *denotes significant difference to C57BL/6 
p<0.05 E-G: Statistical difference between untreated and irradiated groups defined by 2-tailed unpaired 
Student’s t-test, * denotes significant difference between untreated and irradiated mice. 
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3.2.4 Cytokine and apoptosis mediating gene expression in irradiated 
mice with abrogated NF-κB signalling 
To investigate the mechanisms responsible for the differences observed in 
apoptosis scores following γ-irradiation in mice lacking specific NF-κB proteins, real-
time PCR for selected cytokines and apoptosis modulating genes was performed. In 
addition, mRNA abundance was assessed for TNF-AIP3 and NIK, negative and 
positive regulators of NF-κB signalling respectively, and for trefoil factors 2 and 3. 
Groups of 3 adult (10-12 week old) female mice were subjected to 12Gy γ-
irradiation and were culled 6 or 48 hours post procedure. Untreated animals of the 
same age were also culled at the same time as control animals. Gastric corpus 
samples were taken for RNA extraction and subsequent cDNA quantification by 
real-time PCR. These assays were assessed statistically using 2-way ANOVAs with 
genotype and treatment considered as factors. Significant differences were 
documented for comparisons with C57BL/6 mice that had undergone the same 
treatment and for untreated animals of the same genotype.  
The most profound differences in cytokine gene expression were again seen 
between C57BL/6 and NF-κB1 null mice, and are summarised in Table 3-3. As 
previously described in section 3.1.6, NF-κB1 null animals had up-regulation of Th1 
cytokines (Figure 3-21 A-C) and IL-4 (Figure 3-22 C) at baseline. These targets also 
demonstrated similar dynamic changes in NF-κB1 null animals following γ-
irradiation. The abundance of these cytokine transcripts was significantly lower 48 
hours post irradiation compared to untreated animals. In keeping with these 
findings, transcripts of the assayed Th1 cytokines were more abundant in NF-κB1 
null mice than wild-type mice in both the untreated group and the group culled 6 
hours post γ-irradiation. In the 48 hours post γ-irradiation group the abundance of 
Th1 cytokine and IL4 transcripts was similar in wild-type mice and NF-κB1 null mice. 
C57BL/6 mice also showed increased IL-4 transcript abundance 6 hours post 
irradiation, resulting in similar levels to NF-κB1 null mice at that time point. By 48 
hours post irradiation, IL-4 transcript abundance had returned to the pre-irradiation 
value in C57BL/6 mice and to a similar abundance in NF-κB1 null animals. 
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Irradiated mice also demonstrated significantly different transcript abundance of IL-
6 (Figure 3-22 A). 6 hours post irradiation, NF-κB1 null mice had more abundant IL-6 
transcripts than C57BL/6 mice, whilst in c-Rel null mice less IL-6 transcript was 
detected than in wild-type mice. However there were no significant dynamic 
changes in response to treatment within any genotype, hence the significance of 
these differences is difficult to interpret.  
IL-1β was the only cytokine that demonstrated dynamic changes in expression in 
NF-κB2 null mice (Figure 3-21 B), transcript abundance was suppressed at 6 but not 
48 hours post irradiation. No changes were observed in the abundance of transcript 
for any of the cytokines in response to γ-irradiation in c-Rel null mice, and IL-14 
abundance did not change in response to any treatment, or in any genotype of 
mouse (Figure 3-22 B). 
Dynamic changes in apoptosis regulating gene transcription were also observed in 
wild-type, NF-κB1 null and c-Rel null mice, but not in NF-κB2 null animals. In wild-
type mice, a 1.8 fold elevation in Fas expression was observed at 6 hours post 
irradiation (Figure 3-23 A). 
In NF-κB1 null mice, c-IAP1 expression was reduced 2.2 fold at 6 hours and 1.5 fold 
at 48 hours relative to untreated mice of the same genotype (Figure 3-23 C). 
Similarly, xIAP expression was relatively reduced, although this only reached 
statistical significance at 48 hours after irradiation when it was reduced 1.8 fold 
(Figure 3-23 E). In c-Rel null mice, xIAP and c-IAP1 transcript abundance did not 
show dynamic changes, but c-IAP2 transcripts were significantly less abundant at 
both 6 and 48 hours after irradiation (1.7 fold and 1.8 fold reductions 
respectively)(Figure 3-23 D). These factors may explain the increase in apoptosis 
that was observed in response to irradiation in these animals. By contrast however, 
there was a 1.6 fold reduction in FasL transcript abundance 6 hours after irradiation 
in NF-κB1 null mice, which was more pronounced at 48 hours post irradiation when 
a 3.3 fold reduction in transcript abundance was observed. Transcripts of anti-
apoptotic Bcl-2 were more abundant 48 hours post irradiation in both NF-κB1 null 
(1.8 fold increase) and c-Rel null (1.6 fold increase) animals than at other time 
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points (Figure 3-23 G). Dynamic changes were not observed in BclxL or p53 cDNAs in 
response to radiation (Figure 3-23 F and H). 
The differences in mucosal cell turnover seen between wild-type and NF-κB null 
animals were also reflected in the relative expression of trefoil factors. In wild-type 
animals, there was a transient 2.2 fold up-regulation of TFF2 6 hours following 
radiation, whilst in animals with NF-κB deletion, this was not observed (Figure 3-24 
C). All groups of animals with abrogated NF-κB signalling had up-regulated TFF3 in 
response to radiation, which was not observed in wild-type mice. Up-regulation of 
TFF3 was observed at the 6 hour time-point for NF-κB2 null and c-Rel null (1.5 fold 
and 1.9 fold up-regulation respectively) mice and at the 48 hour time-point for NF-
κB1 and NF-κB2 (1.7 fold and 1.6 fold up-regulation respectively) null animals 
(Figure 3-24 D). The later responses of NF-κB1 null mice may reflect the use of an 
alternative signalling mechanism to standard classical pathway signalling. 
Supporting this, the NF-κB1 null group also demonstrate 1.5 fold up-regulation of 
NIK at 48 hours post irradiation (Figure 3-24 B), in keeping with activation of the 
alternative pathway of NF-κB signalling in these animals at this time point. 
Table 3-3: Selected cytokine gene expression in NF-κB1 null and C57BL/6 mice with and without irradiation. 
Data expressed as ratio of NF-κB1 null expression and C57BL/6 expression after same treatment, figures in 
brackets are C57BL/6 expression and NF-κB1 null expression. 
Gene Relative untreated 
expression 
Relative expression 6 
hours post irradiation 
Relative expression 
48 hours post 
irradiation 
TNF-α 29 (1.0, 30.3) 16 (1.9, 31.0) 1.0 (1.5, 1.5) 
IL-1β 2.0 (1.1, 2.1) 2.1 (0.9, 1.9) 1.3 (0.9, 1.2) 
Interferon-γ 2.3 (1.0, 2.4) 3.0 (0.9, 2.7) 1.3 (0.9, 1.3) 
IL-4 8.6 (1.0, 8.8) 1.1 (7.9, 8.6) 1.0 (1.5, 1.5)  
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Figure 3-22: Relative quantification of other cytokine 
transcripts in the gastric corpus of untreated mice 
and mice 6 and 48 hours after 12Gy whole-body γ-
irradiation. A: relative expression of IL-6. B: relative 
expression of IL-14. C: relative expression of IL-4. 
 * marks difference in expression compared with 
untreated of same genotype.  
# marks difference in expression compared to wild-
type in same treatment group.  
p<0.05 by 1-way ANOVA and Holm-Sidak post-hoc 
test, n=3 mice per group. 
Figure 3-21: Relative quantification of Th1 cytokine 
transcripts in the gastric corpus of untreated mice 
and mice 6 and 48 hours after 12Gy whole-body γ-
irradiation. A: relative expression of TNF-α. B: 
relative expression of IL-1β. C: relative expression of 
Interferon-γ. 
 * marks difference in expression compared with 
untreated of same genotype.  
# marks difference in expression compared to wild-
type in same treatment group.  
p<0.05 by 1-way ANOVA and Holm-Sidak post-hoc 
test, n=3 mice per group. 
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Figure 3-23: Relative quantification of apoptosis modulating gene transcripts in the gastric corpus of untreated 
mice and mice 6 and 48 hours after 12Gy whole-body γ-irradiation. A: relative expression of Fas. B: relative 
expression of FasL. C: relative expression of c-IAP1. D: relative expression of c-IAP2. E: relative expression of 
xIAP. F: relative expression of p53. G: relative expression of Bcl-2. H: relative expression of Bcl-xL. 
 * marks difference in expression compared with untreated of same genotype.  
# marks difference in expression compared to wild-type in same treatment group.  
p<0.05 by 1-way ANOVA and Holm-Sidak post-hoc test, n=3 mice per group. 
A 
D C 
B 
FE 
G H
162 
  
  
A B 
C D 
Figure 3-24: Relative quantification of NF-κB modulating transcripts (A and B) and trefoil factors (C and D) in 
the gastric corpus of untreated mice and mice 6 and 48 hours after 12Gy whole-body γ-irradiation. A: relative 
expression of TNF-AIP3. B: relative expression of NIK. C: relative expression of TFF-2. D: relative expression of 
TFF-3. 
* marks difference in expression compared with untreated of same genotype.  
# marks difference in expression compared to wild-type in same treatment group.  
p<0.05 by 1-way ANOVA and Holm-Sidak post-hoc test, n=3 mice per group. 
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3.3 Discussion 
The data presented in this chapter emphasise both the importance of specific NF-κB 
family members in regulating gastric epithelial homeostasis and the non-
redundancy present in the NF-κB pathway. The observation that classical pathway 
NF-κB signalling influences baseline gastric epithelial cell turnover through an NF-
κB1 dependent mechanism is a novel finding. Evidence for this is provided both by 
the consistency of these observations at two sites in the stomach and across both 
genders of mice, and by the corroborative finding of elongated gastric glands seen 
particularly in the antrum of NF-κB1 null mice. These data are consistent with 
previously published observations demonstrating that abrogation of classical 
pathway NF-κB signalling results in enhanced epithelial proliferation in various 
tissues. Keratinocyte specific deletion of IKK-β resulted in enhanced keratinocyte 
proliferation as demonstrated by Ki67 immunohistochemistry (230). Inan et al 
investigated the effect of NF-κB1 deletion on colonic proliferation and showed that 
NF-κB1 null mice had longer colonic crypts than wild-type mice, and that these 
crypts also had longer proliferating zones (248).  
To define the mechanisms responsible for the changes in gastric homeostasis in NF-
κB1 null mice, quantitative PCR assays were performed. These assays provide 
evidence of elevated basal Th1 cytokine transcription in the gastric corpus of 
untreated NF-κB1 null mice, suggesting that cytokines may mediate the drive 
towards increased cell turnover. This observation is supported by previous data 
assessing proliferation at different sites in these animals. In the colon, Inan et al 
demonstrated enhanced TNF-α expression in NF-κB1 null mice by in-situ 
hybridisation (248), whilst Van Hogerlinden et al showed enhanced 
immunohistochemical staining for TNF-α in the skin of NF-κB1 null mice (230). Our 
observations of increased abundance of transcripts of interferon-γ and IL-1β have 
not been reported in previous studies of proliferation in these animals, but they are 
consistent with findings that NF-κB1 null animals demonstrate increased expression 
of Th1 cytokines compared to wild-type mice in other contexts including 
gastrointestinal infections (282). 
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The effects of NF-κB1 deletion upon apoptosis have not previously been addressed 
in the stomach. Previous studies that assessed proliferation in the colon and skin 
did not investigate apoptosis. However there is a wealth of evidence that classical 
pathway NF-κB signalling has a role in the prevention of hepatocyte apoptosis. Mice 
that have constitutive deletions of RelA, IKK-β and IKK-γ all undergo massive 
hepatocyte apoptosis, which results in pre-natal death (223, 225, 226). The real-
time PCR data described in section 3.1.6 demonstrates that in untreated NF-κB1 
animals, a number of pro- and anti- apoptotic genes show differential levels of 
expression in the stomach compared to wild-type mice. Observed differences 
include up-regulation of Fas and FasL, conventionally considered pro-apoptotic, and 
also of anti-apoptotic targets cIAP-1, xIAP and BclxL. These genes are all recognised 
as potential NF-κB transcription targets, but they have not previously been shown 
to be differentially regulated in animals with transgenic deletions of NF-κB proteins. 
The observation of increased transcripts of mixed pro- and anti-apoptotic genes in 
these animals reflects the complex role that NF-κB signalling plays in controlling 
apoptotic responses. The overall effect could be considered to be the generation of 
a pro-apoptotic milieu in the gastric mucosa of NF-κB1 null mice, resulting in the 
increased level of apoptosis observed at baseline. These animals also demonstrated 
up-regulated trefoil factor 2 compared to wild-type mice. Trefoil factor 2 has not 
previously been shown to be under direct transcriptional control of NF-κB signalling; 
hence this difference in transcription may reflect the role of TFF2 as a regulator of 
epithelial repair and remodelling, rather than direct alteration in transcriptional 
activity under the control of NF-κB1. 
Untreated NF-κB2 null and c-Rel null mice were not shown to have significantly 
different amounts of apoptosis or mitosis in comparison to wild-type mice. In 
keeping with this, few differences in gene expression were detected in these 
animals compared to un-treated C57BL/6 mice. NF-κB2 null mice had up-regulated 
FasL compared to wild-type mice, but by a factor of only 1.8 (c.f. the fold change of 
4.8 between NF-κB1 null mice and wild-type). No differences in the expression of 
cytokines or apoptosis-regulating genes were detected in the c-Rel null group.  
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Previous studies have examined the effect of abrogated classical pathway NF-κB 
signalling on radiation induced apoptosis in the GI tract, but have not addressed the 
function of alternative pathway signalling. Both NF-κB1 null mice (247) and mice 
with intestinal epithelial cell specific deletion of IKK-β (227) have been shown to 
undergo increased small intestinal epithelial apoptosis in response to γ-irradiation. 
Similarly, mice with gastric epithelial specific IKK-β deletion have been shown to 
have a 4 fold increase in apoptosis in the stomach 48 hours after 12Gy γ-irradiation, 
compared to wild-type mice (75). Our data are therefore consistent with a role of 
classical pathway NF-κB signalling in limiting gastric epithelial apoptosis after DNA 
damage. They also demonstrate that this is mediated through a predominantly NF-
κB1 dependent mechanism, with only a modest effect from c-Rel dependent 
signalling. We also provide the first evidence that alternative pathway signalling has 
a role in the regulation of radiation induced epithelial apoptosis. The effect of NF-
κB2 deletion is less than the effect of NF-κB1 deletion, but is comparable to the 
effect of c-Rel deletion. Overall, this suggests that the role of alternative pathway 
NF-κB signalling in protecting the gastric epithelium from radiation induced 
apoptosis is subsidiary to the role of the classical pathway. 
The mechanisms involved in determining these altered responses to radiation were 
assessed by quantitative PCR studies. These demonstrated differences in the 
dynamic response of the gastric epithelium to radiation in each group of mice. Wild-
type mice showed up-regulated IL-4 6 hours post radiation, which resulted in levels 
of IL-4 transcript similar to those seen in NF-κB1 null mice at baseline. Similarly, IL-4 
was up-regulated in c-Rel null mice, but only at the 48 hour time-point. In contrast, 
IL-4 levels were persistently low in NF-κB2 null mice. 
 IL-4 has previously been reported to be up-regulated in T-cells in response to γ-
irradiation (283) and more generally in response to cutaneous UV irradiation (284), 
but has not been shown to be up-regulated in the GI tract in response to this 
stimulus before. 
Wild-type mice also demonstrated up-regulation of Fas at 6 hours, to levels that 
were similar to those seen in NF-κB1 null mice before treatment. The Fas / Fas-
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ligand pathway is known to be important in the mediation of apoptosis signals 
induced by γ-irradiation mediated DNA damage (285), and animals with transgenic 
deficiency of both Fas and FasL have been generated (286), however to date no 
data have been published assessing the susceptibility of these animals to radiation 
induced apoptosis either in the GI tract, or in other organ systems. 
As described above, Th1 cytokines and IL-4 were up-regulated at baseline in animals 
with NF-κB1 deletions. The effect of radiation on these transcripts was identical 
across all four assays. Assessments at baseline and at six hours demonstrated 
similarly elevated levels of transcript in NF-κB1 null mice, but in mice culled 48 
hours after irradiation the expression of these genes was reduced to levels 
equivalent to untreated wild-type mice. These assays cannot define the cellular 
origin of cytokine transcripts. Either epithelial or immune cells could be responsible 
for their production, but the marked reduction in cytokine production at 48 hours 
suggests that the cells generating these cytokines have undergone significant 
alterations in their function, possibly due to radiation induced apoptosis. Our 
studies have defined the effect of radiation on epithelial apoptosis, but have not 
examined the effect on the immune compartment. The dose of radiation used in 
these studies (12Gy whole body γ-irradiation) is significantly higher than the dose 
used for myeloablation in adult mice (commonly 9-9.5Gy (287)), therefore it is 
possible that cytokines of immunological origin have been ablated by 48 hours post 
irradiation due to the destruction of immunological as well as epithelial 
compartments. 
In NF-κB1 null mice, dynamic changes were also seen in the expression of several of 
the apoptosis mediating genes that were assessed. FasL was significantly up-
regulated in these animals at baseline, but the abundance of FasL transcripts was 
reduced following irradiation. Similarly the quantities of c-IAP1 and xIAP transcripts 
were lower in irradiated mice than untreated animals. There was also a significant 
up-regulation of Bcl-2 in these animals at the 48 hour time point. The Bcl-2 
promoter is a recognised target of classical pathway NF-κB signalling (215), and its 
up-regulation at a late time-point may reflect resolving differences in apoptotic 
responses between genotypes. Our observations of apoptosis in the corpus 
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continue to demonstrate differences between NF-κB1 null mice and C57BL/6 at 48 
hours, however in the corpus these differences have resolved. To further 
investigate this, studies quantifying apoptosis in the gastric corpus at a later time 
point may be helpful to assess whether up-regulation of Bcl-2 does herald 
resolution of the phenotype observed at 48 hours in NF-κB1 null mice. 
In c-Rel null mice, the only cytokine that demonstrated dynamic responses to 
irradiation was IL-4, similar to the situations observed in wild-type mice. However, 
this response appeared to be impeded in c-Rel null mice as up-regulation occurred 
only at the 48 hour, rather than 6 hour time-point, suggesting that c-Rel is 
important in the efficient induction of IL-4 in this context. Amongst the apoptosis 
modulating genes, only Bcl-2 was differentially expressed, with a similar up-
regulation at 48 hours as was seen in NF-κB1 null mice, suggesting there may be a 
generic effect of classical pathway signalling on the suppression of Bcl-2 
transcription.  
In animals with abrogated alternative pathway NF-κB signalling, no differences were 
observed in quantification of any of the cytokines or apoptosis inducing genes that 
were tested following irradiation. This reflects a significant difference to wild-type 
mice where IL-4 was up-regulated 6 hours post irradiation. There is also an apparent 
difference in the trend of Fas responses in these animals compared to wild-type 
mice. Wild-type animals demonstrated up-regulation of Fas 6 hours following 
radiation, whilst no change in Fas expression was seen between NF-κB2 groups 
after different treatments. However as the up-regulation observed in wild-type 
mice was of a small magnitude, and NF-κB2 null mice had insignificantly higher 
levels of Fas expression at baseline, the difference in Fas expression between wild-
type and NF-κB2 null groups treated in the same way was not statistically 
significant. Therefore it is unclear whether any of these differences represent a 
biological difference between groups. 
Different patterns of gene regulation in different transgenic animals suggest that 
classical and alternative pathways of NF-κB signalling impose controls on epithelial 
apoptosis through different mechanisms. Classical pathway signalling appears to 
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control cytokine expression, both at baseline and in response to irradiation, with 
NF-κB1 having a profound and generalised effect on Th1 cytokine production. Wild-
type mice appear to respond to irradiation by inducing IL-4 to similar levels as are 
present in NF-κB1 null mice prior to irradiation. c-Rel null mice also induce IL-4 
transcription following radiation, however NF-κB2 null mice do not. Hence it 
appears that NF-κB2 is essential for the induction of IL-4 in response to radiation. 
When analysing quantitative PCR results, it is important to consider how relevant 
transcriptional control is to the pathway under investigation. Transcription may or 
may not result in enhanced protein translation, depending upon post transcriptional 
effects, including post-transcriptional decay of mRNAs. It is also important to 
consider the importance of protein stoichiometry. Induction of apoptosis can be 
triggered through post translational modifications that do not directly rely upon 
transcriptional regulation. Relevant examples of this include the control of BclxL 
activity by Bad. Bad is a Bcl2 family member that transduces apoptosis signals to the 
mitochondrion, and results in activation of intrinsic pathway apoptosis. In the 
resting state, Bad is phosphorylated and binds preferentially to scaffold proteins. 
On death signalling, Bad is dephosphorylated by calcineurin, which alters its binding 
activity, causing preferential binding to BclxL. In a resting cell, BclxL exerts its anti-
apoptotic effect by inhibiting the activity of the pro-apoptotic Bcl2 family members 
Bak and Bax. When bound by Bad, the inhibitory role of BclxL is lost, thereby leading 
to the activation of apoptosis by Bak and Bax.  
These considerations demonstrate the frailties of quantitative PCR as a tool for 
investigating the mechanisms behind differential levels of apoptosis in animals with 
abrogated NF-κB signalling. However as the underlying mechanism under study is a 
transcription factor system, quantifying transcriptional activity does potentially 
provide insight into direct effects of this pathway. These data could be made more 
robust by the confirmation of changes at the protein level, either through 
immunohistochemical staining, or Western blotting for targets that have been 
shown to have altered cDNA quantification. 
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Both Western blotting and a DNA binding ELISA technique have been employed to 
attempt to analyse the activity of specific NF-κB proteins. Unfortunately, neither 
technique provided satisfactory results. Western blotting has been shown to be 
non-specific, with antibodies targeted against NF-κB2 and c-Rel detecting proteins 
in samples from mice that do not express these genes (as confirmed by PCR in 
section 2.1). This technique is also flawed in that assessment of total protein does 
not provide any insight into the transcriptional activity of NF-κB proteins or into the 
sub-cellular localisation of these proteins. 
The proprietary DNA binding ELISA assay is dependent upon functional NF-κB 
dimers binding DNA before the NF-κB proteins are quantified by ELISA. This assay 
therefore addresses one of the weaknesses of Western blotting and attempts to 
assay NF-κB activity, rather than simply quantifying protein levels. In untreated 
animals, no significant differences were observed in NF-κB DNA binding activity 
between genotypes. After irradiation, wild-type mice showed a significant reduction 
in NF-κB2 DNA binding activity, whereas NF-κB1 null mice demonstrated an increase 
in this parameter. The reasons behind these differences are not clear, but it could 
be speculated that in the absence of NF-κB1, these animals employ an element of 
pathway redundancy by inducing an NF-κB2 response rather than NF-κB1. 
Unfortunately however, the DNA binding ELISA assay in this context appears to be 
performing at the edge of its functional threshold. Little difference was observed in 
NF-κB1 DNA binding activity between wild-type animals and those with transgenic 
deletion of NF-κB1. This suggests that there were very low, or undetectable levels of 
DNA binding in untreated animals, and without clear changes in response to 
radiation, it is hard to interpret whether this assay has been reliable or not. In 
support of the hypothesis that this assay is being attempted here below its limit of 
detection is the fact that positive control samples (supplied nuclear extract from 
RajiB human B-cell lymphoma cell line) show higher levels of NF-κB1 and RelA DNA 
binding than test lysates. In addition, the DNA binding ELISA relies upon a 
proprietary antibody combination. Experience with Western blotting has 
demonstrated that the commercially available antibodies for NF-κB proteins may 
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have inadequate specificity for use in these animal models, and the DNA binding 
ELISA may also be subject to this lack of specificity. 
Clearly, future studies to investigate the mechanisms responsible for the phenotype 
observed in these animals are needed. Further studies confirming the potential 
mechanisms behind apoptosis induction at the protein or post translational 
modification level could potentially confirm the mechanisms that have been 
suggested here.  
Assessment of the interactions between different members of the NF-κB protein 
family may also be useful for further investigating this pathway. Assessing whether 
NF-κB2 / c-Rel double knockout mice demonstrate a similar phenotype to that seen 
in NF-κB1 null animals could provide valuable data. Similarly, the effect of RelB 
deletion on apoptosis regulation in the stomach could also be assessed. The 
relevant animal strains already exist, and their use would provide strong 
corroborative evidence for the role of alternative pathway NF-κB signalling in 
regulating epithelial homeostasis. As NF-κB signalling clearly has profound epithelial 
and immunological effects, the segregation of these two systems could assist in 
delineating the precise mechanism by which NF-κB signalling imparts its influence 
on gastric cell turnover. This might be achieved either through the generation of 
epithelium specific knockout mice, potentially using a Cre-lox system and the Foxa3 
promoter, or through the use of immune reconstitution experiments between wild-
type mice and the existing transgenic animals. In addition to these animal models, 
which collectively could provide greater insight into the function of NF-κB signalling 
in the stomach, there is also a clear need for a robust method of analysing the 
activity of individual NF-κB proteins. A more robust method for achieving this could 
be either to investigate the use of electrophoretic mobility shift assays (EMSAs) as a 
method of quantifying the DNA binding activity of specific NF-κB proteins, or to use 
Chromatin Immuno-Precipitation (ChIP) as a technique for assaying both NF-κB 
protein activity and also a means of identifying the promoters to which NF-κB is 
targeted in the context of different deletions, or after different treatments. Chipset, 
in which Chip is combined with sequencing of the bound target DNA, could prove a 
powerful, non-hypothesis driven tool to further clarify NF-κB pathway targets not 
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only in the interpretation of altered patterns of proliferation and cell death, but also 
potentially as a method of assessing pathway redundancy.  
 
172 
4  The effects of abrogating NF-κB signalling on acute gastric 
injury  
Chapter 3 established a role for classical and alternative pathway NF-κB signalling in 
regulating gastric epithelial cell turnover, and demonstrated the role that these 
pathways play in modulating gastric epithelial responses to irradiation. To establish 
whether NF-κB signalling pathways are also important in modulating gastric 
epithelial responses to other forms of injury, two established models of epithelial 
injury were employed.  
The acute ethanol induced ulcer model was established in the mid-1970s (288). 
Gastric epithelial ulcers are induced in a dose and concentration dependent 
manner, with macroscopic injuries being seen one hour after ethanol 
administration. These lesions heal over a period of approximately 72 hours, and 
studies have previously reported that repeated administration of ethanol over 
several days results in no significant increase in the number or size of lesions, 
presumably because of rapid mucosal healing. Therefore this models a hyper-acute 
chemically induced gastric injury. 
Helicobacter felis infection induces mucosal damage over a longer timescale with 
histological changes being observed in the gastric epithelium of mice infected with 
this organism over 1 week to 24 months. Animals infected with H. felis develop 
mucosal lesions that model the Correa sequence of gastric carcinogenesis in man 
(see section 1.2.3.2). Acute H. felis infection results in the rapid recruitment of 
neutrophils into the gastric mucosa, which is followed by epithelial apoptosis, 
increased proliferation and parietal cell loss. These events have been extensively 
studied 6 weeks after induction of infection, at which time point mixed acute and 
chronic inflammatory infiltrates and early gastric atrophy have been reported in the 
C57BL/6 mouse (289).  
We therefore investigated the effects of abrogating NF-κB signalling on gastric 
epithelial responses to both ethanol induced ulceration and short term Helicobacter 
felis infection. 
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4.1 Acute ethanol induced ulceration 
Groups of 10 male and 10 female adult (10-12 week old) mice of each genotype 
were administered 100 microlitres of 100% ethanol and were culled 1 hour post 
procedure. Lesions were scored and macroscopic pathology tabulated as described 
in section 2.2.3 above. No significant differences in number (Figure 4-2 A and C) or 
length (Figure 4-2 B and D) of lesions were observed between mice of different 
genotype or gender. 
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Figure 4-1: Representative images of gastric mucosa of mouse 1 hour following 100 μl oral gavage of 
water (left hand side) or 100% ethanol (right hand side). Arrows indicate mucosal ulcers. 
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Figure 4-2: Number (A and C) and total length (B and D) of gastric ulcers induced by gavage of 100μL of 100% 
ethanol separated by genotype (A and B) and both genotype and gender (C and D). 
No significant differences demonstrated by 2-way ANOVA. n=10 per genotype of each gender. 
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4.2 Short term Helicobacter felis infection 
Helicobacter felis was cultured as described in section 2.2.4.1 above. Groups of 6 
female 6 week old animals were administered 0.5mL of Helicobacter felis 
suspension by oral gavage on three occasions over the course of 1 week. Following 
infection, animals were maintained in standard animal house conditions before 
being culled 6 weeks post procedure. Samples were taken from separate 
experiments for histological examination (n=6 per group) or nucleic acid, cellular 
fractionation and protein assays (n=3 per group). 
4.2.1 Helicobacter felis colonises the gastric mucosa of all strains of 
mice 
Primary assessment of bacterial colonisation was achieved by microscopy of 
haematoxylin and eosin stained sections of gastric antral mucosa. Helicobacter felis 
were observed as helical organisms staining dark blue in the lumen of gastric glands 
(Figure 4-4). Bacterial colonisation was assessed by single blinded scoring of 
histological sections using the visual analogue scale described in section 2.8.1 above 
(Figure 4-4A). Bacterial colonisation was also confirmed by quantitative PCR for the 
Helicobacter FlaA gene product (Figure 4-4 B). These two assays confirmed that all 
animals were colonised. The visual analogue scoring suggested heavier colonisation 
of the gastric antrum in NF-κB2 null animals than other groups, but this was not 
confirmed by quantitative PCR analysis, when no significant differences in 
colonisation were observed between infected animals of different genotypes. This 
may reflect differences in sampling site. In the mouse, Helicobacter felis colonises 
predominantly antral mucosa (which was assessed histologically), but nucleic acid 
samples for quantitative PCR were obtained from the gastric corpus. Therefore 
whilst these data confirm colonisation of the stomach with Helicobacter felis they 
may not fully reflect the density of bacterial colonisation. H. felis organisms were 
not seen in substantial numbers in histological sections of the corpus in any 
genotype of mouse (data not shown). 
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Not colonised Colonised 
  
Antral Helicobacter felis colonisation 
Figure 4-3: Representative photomicrographs of the antral mucosa of untreated and infected animals. Closed 
arrow marks uncolonised gland lumen. Open arrow highlights Helicobacter felis organisms colonising antral 
gland lumen. Original magnification *40 objective. 
Figure 4-4: Quantification of Helicobacter felis colonisation 6 weeks after infection by microscopy (A, n=6 per 
group) and by quantitative PCR for the Helicobacter felis FlaA gene product (B, n=3 per group).  
Statistical analyses carried out by Kruskall-Wallis test and Tukeys post-hoc multiple comparisons procedure 
(A) and 2-way ANOVA with Holm-Sidak post hoc test (B). 
Horizontal lines in A mark median values. 
# denotes significantly higher scores than C57BL/6. 
* denotes significantly higher gene expression than untreated of the same genotype. 
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4.3 Classical and alternative pathway NF-κB signalling 
differentially regulate gastric corpus mucosal responses to 
H. felis infection 
As all groups of mice were successfully colonised with Helicobacter felis, the degree 
of mucosal injury induced in these animals was assessed. Severity of inflammation, 
mucosal thickening and parietal cell loss were scored on the basis of the visual 
analogue scale for haematoxylin and eosin stained sections described in 2.8.1 
above. To validate the findings of this scoring system an alternative graticule based 
scoring system (described in section 2.8.3 above) was also used with the same 
histological sections. This system generated numbers of parietal cells, a quantitative 
score of mucosal thickness and a representation of the distribution of parietal cells 
by position within the mucosa, measured from the basement membrane of cells at 
the base of the gastric gland. 
4.3.1 H. felis infection induced an inflammatory cell infiltrate 
Sections were scored using a *20 objective to assess the presence of mucosal and 
sub-mucosal inflammatory cells (Figure 4-6). The severity of inflammatory cell 
infiltrate was then graded and plotted by dot plot (Figure 4-5); these data were 
assessed for statistical significance by Kruskall Wallis one-way analysis of variance 
on ranks and Tukey’s post hoc test.  
In untreated mice no inflammatory cell infiltrate was observed in wild-type mice, 
NF-κB2 null or c-Rel null mice, whilst several NF-κB1 null mice had low grade 
inflammation, reflected by a median inflammation score of 1 in this group. These 
differences did not however reach statistical significance. Amongst the infected 
groups, NF-κB1 null mice had the highest inflammation scores, with a median score 
of 3, whilst NF-κB2 null mice had no increase in inflammatory cell infiltrate, 
resulting in a statistically significantly lower median score of 0. C57BL/6 mice had a 
median score of 2, whilst c-Rel null animals had a median inflammation score of 0.5; 
scores for these groups were not significantly different from infected mice of other 
genotypes.  
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Figure 4-5: Dot plots showing visual analogue scores for gastric inflammatory cell infiltration in uninfected 
(A) and infected (B) samples.  
Horizontal lines mark median values. 
# represents significantly higher scores than NF-κB2 null animals. 
ψ represents significantly different scores across genotypes by Kruskall Wallis independent samples test, but 
with no specific differences between genotypes demonstrable by Tukeys post-hoc multiple comparisons 
procedure. 
Figure 4-6: Representative images of gastric corpus mucosa from animals that have (lower panels) or have 
not (upper panels) been infected with Helicobacter felis for 6 weeks. Closed arrows mark inflammatory cell 
infiltration. Open arrows highlight glands with reduced parietal cell numbers. 
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4.3.2 Classical and alternative pathway NF-κB signalling 
differentially regulate the development of gastric atrophy after 
H. felis infection 
Visual analogue scoring of gastric corpus sections revealed median scores of 0 for all 
untreated groups of mice for parietal cell loss (Figure 4-7 A). Infected wild-type mice 
had a median parietal cell loss score of 0.5, whilst infected NF-κB1 null mice had a 
median score of 2 (Figure 4-7 B and D). NF-κB2 null mice demonstrated no parietal 
cell loss by this scoring system, and hence had median scores of 0, which was 
statistically significantly different from the scores of NF-κB1 null mice, but not wild-
type mice. c-Rel null mice did exhibit parietal cell loss in some cases, but the median 
score for these animals was 0; by statistical testing this was not significantly 
different from other groups of infected mice. 
Mucosal thickening scores for untreated mice were universally 0. In infected 
animals, scores were in keeping with NF-κB1 null animals suffering worse mucosal 
atrophy, however differences did not reach statistical significance. NF-κB1 null 
animals had a median mucosal thickening score of 0.5, whilst all other groups had 
median mucosal thickening scores of 0. 
To validate the observations made using the non-parametric scoring system 
described above, a graticule based score was performed. This system generated 
scores of mean mucosal thickness and mean number of parietal cells (Figure 4-8 A 
and B respectively). Mucosal thickness was not shown to be statistically significantly 
increased in any genotype of mouse, whether infected or not by this scoring 
system.  
Quantification of parietal cell number using the graticule scoring system however 
confirmed a differential effect of classical and alternative pathway NF-κB signalling 
on the development of gastric atrophy in response to Helicobacter felis infection. 
Untreated mice of each genotype had similar numbers of parietal cells to one 
another. Following infection with H. felis for 6 weeks, C57BL/6, NF-κB1 null and c-
Rel null mice were all found to have significantly fewer parietal cells than untreated 
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control mice of the same genotype. In contrast, infected NF-κB2 null mice showed 
no significant change in parietal cell number compared to untreated animals. 
 When the magnitude of parietal cell loss was compared across infected groups of 
animals, it was clear that NF-κB1 null mice had more severe parietal cell loss than 
other genotypes, with infected mice having 38% as many parietal cells present as 
untreated mice; this compared with 71% in C57BL/6, 73% in c-Rel null mice and 97% 
in NF-κB2 null mice. The distribution of parietal cells was compared by plotting 
percentage parietal cell index against distance from the basement membrane of 
cells located at the base of the gland. No differences were observed in untreated 
mice of different genotypes (Figure 4-8 C). However, amongst infected mice, a 
significant reduction in parietal cell numbers was observed between NF-κB1 null 
mice and other genotypes between 75 and 125μm from the basement membrane 
(Figure 4-8 D). 
  
181 
 
 
 
 
 
 
  
Figure 4-7: Dot plots showing visual analogue scores for parietal cell loss in uninfected (A) and infected (B) 
mice, and dot plots showing visual analogue scores for mucosal thickening in uninfected (C) and infected (D) 
mice. 
Horizontal lines mark median values. 
# represents significantly higher scores than infected NF-κB2 null animals by Kruskall Wallis independent 
samples test and Tukeys post-hoc multiple comparisons procedure (p<0.05). 
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Figure 4-8: Graticule scoring of mucosal thickness (A) and number of parietal cells scored (B, C and D) in 
untreated and infected mice. A and B represent mean scores per group. C and D represent parietal cell 
number by distance from basement membrane at gland base for untreated and infected mice respectively. 
n= 6 mice per group.  
Statistically significant differences between groups tested by 2-way ANOVA and Holm-Sidak post-hoc 
analysis A and B, and by Kruskal-Wallis One Way Analysis of Variance on Ranks and Dunn’s post hoc analysis 
at each position from gland base for C and D. 
p<0.05 considered to be significant difference. 
* represents significant difference to untreated group of same genotype. 
# represents significant difference to C57BL/6 undergoing same treatment.  
 Represents significant difference between NF-κB1 null and C57BL/6 at annotated distances 
from basement membrane. 
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4.3.3 Cell turnover is altered in the gastric mucosa of NF-κB1 null 
mice following H. felis infection 
To further examine the effects of Helicobacter felis infection on the gastric mucosa 
of mice with abrogated NF-κB signalling, cell turnover was assessed in the gastric 
corpus. Proliferating cells were labelled by Ki67 immunohistochemistry, whilst 
apoptotic cells were recognised by immunohistochemistry for cleaved caspase 3. 
Proliferation indices were obtained by graticule based scoring as described in 
section 2.8.3. Due to the low frequency of apoptotic cells in the gastric mucosa, 
apoptotic indices were calculated by counting apoptotic cells in 10 separate 
microscope fields per section using a *63 objective. 
Peak proliferation index was observed in untreated C57BL/6 mice at 125-150μm 
from the basement membrane, and proliferating cells were observed between 100 
and 225μm from the basement membrane. Similar numbers and distributions of 
proliferating cells were observed across all genotypes of untreated mice. Amongst 
infected mice there was a significant increase in proliferating cells in NF-κB1 null 
mice, but not in any other group. These animals had a 2.5 fold increase in mean 
number of proliferating cells, and peak proliferation was observed 150-175μm from 
the basement membrane with proliferative activity being observed from the gland 
base up to 275 μm above the basement membrane.  
In addition apoptotic indices were similar across wild-type mice, NF-κB2 null mice 
and c-Rel null mice, but were increased in NF-κB1 null mice. In untreated mice there 
was a 2.8 fold increase in apoptotic index in NF-κB1 null mice compared to wild-
type mice. Apoptotic indices did not change significantly following infection in wild-
type, NF-κB2 null or c-Rel null groups, however there was a 2.7 fold increase in 
apoptosis in infected NF-κB1 null mice compared to untreated mice of the same 
genotype. 
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Figure 4-9: Representative images of Ki67 (upper 2 panels) and cleaved caspase 3 (lower 2 
panels) immunostaining in untreated (left) and Helicobacter felis infected (right) wild-type mice. 
Original magnification *20 for low power images *63 for high power images. 
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Figure 4-10: Graticule scoring of mean number of cells proliferating (A) and mean number of apoptotic cells 
scored per high powered field (B) in untreated and infected mice. Proliferating cell indices plotted against 
distance from basement membrane for untreated mice (C) and mice infected with Helicobacter felis for 6 
weeks (D).  
n= 6 mice per group. Significance of differences between groups tested by 2-way ANOVA and Holm-Sidak 
post-hoc analysis for A and B, and by Kruskal-Wallis One Way Analysis of Variance on Ranks followed by 
Dunn’s post-hoc test for C and D. p<0.05 considered to be significant difference. 
* represents significant difference to untreated group of same genotype.  
# represents significant difference to C57BL/6 undergoing same treatment. 
  Represents significant difference between NF-κB1 null and C57BL/6 at annotated 
distances from basement membrane by Kruskal-Wallis One Way Analysis of Variance on Ranks. 
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4.3.4 Changes in NF-kB activity in response to H. felis infection 
To establish the NF-κB responses of mice following short term infection with 
Helicobacter felis, DNA binding ELISAs were performed. Nuclear protein lysates 
were extracted from adult (10-12 weeks old) mice that had either been housed in 
conventional conditions, or that had been infected with Helicobacter felis for 6 
weeks (as per protocol described in section 2.2.4). Groups of 3 female animals were 
used for these experiments. DNA binding ELISAs establishing DNA binding activity of 
RelA, RelB, NF-κB1 and NF-κB2 were carried out as described in section 2.10. 
No differences in RelA, RelB or NF-κB1, DNA binding were observed in response to 
Helicobacter felis infection in any group (Figure 4-11 A-C). In contrast, NF-κB2 DNA 
binding was up-regulated by a factor of 4.7 in NF-κB1 null mice after Helicobacter 
felis infection (Figure 4-11 D). Statistically there was significantly less NF-κB2 DNA 
binding in NF-κB2 null mice than wild-type mice following infection, but in both 
cases these were low values, and presumably reflect 2 values below the threshold 
of detection for this assay. Positive control values are also represented. These were 
derived from a proprietary nuclear extract from the RajiB cell line, and produced 
positive results in all assays.  
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Figure 4-11: NF-κB protein DNA binding assays for untreated mice and mice infected with Helicobacter felis 
for 6 weeks. A: Relative RelA DNA binding. B: Relative RelB DNA binding. C: Relative NF-κB1 DNA binding. D: 
Relative NF-κB2 DNA binding. 
n=3 mice per group. Statistical differences assessed by 2-way ANOVA and Holm-Sidak post-hoc test. 
* represents significant difference to untreated group of same genotype.  
# represents significant difference to C57BL/6 undergoing same treatment. 
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4.3.5 Changes in gene expression after H. felis infection 
To investigate the mechanisms behind the differential responses to short term 
Helicobacter felis infection observed in wild-type mice and mice with classical or 
alternative pathway NF-κB deletions, real-time PCR assays were used to quantify a 
number of targets. Groups of 3 female animals were infected by oral gavage with 
Helicobacter felis cell suspension at 6 weeks of age. These animals were then culled 
6 weeks after the final treatment; control groups of untreated adult mice were 
culled at similar ages. Gastric corpus samples were taken for RNA extraction and 
subsequently quantitative PCR assays were used to assess gene expression. 
In wild-type mice, infection with Helicobacter felis induced a marked Th1 cytokine 
response. TNF-α was up-regulated 17 fold in infected mice, whilst interferon-γ was 
up-regulated by a factor of 1.6, Il-1β expression was not significantly increased.  
Of the other cytokines assessed, IL-6 was up-regulated (by a factor of 1.9) in wild-
type animals after infection, possibly reflecting the acute phase response that is 
induced by Helicobacter infection. IL-4 and IL-14 transcript abundances were not 
significantly altered. 
Amongst the apoptosis mediators that were studied FasL, xIAP and p53 were all up-
regulated in infected wild-type mice compared to uninfected mice (by factors of 4.5, 
4.4 and 1.8 respectively). No differences were observed in the transcript 
abundances of Fas, c-IAP1, c-IAP2, Bcl-2 or BclxL between untreated and infected 
wild-type mice.  
Differences in the control of NF-κB signalling in response to Helicobacter infection 
were evident in wild-type mice. A 3.2 fold reduction in TNF-AIP3 and a 2.0 fold 
reduction in NIK transcripts were observed in infected wild-type animals compared 
to untreated. This suggests that classical pathway signalling was up-regulated, 
whilst alternative pathway signalling may have been relatively suppressed. These 
animals also demonstrated an increase in TFF-2 transcripts, in keeping with the 
changes observed in epithelial structure following infection. 
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Deletion of NF-κB1 in untreated mice led to the up-regulation of Th1 cytokines, as 
described in detail in section 3.1.6. In response to Helicobacter infection there was 
further up-regulation of TNF-α and IL-1β (by factors of 1.4 and 1.6 respectively). 
Interferon-γ transcripts were not statistically significantly more abundant in 
infected animals compared to untreated NF-κB1 null animals, however all NF-κB1 
null mice had greater abundance of interferon-γ transcripts than either infected or 
untreated wild-type mice. 
Similarly to wild-type mice, NF-κB1 null mice demonstrated an increase in 
abundance of IL-6 transcripts (by a factor of 1.5) in response to Helicobacter 
infection. However in NF-κB1 null animals there was also an up-regulation of IL-4 by 
a factor of 1.7 and a down-regulation of IL-14 by a factor of 1.6. 
Several apoptosis modulating factors were down-regulated in NF-κB1 null mice 
after infection. Fas was down-regulated by a factor of 1.6, c-IAP1 by a factor of 4.1, 
c-IAP2 by a factor of 1.5, Bcl2 by a factor of 1.5 and BclxL by a factor of 1.6. This 
represents a markedly different response in terms of apoptosis modulating genes 
compared to wild-type mice. FasL, xIAP and p53, all of which were up-regulated in 
wild-type mice, were unchanged in response to infection in NF-κB1 null mice. 
No significant changes were observed in the abundance of TNF-AIP3 transcript 
between untreated and infected NF-κB1 null mice, although transcript abundance 
was persistently lower than observed in untreated wild-type mice, and similar to 
the quantities observed in infected wild-type mice. NF-κB1 null mice demonstrated 
a 1.9 fold down-regulation of NIK following infection, similar to that seen in wild-
type mice. No dynamic changes were seen in trefoil factors in NF-κB1 null mice in 
response to Helicobacter infection.  
The Th1 cytokine responses to Helicobacter felis infection of c-Rel null mice were 
similar, but slightly blunted in comparison to wild-type mice. A 6.9 fold up-
regulation of TNF-α was observed, with c-Rel null mice showing similar results to 
wild-type mice both before and after infection. IL-1β and IFN-γ transcript 
abundance were not increased in c-Rel null mice following infection. This represents 
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a relatively blunted Th1 response compared to wild-type mice in which a 1.6 fold 
increase in IFN-γ transcript abundance was observed. 
c-Rel null mice also demonstrated up-regulated FasL and xIAP expression (by factors 
of 3.5 and 1.8 respectively), which are similar patterns to those observed in wild-
type mice. However, no dynamic differences in expression were seen between 
untreated and infected c-Rel null mice for IL-6, p53, TNF-AIP3 or NIK, all of which 
altered in wild-type mice following infection. In addition, c-Rel null mice 
demonstrated 6.6 fold up-regulation of IL-4 and 1.3 fold down-regulation of BclxL in 
response to Helicobacter infection, responses that were observed in NF-κB1 null, 
but not wild-type mice. These data demonstrate that the responses of c-Rel null 
mice to infection do differ compared to those of wild-type mice, despite the similar 
histological outcomes that were observed in these genotypes after infection.  
In contrast to the animals that demonstrated significant inflammation and epithelial 
remodelling in response to Helicobacter felis infection, the transcript changes 
observed in NF-κB2 null mice were quite different. As with other genotypes, TNF-α 
transcripts were more abundant following infection (7.2 fold), however IL-1β 
transcripts were 2.2 fold less abundant after infection than before in these animals. 
Moreover IL-1β transcripts were significantly less abundant in infected NF-κB2 null 
animals than in wild-type mice. Similarly there was a reversal in the IL-6 response 
compared to wild-type mice. NF-κB2 null mice showed 1.7 fold down-regulation of 
IL-6 expression in response to infection. This contrasts with an up-regulation of IL-6 
to a similar magnitude observed in wild-type mice following infection. IFN-γ and IL-4 
transcript abundance did not alter following H. felis infection in NF-κB2 null mice. 
Similarly, changes in p53 expression were different in NF-κB2 null mice compared 
with wild-type animals. NF-κB2 null mice showed a 1.6 fold reduction in p53 
transcript abundance after infection, whereas wild-type mice showed a 1.8 fold 
increase in transcript abundance. 
Despite the profound differences in histological outcome following short term 
infections between NF-κB1 null and NF-κB2 null mice, some common gene 
expression responses were observed between these groups. Both genotypes 
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demonstrate down-regulation of Fas (NF-κB1 by 1.6 fold, NF-κB2 by 1.8 fold), c-IAP2 
(NF-κB1 by 1.5 fold, NF-κB2 1.8 by fold), Bcl-2 (NF-κB1 by 1.5 fold, NF-κB2 2.9 by 
fold) and BclxL (NF-κB1 by 1.6 fold, NF-κB2 by 2.1 fold). Intriguingly NF-κB2 null mice 
were the only group that demonstrated any change in TFF3 transcript abundance 
after short term H. felis infection; they showed a 1.8 fold reduction in TFF3 
expression after infection.  
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Figure 4-13: Relative quantification of Th1 cytokine 
transcripts in gastric corpus of untreated mice and 
mice after 6 weeks Helicobacter felis infection. A: 
relative expression of TNF-α. B: relative expression 
of IL-1β. C: relative expression of Interferon-γ. 
p<0.05 by 1-way ANOVA and Holm-Sidak post-hoc 
test, n=3 mice per group. 
* marks difference in expression compared with 
untreated of same genotype.  
# marks difference in expression compared to wild-
type in same treatment group.  
Figure 4-12: Relative quantification of other 
cytokine transcripts in gastric corpus of untreated 
mice and mice after 6 weeks Helicobacter felis
infection. A: relative expression of IL-6. B: relative 
expression of IL-14. C: relative expression of IL-4. 
p<0.05 by 1-way ANOVA and Holm-Sidak post-hoc 
test, n=3 mice per group. 
* marks difference in expression compared with 
untreated of same genotype.  
# marks difference in expression compared to wild-
type in same treatment group.  
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Figure 4-14: Relative quantification of apoptosis modulating gene transcripts in gastric corpus of untreated 
mice and mice after 6 weeks of Helicobacter felis infection. A: relative expression of Fas. B: relative 
expression of FasL. C: relative expression of c-IAP1. D: relative expression of c-IAP2. E: relative expression of 
xIAP. F: relative expression of p53. G: relative expression of Bcl-2. H: relative expression of Bcl-xL, 
p<0.05 by 1-way ANOVA and Holm-Sidak post-hoc test, n=3 mice per group. 
* marks difference in expression compared with untreated of same genotype.  
# marks difference in expression compared to wild-type in same treatment group.  
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Figure 4-15: Relative quantification of NF-κB modulating transcripts (A and B) and trefoil factors (C and D) in 
gastric corpus of untreated mice and mice after 6 weeks Helicobacter felis infection. A: relative expression of 
TNF-AIP3. B: relative expression of NIK. C: relative expression of TFF-2. D: relative expression of TFF-3. 
p<0.05 by 1-way ANOVA and Holm-Sidak post-hoc test, n=3 mice per group. 
* marks difference in expression compared with untreated of same genotype.  
# marks difference in expression compared to wild-type in same treatment group.  
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4.4 The impact of cytokines on primary cultures of gastric 
glands 
To investigate whether the gastric epithelia of mice with specific deletions of NF-κB 
show altered responses to Th1 cytokines, primary cultures of gastric glands from 
animals of each genotype were derived. In all cases primary cultures were viable, 
and were maintained in standard conditions (described in section 2.7) for a total of 
5 days after harvesting. 
36 hours after establishing cultures, exogenous cytokines, or sham treatments were 
established. Cytokines were administered at the supra-physiological dose of 
150ng/mL for 48 hours. Previous dose finding studies in our laboratories have 
established this dose to reliably induce apoptosis in primary cultures of gastric 
glands derived from C57BL/6 mice (unpublished data). 
Following fixation with 2% paraformaldehyde in PBS, glands were subjected to 
immunocytochemical staining for cleaved caspase-3, and apoptotic events were 
scored on a percentage basis. Cultures were derived from groups of 5 adult (10-12 
weeks old) female animals per group and data were collected from at least 2 
matched wells per culture for each treatment.  
Mean gland size did not differ either across genotypes, or after treatment with 
specific cytokines (Figure 4-17 A). As observed previously in our laboratory, C57BL/6 
derived glands demonstrated significant amounts of apoptosis in response to all 
three tested cytokines, with increases of 1.4 to 1.7 fold compared to untreated 
glands (Table 4-1 and Figure 4-17 B). Glands derived from NF-κB1 null or NF-κB2 null 
mice did not develop increased apoptosis on exposure to Th1 cytokines, whilst 
glands derived from c-Rel null mice had a blunted response. These animals 
developed 1.5 fold increased apoptosis scores in response to interferon-γ 
administration, but were resistant to apoptosis stimulated by either IL-1β or TNF-α. 
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Table 4-1: Fold change of apoptosis scores observed in primary cultures following 48 hours 
incubation with Th1 cytokines. 
Genotype Interferon-γ Tumour Necrosis Factor-α Interleukin-1β 
C57BL/6 1.6 1.4 1.7 
NF-κB1 null 1.3 1.0 1.0 
NF-κB2 null 1.1 1.1 0.99 
c-Rel null 1.5 1.1 1.3 
Text in red indicates significant difference to untreated cultures from mice of same genotype. 
Statistical differences tested by 2-way ANOVA and Holm-Sidak post-hoc analysis.  
 
  
Figure 4-16: Representative images of primary gastric gland cultures derived from wild-type mouse and 
not treated with exogenous cytokine. Stained with anti-cleaved caspase 3 (green channel) and DAPI (Blue 
channel).  
Top left panel: bright-field phase contrast image. Top right: dark-field FITC channel, reflecting presence of 
cleaved caspase 3 positive apoptotic cells. Bottom left: dark-field DAPI channel. Bottom right combined 
FITC, DAPI and phase contrast image.  
Original magnification *40. 
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Figure 4-17: A: Mean size of gastric glands in primary cultures derived from mice of annotated genotype 
either untreated, or 48 hours after administration of 150ng/mL of listed cytokine. B: Apoptotic cells in 
primary cultures derived from mice of annotated genotype relative to untreated glands after 48 hours of 
150ng/mL of listed cytokine. n=5 per group, statistical differences defined by 2-way ANOVA and Holm-Sidak 
post-hoc test: 
* marks difference in apoptosis compared with untreated of same genotype.  
# marks difference in expression compared to wild-type in same treatment group.  
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4.5 Discussion 
The data presented in this chapter demonstrate the role that NF-κB signalling plays 
in modulating the mucosal response to gastric injury. Initial studies with ethanol 
induced gastric ulceration examined a hyper-acute time-point (1 hour after 
induction of mucosal damage) and demonstrated no significant differences 
between wild-type mice and mice that had deletions in NF-κB signalling pathways. 
This model has not previously been investigated in mice with NF-κB deletions, nor 
have any data been published assessing whether either classical or alternative 
pathway NF-κB activity are involved in the induction of these lesions. It is 
conceivable that the acute nature of ethanol induced gastric ulceration means that 
epithelial and immune responses are effected only by proteins that have already 
been synthesised (or are at an advanced stage of synthesis) on induction of 
ulceration. New transcriptional activity may therefore not be relevant to the injury 
induced by this model. This would negate any role for NF-κB induced transcription 
influencing the responses to gastric mucosal injury. This supports the concept that 
the ethanol induced ulceration model is an assessment of baseline mucosal and 
epithelial function, rather than a method for assessing the transcriptional response 
within an organism. Since no differences in response were observed between wild-
type mice and any of the NF-κB null mice, it appears that the abrogation of specific 
NF-κB family members does not alter baseline mucosal susceptibility to chemically 
induced gastric injury. 
Having established that, in a hyper-acute model, NF-κB deletion did not render the 
gastric mucosa more susceptible to chemically induced injury, we aimed to 
investigate the effects of short term Helicobacter infection on the gastric mucosae 
of these animals. Short term Helicobacter felis infection is an established model of 
gastric atrophy (80, 93, 289, 290) (see section 1.2.5.2 for full description) and all 
genotypes of mouse used in our studies were susceptible to Helicobacter felis 
colonisation. Wild-type mice developed gastric atrophy following infection as 
previously described. This pathology was replicated in animals with transgenic 
deletions affecting classical pathway NF-κB signalling, but animals with NF-κB2 
deletions were not susceptible to Helicobacter felis induced gastric atrophy. This 
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demonstrates that classical and alternative pathway NF-κB signalling have different 
roles in the modulation of pathology after Helicobacter felis infection. 
In mice with NF-κB1 deletion, gastric atrophy was significantly more pronounced 
than in wild-type mice, whilst c-Rel null mice demonstrated similar pathology to 
wild-type mice. These data are in keeping with previous studies that have shown 
more severe pathology in the gastric corpus of mice with epithelial specific 
deletions of IKKβ following Helicobacter felis infection (75). Our studies provide 
insight into the roles that specific members of the NF-κB family play in modulating 
gastric atrophy, and suggest that NF-κB1 dependent signalling protects against the 
development of gastric atrophy in-vivo.  
Neither our studies, nor those of Shibata et al (75) have been able to address the 
degree to which RelA is involved in this process. RelA / NF-κB1 dimers are 
considered to be the predominant NF-κB dimers responsible for classical pathway 
NF-κB activity (291), and hence RelA might be expected to play some role in this 
process. In-vivo analysis of RelA activity is challenging as constitutive deletions of 
RelA are embryonically lethal (226). We therefore attempted to quantify the role 
that RelA played in our animal model using a DNA binding ELISA technique. The 
magnitude of RelA DNA binding activity that we observed in all animal groups was 
significantly lower than that obtained from a positive control lysate derived from 
the RajiB cell line. Furthermore no dynamic changes in RelA activity were observed 
in response to Helicobacter felis infection either in wild-type mice, or in mice with 
any deletions in the NF-κB pathways. These data suggest either that RelA is not 
involved in the response to Helicobacter infection, or that this assay has failed to 
detect RelA activity in this context. Whilst the role of RelA has not been examined 
following Helicobacter felis infection, there are both in-vitro and in-vivo data which 
demonstrate that Helicobacter pylori can induce RelA activity. Nuclear translocation 
and DNA binding of RelA has been demonstrated by EMSA in co-cultures of the AGS 
cell line and Helicobacter pylori (292), whilst anti-sense oligonucleotides to p65 
have been shown to inhibit Th1 cytokine responses in C57BL/6 mice that had been 
infected with Helicobacter pylori for 24 hours (293). It therefore remains possible 
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that the DNA binding ELISA used in this chapter has failed to establish the true 
degree of RelA activity in these animals. 
In contrast to the pathology induced in either NF-κB1 null mice or wild-type mice, 
the gastric epithelium of infected NF-κB2 null mice was histologically remarkably 
similar to untreated animals. No significant increase in inflammatory cell infiltrate, 
parietal cell loss, mucosal thickness, epithelial cell proliferation or epithelial 
apoptosis was observed in these animals, despite heavy colonisation with 
Helicobacter felis organisms.  
A single paper has reported that, in-vitro, Helicobacter pylori is able to activate both 
classical and alternative pathway NF-κB signalling in human peripheral B-
lymphocytes. NF-κB2 p100 was cleaved and activated when primary B-lymphocytes 
were co-cultured with H. pylori for 8 hours. These findings were replicated both in 
the presence and absence of ammonium pyrrolidine dithiocarbamate, a classical 
pathway NF-κB inhibitor, suggesting that there is a direct activation of alternative 
pathway NF-κB signalling by Helicobacter pylori in this cell type. These findings 
suggest that NF-κB2 may have a specific role in the modulation of an inflammatory 
response to Helicobacter infection, which is in keeping with our observations that 
NF-κB2 null mice have an attenuated inflammatory response after 6 weeks of 
infection with Helicobacter felis.  
No previous data have been published addressing the role of alternative pathway 
NF-κB signalling in mucosal responses to Helicobacter infections. Indeed the only 
published data examining responses to pathogens in the GI tract of NF-κB2 null 
animals has investigated the effect on infestation with the helminth Trichuris muris. 
This model depends upon Th2 responses to expel the organism and avoid chronic 
infestation. NF-κB2 null mice had an initial infestation that caused similar epithelial 
pathology to that observed in wild-type mice, however they were unable to mount 
a sufficient Th2 response to expel the organisms and hence chronic colonisation of 
the parasite occurred (251). In this model NF-κB1 null animals were also unable to 
mount adequate Th2 responses to Trichuris muris infection, but they did establish a 
potent Th1 response, resulting in particularly severe inflammation in these animals.  
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This is of significance when considering the responses to Helicobacter felis infection 
observed in our studies. The role of Th1 cytokines in gastric carcinogenesis have 
been extensively studied both in human disease and in murine models of 
Helicobacter induced gastric cancer. Activating polymorphisms in IL-1β and its 
receptor have been shown to have an overall pro-carcinogenic effect in human 
populations, as have polymorphisms in TNF-α (160). In humans, polymorphisms of 
interferon-γ have not been shown to be associated with Helicobacter induced 
gastric cancer, however recent animal studies have suggested that overexpression 
of this cytokine may protect against gastric carcinogenesis (294). This study used a 
transgenic mouse that constitutively overexpressed interferon-γ and demonstrated 
that whilst it was able to be colonised with Helicobacter felis, it did not develop 
significant gastric pathology even after infection for 12 months. Further studies 
established that these animals underwent T-cell apoptosis in response to 
Helicobacter infection and subsequently failed to mount a broader Th1 cytokine 
response. It is not clear from these studies to what extent interferon-γ was over-
expressed, and clearly from our studies transcription of the other Th1 cytokines was 
not suppressed in any of the groups that showed up-regulation of interferon-γ. 
Previous studies have also demonstrated that a Th1 polarised inflammatory 
response leads to more severe pathology in mice infected with H. felis. Our data 
support this hypothesis in that there was a marked Th1 response in wild-type mice, 
but that response was more pronounced in NF-κB1 null animals than wild-type, and 
was weakest amongst the NF-κB2 group which developed least pathology in 
response to infection. 
In common with previous studies (294) we have demonstrated increased transcript 
abundance of TNF-α, IFN-γ and interleukin-6 following H. felis infection of wild-type 
mice. Increased abundance of TNF-α transcripts was a common feature of all 
genotypes of mouse with NF-κB2 null mice and c-Rel null mice showing similar 
quantities to wild-type mice in both untreated and infected groups. NF-κB1 null 
mice by contrast, demonstrated significantly higher baseline TNF-α transcript 
abundance than untreated mice and following infection, these animals continued to 
show higher TNF-α transcript abundance than wild-type animals. These 
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observations tally with those of Shibata et al (75) who demonstrated that TNF-α 
transcripts were more abundant in animals with gastric epithelial IKKβ deletions 
than wild-type mice following long term infection with Helicobacter felis. 
In addition to increased TNF-α transcript abundance, the other Th1 cytokines 
assayed were also more abundant in infected NF-κB1 null mice than infected wild-
type mice. IL-1β transcripts were also more abundant in infected than untreated 
NF-κB1 null mice. At the time-point assayed by Shibata et al, their model 
demonstrated a tendency towards increased IL-1β transcript abundance, but this 
did not reach statistical significance. In contrast to these observations for NF-κB1 
null mice, NF-κB2 null animals demonstrated a reciprocal response in terms of 
interleukin-1β transcripts. At baseline, this group showed similar transcript 
abundance to wild-type mice, but it decreased following infection. This group also 
showed no increase in interferon-γ transcript abundance after infection. These 
observations combine to demonstrate that the Th1 cytokine responses to infection 
following Helicobacter felis infection were differentially regulated by individual 
members of the NF-κB family. These differences are the most consistent and 
coherent of the differences in gene expression that have been demonstrated in our 
studies, and hence are the strongest candidates for being responsible for the 
differences in pathological responses observed between different groups. 
To further assess the role of Th1 cytokines, primary cultures of gastric glands 
derived from mice of each strain were generated and subsequently subjected to 
Th1 cytokine treatment. In wild-type mice, all the tested Th1 cytokines resulted in 
increased apoptotic scores in primary cultures of gastric glands. However deletion 
of NF-κB sub-units abrogated these responses. Primary cultures of gastric glands 
derived from NF-κB1 and NF-κB2 null mice were resistant to direct Th1 cytokine 
induced apoptosis, whilst glands derived from c-Rel null mice remained sensitive to 
interferon-γ, but not to Il-1β or TNF-α. These data suggest that direct epithelial 
apoptosis in response to Th1 cytokines is therefore unlikely to be the mechanism 
through which different responses to Helicobacter felis infection are mediated in 
these mouse strains. 
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Th2 effector cytokines were not assayed, however the Th2 regulatory cytokine IL-4 
was up-regulated in both NF-κB1 and c-Rel null mice following infection with H. 
felis. This suggests that there is a drive towards a Th2 response in these groups, but 
whether this results in Th2 effector cytokines being generated remains to be 
established. No increase in drive towards a Th2 response was detected in NF-κB2 
null mice following H. felis infection. 
Only NF-κB1 null mice demonstrated significant differences in apoptotic indices 
following infection. However all genotypes of mice demonstrated changes in the 
transcript abundance of key apoptosis modulating genes. Wild-type mice 
demonstrated increased FasL, p53 and xIAP transcript abundance following H. felis 
infection. Similarly infected c-Rel null mice demonstrated up-regulated FasL and 
xIAP, but down-regulated BclxL. NF-κB2 null mice maintained static apoptotic indices 
following H. felis infection, but showed reduced transcript abundances of Fas, cIAP-
2, p53, Bcl-2 and BclxL.  
NF-κB1 null mice demonstrated persistently elevated apoptotic indices in the gastric 
corpus compared to other genotypes, and were shown to have down-regulated c-
IAP1, c-IAP2, Bcl-2 and BclxL following Helicobacter felis infection on the basis of 
transcript abundance. Each of these targets is generally considered to be anti-
apoptotic, therefore inhibiton of their transcription may represent a mechanism 
through which apoptosis could be enhanced. 
There are in-vitro data demonstrating that Bcl-2 expression may be suppressed 
after infection with Helicobacter sp, Choi et al having studied AGS cells co-cultured 
with Helicobacter pylori. They demonstrated down-regulation of Bcl-2 at both 
messenger RNA and protein levels (295). Other in-vitro studies have shown no 
changes in expression of Bcl-xL, and have shown possible up-regulation of c-IAP1 
and c-IAP2. The expression of Bcl-2 and BclxL have recently been studied in C57BL/6 
mice infected with Helicobacter felis, but studies investigating the effects of 
transgenic deletion of these proteins on Helicobacter felis induced pathology have 
yet to be published.  
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In untreated C57BL/6 mice, a low level of gastric corpus Bcl-2 expression has 
previously been demonstrated. Immunostaining for Bcl-2 localised to chief and 
surface mucous cells in untreated mice. Following Helicobacter pylori infection Bcl-2 
staining persisted in mucous cells and the remaining chief cells; however there was 
also strong Bcl-2 staining in metaplastic cells (296). At the time point that has been 
investigated in our studies metaplastic lesions are unlikely to be present, however 
gastric atrophy has been established in wild-type mice, NF-κB1 null mice and c-Rel 
null mice. It is therefore intriguing that amongst these strains only NF-κB1 null mice 
demonstrate a dynamic reduction in Bcl-2 expression. It is also counter-intuitive 
that NF-κB2 null mice should have a reduction in the transcript abundance of this 
target. Presumably the cause for this lies in another mechanism, since these animals 
do not demonstrate the atrophic changes seen in other mouse strains after 
Helicobacter felis infection. 
BclxL expression has previously been shown to be confined to chief cells in 
untreated mice, and this was attenuated following Helicobacter induced atrophy. 
However on the onset of metaplasia, metaplastic lineages were also seen to express 
Bcl-xL at moderate levels (296). Therefore the observations demonstrating a 
reduction in BclxL transcript abundance amongst infected NF-κB1 null and c-Rel null 
mice would be in keeping with an attenuation of BclxL transcription during the onset 
of atrophy. The reason for reduced BclxL transcript abundance in infected NF-κB2 
null mice that do not demonstrate significant atrophy is currently unclear.  
NF-κB1 null mice also demonstrated reduced Fas transcript abundance following H. 
felis infection. This would conventionally be considered to reduce the susceptibility 
of cells to undergoing apoptosis. As discussed in section 3.3 above, the assessment 
of apoptotic mediators by transcript quantification does not generate a complete 
analysis, as post translational events are also critical for the induction of apoptosis. 
These factors may explain the disparity between our data that show an up-
regulation of FasL, but no change in Fas expression and previous murine studies 
that have reported increased immunostaining for Fas in wild-type mice following 
infection with Helicobacter felis. A number of factors may explain this disparity: 
Rather than relying on increased protein production, Helicobacter infection may 
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result in stabilisation of Fas, similarly there may be a reduction in post-translational 
decay of transcript that has not been recognised in our assays. To address these 
possibilities it would be useful to carry out immunostaining or Western blotting to 
verify Fas expression at the protein level in our studies. This is of particular 
relevance as studies using the lpr mouse, which expresses a mutant form of Fas that 
fails to initiate apoptosis in the presence of FasL, have revealed that Fas / FasL 
mediated apoptosis is a mechanism through which the risk of development of 
Helicobacter induced cancers may be reduced (297).  
Overall the predominant mechanism that appears to drive the differences in 
outcome that were observed following Helicobacter felis infection in animals with 
abrogated NF-κB signalling pathways appears to be the cytokine response that is 
induced by infection. A key question that this raises is whether the differences in 
response observed between different genotypes of mice represents an epithelial 
effect, a result of differences in immune system activity, or a combination of both of 
these effects? Our current studies are unable to answer this research question, 
hence further investigations are required. A number of different approaches could 
be utilised to investigate this, the most obvious being conditional knockout models, 
deleting specific NF-κB proteins in epithelial or immune cell lineages specifically. 
Alternatively bone marrow chimeras could be generated to reconstitute wild-type 
immune systems within NF-κB knockout mice or vice-versa. Another question that 
these studies raise is whether the protective effect of deletion of NF-κB2 is an NF-
κB2 specific effect or whether deletion of the other alternative pathway family 
member RelB also results in a similar phenotype. Since RelB null mice are already 
available, this question could be addressed by a relatively simple extension of the 
current studies. 
Since the principal mechanism that has been elucidated in these studies focuses on 
Th1 cytokine activity, it would also be interesting to address whether extrinsic 
methods of inhibiting Th1 cytokine activity have any effect on the outcome of 
Helicobacter infections. Several drugs that influence TNF-α activity are in routine 
clinical use in humans, but do not appear to have been tested in relation to early 
gastric pathology either in humans or in murine models. Therefore in the first 
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instance it would be of interest to examine the effects of these agents (particularly 
pentoxyphylline which has been shown to reduce the severity of stress and alcohol 
induced ulceration in rats (298, 299)) in wild-type mice subjected to Helicobacter 
felis infections.  
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5 The effects of abrogating NF-κB signalling on long term 
gastric outcomes following Helicobacter felis infection 
Chronic Helicobacter infection can have many different outcomes in man including 
both epithelial and gastric lymphoid malignancies. Chapter 4 established evidence 
for differential regulation of gastric epithelial responses following short term 
Helicobacter felis infection in mice with deletions of specific members of the NF-κB 
family. To address whether these differences in early epithelial pathology lead to 
differences in long term outcome following infection with Helicobacter felis, groups 
of mice were infected with Helicobacter felis at 6 weeks of age and were 
subsequently aged for 48 weeks. Animals were culled at this time-point and gastric 
tissues were prepared for histological analysis. 
5.1 Clinical infection and ageing course 
Groups of at least 5 female animals per genotype were inoculated with Helicobacter 
felis as previously described in section 2.2.4, and were housed in standard animal 
house conditions until 48 weeks post infection. Similar groups of sex and age 
matched untreated control mice were simultaneously aged in the same facility. 
Exceptions to this protocol were made for animals that lost >20% body weight 
during the experimental period. Two NF-κB2 null mice that had been infected with 
Helicobacter felis for 6 and 8 months respectively lost >20% body weight and were 
therefore euthanased prematurely in accordance with conditions stipulated in the 
Home Office project licence. Post mortem examinations were carried out by a 
veterinary pathologist on these animals. In both cases features of chronic 
pyelonephritis and marked renal amyloid deposition were noted. Cause of death 
was attributed to this pathology. Gastric tissues from these animals were reported 
as showing Helicobacter colonisation, but were otherwise normal. These mice were 
not included in analyses for the data in this chapter due to the difference in 
duration of infection. Other groups of mice survived to completion of the 
experiment without clinical signs of distress.   
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5.2 Gastric antral pathology in mice infected with Helicobacter 
felis for 48 weeks. 
The gastric antra of mice infected with Helicobacter felis for 48 weeks were 
assessed by blinded visual analogue scoring for bacterial colonisation, inflammatory 
cell infiltrate and evidence of mucosal thickening (Figure 5-1 and Figure 5-2). Using 
this scoring method, no significant differences were observed between any of the 
non-infected groups for the variables assessed, although NF-κB1 null mice had a 
trend towards higher median inflammation and hyperplasia scores than other 
groups. Amongst infected mice, there were significantly higher bacterial 
colonisation scores in NF-κB2 null mice than NF-κB1 null mice. All surviving NF-κB2 
null mice had colonisation scores of 3, similarly all c-Rel null mice demonstrated 
persisting bacterial colonisation. However NF-κB1 null and C57BL/6 groups both 
contained animals with no visible Helicobacter felis in the section of gastric antrum 
examined. NF-κB1 null mice also had significantly higher antral inflammation scores 
than other groups of infected mice. These animals had a median inflammation score 
of 2.5, whereas all other mice showed no increase in inflammatory cell infiltrate in 
the antrum.  
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C57BL/6 NF-κB1 null NF-κB2 null c-Rel null 
        
ANTRUM 
  
Figure 5-1: Representative photomicrographs of antral mucosa of untreated (upper panels) and infected 
(lower panels) animals. Arrows highlight Helicobacter felis organisms. Original magnification *20. 
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Figure 5-2: Antral pathology scores by visual analogue scoring method. A, C and E aged, untreated mice. B, D 
and F mice infected with Helicobacter felis at 6 weeks of age and aged for 48 weeks. A and B: Helicobacter 
felis colonisation scores. C and D: Antral mucosa inflammatory cell infiltration scores. E and F: Antral mucosal 
thickening scores. 
* represents significantly higher scores than other groups by Kruskall Wallis independent samples test and 
Tukeys post-hoc multiple comparisons procedure. 
# represents significantly higher scores than NF-κB1 null mice by Kruskall Wallis independent samples test 
and Tukeys post-hoc multiple comparisons procedure. 
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5.3 Gastric corpus pathology in mice infected with Helicobacter 
felis for 48 weeks. 
Pathological changes in the gastric corpus of mice that had been infected with 
Helicobacter felis infection were scored in 3 separate ways. Initial data were 
collected using the visual analogue scoring system described previously. Numeric 
values were then attributed to mucosal thickness, parietal cell numbers and 
proliferation indices by graticule based scoring, whilst apoptotic indices were scored 
by high power field scoring as described in section 2.8.4. In addition to these 
quantitative measures a qualified veterinary pathologist reported cases on the basis 
of haematoxylin and eosin stained slides, with access to slides immunostained for 
Ki67, cleaved caspase 3 and CD3 / CD20.  
5.3.1 Classical and alternative pathway NF-κB signalling 
differentially regulate gastric corpus inflammation after long 
term H. felis infection 
Sections were scored using a *20 objective to assess the presence of mucosal and 
sub-mucosal inflammatory cells (Figure 5-4). The severity of inflammatory cell 
infiltrate was then graded and plotted by dot plot (Figure 5-3); these data were 
assessed for statistical significance by Kruskall Wallis one-way analysis of variance 
on ranks and Tukey’s post hoc test. Amongst untreated mice there were 
significantly higher inflammation scores in NF-κB1 null mice, with median scores of 
2 as opposed to 0 for other untreated groups. All groups of Helicobacter felis 
infected mice developed an inflammatory cell infiltrate. For infected wild-type, NF-
κB1 null and c-Rel null mice the median inflammatory cell infiltrate score was 3. In 
infected NF-κB2 null mice the median score was 1, but, due to the small number of 
mice scored, this did not reach statistical significance.  
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C57BL/6 NF-κB1 null NF-κB2 null c-Rel null 
    
CORPUS 
Figure 5-4: Dot plots showing visual analogue scores for inflammatory cell infiltration in corpus of uninfected 
(A) and infected (B) mice.  
Horizontal line denotes median value. 
* represents significantly higher scores than other groups by Kruskall Wallis independent samples test and 
Tukeys post-hoc multiple comparisons procedure. 
 
 
 
Figure 5-3: Representative images of gastric corpus mucosa from 1 year old animals that have 
(lower panels) or have not (upper panels) been infected with Helicobacter felis at 6 weeks of 
age. Original magnification *20. 
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5.3.2 Classical and alternative pathway NF-κB signalling 
differentially regulate gastric atrophy after long term H. felis 
infection 
Visual analogue scoring of parietal cell loss demonstrated little or no parietal cell 
loss in untreated wild-type, NF-κB2 null and c-Rel null mice, consequently these 
groups all had median parietal cell loss scores of 0. Aged, untreated NF-κB1 null 
mice did demonstrate some evidence of parietal cell loss, and had a median score 
of 1, however this was not significantly different to wild-type (Figure 5-5 A). 
Similarly, untreated NF-κB1 null mice showed mild degrees of mucosal thickening in 
some animals by this scoring method, but this was mild and infrequent such that 
the median score for this variable was in this group 0, as it was for all other 
untreated genotypes (Figure 5-5 C). 
Amongst infected animals parietal cell loss and mucosal thickening were observed 
in all genotypes, however only one NF-κB2 null mouse demonstrated these 
features, and this animal had low scores. Therefore for both of these parameters 
the median score for NF-κB2 null mice was 0. This was significantly different to the 
parietal cell loss scores in both NF-κB1 null mice and c-Rel null mice, both of which 
had median scores of 2. Wild-type mice fell between these groups with median 
parietal cell loss scores of 1 (Figure 5-5 B). No statistically significant differences 
were seen by this quantification method in the mucosal thickening scores, although 
NF-κB1 null mice had median scores of 2 whilst C57BL/6 and c-Rel null groups had 
scores of 1 and NF-κB2 null mice had a median mucosal thickening score of 0 (Figure 
5-5 D). 
Graticule based scoring provided more detailed quantification of these parameters. 
Mean mucosal thickness in untreated mice of each genotype was similar, with wild-
type corpus having a mean thickness of 230μm, which was very similar to the mean 
mucosal thickness of untreated 12 week old mice, which was 210μm. In wild-type 
mice 48 weeks after inoculation with Helicobacter felis, this parameter increased by 
1.7 fold to 380μm. Similar increases in mean mucosal thickness were observed in 
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NF-κB1 null mice and c-Rel null mice. In contrast, the mucosal thickness of infected 
NF-κB2 null mice was unchanged at 220μm (Figure 5-6 A). 
In untreated mice, similar numbers of parietal cells were recorded in each genotype 
of mouse. Following H. felis infection wild-type, NF-κB1 null and c-Rel null mice all 
demonstrated significantly lower numbers of parietal cells than their untreated 
counterparts. The magnitude of change was greater in c-Rel null (3.6 fold) and NF-
κB1 null (3.1 fold) than wild-type mice (1.7 fold), although this did not reach 
statistical significance. In contrast, there was no significant reduction in parietal cell 
number between untreated and infected groups of NF-κB2 null mice (Figure 5-6 B). 
Distribution of parietal cells was also assessed by plotting parietal cell index against 
distance from the basement membrane of cells at the base of the gland. In 
untreated wild-type mice, parietal cells were distributed over a range from 50 to 
250μm from the base of the gland, with the peak parietal cell index of 1.8 being 
observed between 75 and 100μm from the gland base. No significant differences in 
parietal cell distribution were observed between untreated mice of different 
genotypes (Figure 5-6 C).  
Amongst infected mice, there was a different distribution of parietal cells. Parietal 
cells were scored from the gland base to 350μm in infected wild-type mice, with a 
peak parietal cell index of 0.76 being observed between 100 and 125μm. Infected 
NF-κB1 null and c-Rel null mice showed similar parietal cell distributions to infected 
wild-type mice, whereas NF-κB2 null mice showed significantly higher parietal cell 
indices between 50 and 100μm. Parietal cells were scored in a zone 50 to 250μm 
from the gland base in this group, with a peak parietal cell index of 2.1 being 
observed at 75-100μm similar, to the profile observed in untreated wild-type mice 
(Figure 5-6 D). 
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Figure 5-5: Dot plots showing visual analogue scores for corpus parietal cell loss in uninfected (A) and 
infected (B) mice, and dot plots showing visual analogue scores for corpus mucosal thickening in uninfected 
(C) and infected (D) mice.  
# represents significantly higher scores than infected NF-κB2 null animals by Kruskall Wallis independent 
samples test and Tukeys post-hoc multiple comparisons procedure (p<0.05). 
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A 
D C 
B 
Figure 5-6: Graticule scoring of mean mucosal thickness (A), mean number of parietal cells (B) in the gastric 
corpus of untreated and infected mice. C and D show distribution of parietal cells through gastric corpus 
mucosa from basement membrane of cells at base of glands.  
n= at least 5 mice per group apart from infected NF-κB2 null mice where n=4. Significance of differences 
between groups tested by 2-way ANOVA and Holm-Sidak post-hoc analysis for A and B, and by Kruskal-
Wallis One Way Analysis of Variance on Ranks followed by Dunn’s post-hoc test at each grid position from 
base of gland for C and D. p<0.05 considered to be a significant difference. 
* represents significant difference to untreated group of same genotype.  
# represents significant difference to C57BL/6 undergoing same treatment. 
Represents significant difference between NF-κB2 null and C57BL/6 at annotated distances from 
basement membrane. 
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5.3.3 Classical and alternative pathway NF-κB signalling 
differentially regulate gastric epithelial cell turnover after long 
term H. felis infection 
Cell proliferation in the gastric corpus of mice infected with Helicobacter felis for 48 
weeks was assessed by Ki67 immunostaining and subsequent graticule based 
scoring (Figure 5-7). Epithelial apoptosis was assessed by immunostaining for 
cleaved caspase 3 and counting apoptotic epithelial cells in 10 high powered (*63 
magnification objective) field per mouse (Figure 5-8). 
Aged, untreated mice of all genotypes had similar baseline proliferation indices 
(Figure 5-9 A), whilst untreated NF-κB1 null mice had elevated apoptotic indices, 
with 2.3 times as many apoptotic events seen compared to untreated wild-type 
mice (Figure 5-9 B). When proliferative events were plotted against depth in the 
mucosa, a difference between wild-type mice and NF-κB1 null mice became 
apparent between 125 and 175μm from the base of the gland (Figure 5-9 C). In 
untreated wild-type mice, proliferative events were observed between 75 and 
275μm from the gland base, with the peak proliferation index of 1.5 being observed 
between 175 and 200μm from the gland base. Untreated NF-κB1 null mice showed 
a peak proliferative index of 3.1 at 150-175μm from the gland base, and 
proliferative events were observed from the gland base to 275μm.  
Amongst infected mice, epithelial apoptosis was not significantly different either 
between different genotypes, or between infected and untreated mice (Figure 5-9 
B), proliferation indices were however significantly different. Wild-type, NF-κB1 null 
and c-Rel null mice all showed significantly elevated proliferation indices 48 weeks 
following H. felis infection compared to untreated mice (by factors of 2.3, 2.1 and 
3.4 respectively) (Figure 5-9 A). Infected NF-κB2 null mice however showed no 
change in proliferation index compared to untreated mice of the same genotype, 
and had significantly lower proliferation indices compared to infected wild-type 
mice. When these data were plotted against position from the basement 
membrane of cells at the base of the gland, wild-type mice were shown to have 
proliferative cells from the gland base to 350μm into the mucosa. In this group, 
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peak proliferative index was between 175 and 200μm with a proliferative index of 
2.5 observed at this point. In infected NF-κB2 null mice, the peak proliferation index 
was seen slightly nearer to the gland base at 125 to 150μm, with a proliferative 
index of 2.9 seen at that position. Proliferative events were seen in a region from 50 
to 275μm from the gland base in these animals (Figure 5-9 D). 
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 KI67 IMMUNOSTAINING 
  
        
C57BL/6 NF-κB1 null NF-κB2 null c-Rel null 
        
Figure 5-7: Representative photomicrographs of gastric corpus mucosa demonstrating 
proliferating cells that immunostain positively for Ki67 antigen. Upper panel demonstrates aged 
untreated mice, lower panel mice infected with Helicobacter felis for 48 weeks. Original 
magnification *20. 
 
CLEAVED CASPASE 3 IMMUNOSTAINING 
Figure 5-8: Representative photomicrographs of aged gastric corpus mucosa of wild-type 
untreated mouse demonstrating apoptotic cells that immunostain positively for cleaved caspase 
3. Left image *20 original magnification, right image *63 original magnification. 
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Figure 5-9: Graticule scoring of mean number of cells proliferating (A) and mean number of apoptotic cells 
scored per high powered field (B) in gastric corpus of untreated and infected mice. Proliferating cell indices 
plotted against distance from basement membrane for untreated mice (C) and mice infected with 
Helicobacter felis for 6 weeks (D).  
n= at least 5 mice per group apart from infected NF-κB2 null mice where n=4. Significance of differences 
between groups tested by 2-way ANOVA and Holm-Sidak post-hoc analysis for A and B, and by Kruskal-
Wallis One Way Analysis of Variance on Ranks followed by Dunn’s post-hoc test at each grid position from 
base of gland for C and D. p<0.05 considered to be significant difference. 
* represents significant difference to untreated group of same genotype.  
# represents significant difference to C57BL/6 undergoing same treatment. 
  Represents significant difference between NF-κB1 null and C57BL/6 at annotated 
distances from basement membrane. 
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5.3.4 Histopathological reporting of gastric corpus of mice infected 
with Helicobacter felis for 48 weeks, and aged control mice. 
Histopathological reporting was also performed by a single veterinary pathologist 
blinded to both genotype and treatment of animals. Haematoxylin and eosin 
stained gastric corpus tissue sections were scored, with serial sections 
immunostained for Ki67 and cleaved caspase 3 as well as sections co-stained for 
CD3 and CD20 available when required. The pathologist was asked to comment 
specifically on the presence or absence of mucosal atrophy, intestinal metaplasia 
and dilated gastric glands, all features that have previously been observed in wild-
type mice infected with Helicobacter felis (300). The results of these observations 
are summarised in Table 5-1 and Table 5-2. Representative images of sections 
demonstrating dilated gastric glands and metaplastic changes are shown in Figure 
5-10. 
Aged, but untreated wild-type mice had predominantly normal gastric mucosa; 1 of 
6 individuals showed a mild neutrophilic infiltration associated with mild 
hyperplasia and minimal atrophy. None of the mice in this group demonstrated 
intestinal metaplasia or dilated gastric glands in the tissue sections examined. Aged, 
untreated NF-κB2 null mice and c-Rel null mice also had normal gastric mucosal 
morphology, with no significant infiltration of inflammatory cells. By contrast only 1 
of 6 untreated NF-κB1 null mice showed normal gastric morphology. The other mice 
in this group had inflammatory cell infiltrates, with mucosal and submucosal 
lymphoid aggregates predominating over neutrophilic infiltrations. These 
inflammatory cell infiltrates were associated with mild to moderate epithelial 
hyperplasia and mild to moderate atrophy. Untreated NF-κB1 null mice also 
demonstrated some cystic gland dilatation, but intestinal metaplasia was not 
observed in the tissue sections examined. 
Amongst the mice infected with Helicobacter felis for 48 weeks, all groups showed 
an inflammatory cell infiltrates. Wild-type mice demonstrated lymphocyte 
predominant inflammatory cell infiltrates in 4 animals, with neutrophilic infiltrates 
predominating in 2 others and a mixed infiltrate being observed in one animal. 
Mucosal atrophy was observed in 5 of 7 of these animals, whilst focal metaplasia 
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was seen in 2. Dilated gastric glands were also observed in 2 animals, one with 
intestinal metaplasia seen in the same section, the other without. 
NF-κB1 null and c-Rel null mice that had been infected with Helicobacter felis for 48 
weeks had lymphocyte predominant inflammatory cell infiltrates in the gastric 
corpus of all individuals. NF-κB1 null mice were reported to have more marked 
intestinal metaplasia than wild-type mice, which was seen in 3 of 6 mice, with 
dilated gastric glands also being observed in 4 of 6 mice. c-Rel null mice also showed 
dilated gastric glands in 3 of 6 mice, but intestinal metaplasia was not seen in this 
strain.  
Two of the c-Rel null mice were reported to have infiltration with lymphocytes with 
abnormal morphology. In one of these mice this consisted of a similar pattern of 
infiltration as was seen in the other mice of the same genotype, but the 
lymphocytes had enlarged nuclei and a slightly increased proliferative index. In the 
other c-Rel null mouse there was a distinctly abnormal pattern of lymphocyte 
infiltration (Figure 5-11). This mouse had circumferential lymphocytic infiltration 
with destruction of the mucosa. The lymphocytic infiltrate was highly proliferative 
by Ki67 staining and was shown to consist of a pure CD20 positive B-cell infiltrate by 
CD3 and CD20 co-staining. A histological diagnosis of an extra nodal B-cell 
lymphoma was therefore made in this animal. 
NF-κB2 null animals that had been infected with Helicobacter felis for 48 weeks 
showed very different morphology to other infected groups. 2 of 4 animals 
demonstrated an inflammatory infiltrate, one having a moderate lymphocytic 
infiltrate, the other having a neutrophil predominant infiltrate, but none of these 
animals showed signs of mucosal atrophy or metaplasia, and dilated gastric glands 
were not seen in any of the tissue samples that were examined. 
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Table 5-1: Histopathological features of individual aged untreated mice 
Genotype Treatment Mucosal Hyperplasia Inflammatory cell infiltrate Atrophy Metaplasia Dilated glands 
Wild-type Control Not seen Not seen Not seen Not seen Not seen 
Wild-type Control Not seen Not seen Not seen Not seen Not seen 
Wild-type Control Not seen Not seen Not seen Not seen Not seen 
Wild-type Control Not seen Not seen Not seen Not seen Not seen 
Wild-type Control Not seen Not seen Not seen Not seen Not seen 
Wild-type Control Mild  Mild neutrophil dominant Minimal Not seen Not seen 
NF-κB1 null Control Not seen 
Focal mild lymphocyte 
dominant 
Not seen Not seen Not seen 
NF-κB1 null Control 
Mild 
 
Moderate mixed lymphocytes 
and neutrophils 
Mild Not seen Present 
NF-κB1 null Control Not seen 
Focal mild lymphocyte 
dominant 
Not seen Not seen Not seen 
NF-κB1 null Control Moderate 
Moderate lymphocyte 
dominant 
Moderate  Not seen Present 
NF-κB1 null 
Control 
 
Moderate  
Moderate lymphocyte 
dominant 
Moderate  Not seen Present 
NF-κB1 null Control Mild 
Moderate lymphocyte 
dominant 
Mild Not seen Not seen 
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  Table 5-1: Histopathological features of individual aged untreated mice (continued) 
Genotype Treatment Mucosal Hyperplasia Inflammatory cell infiltrate Atrophy Metaplasia Dilated glands 
NF-κB2 null Control Not seen Not seen Not seen Not seen Not seen 
NF-κB2 null Control Not seen Not seen Not seen Not seen Not seen 
NF-κB2 null Control Not seen Not seen Not seen Not seen Not seen 
NF-κB2 null Control Not seen Not seen Not seen Not seen Not seen 
NF-κB2 null Control Not seen Not seen Not seen Not seen Not seen 
NF-κB2 null Control Not seen Not seen Not seen Not seen Not seen 
c-Rel null Control Not seen Not seen Not seen Not seen Not seen 
c-Rel null Control Not seen Not seen Not seen Not seen Not seen 
c-Rel null Control Not seen Not seen Not seen Not seen Not seen 
c-Rel null Control Not seen Not seen Not seen Not seen Not seen 
c-Rel null Control Not seen Not seen Not seen Not seen Not seen 
c-Rel null Control Not seen Not seen Not seen Not seen Not seen 
c-Rel null Control Not seen Not seen Not seen Not seen Not seen 
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Table 5-2: Histopathological features of individual mice infected with Helicobacter felis and then aged for 48 weeks 
Genotype Treatment Mucosal Hyperplasia Inflammatory cell infiltrate Atrophy Metaplasia Dilated glands 
Wild-type H. felis Moderate 
Moderate neutrophil 
dominant  
Moderate Not seen Not seen 
Wild-type H. felis Moderate  
Moderate lymphocyte 
dominant 
Mild Not seen Not seen 
Wild-type H. felis Moderate 
Moderate lymphocyte 
dominant 
Moderate Focal nest Not seen 
Wild-type H. felis Mild Mild lymphocyte dominant Not seen Not seen Not seen 
Wild-type H. felis Not seen 
Mild focal neutrophil 
dominant 
Not seen Not seen Not seen 
Wild-type H. felis Moderate  Severe lymphocyte dominant  Marked Focal nest Present 
Wild-type H. felis Marked  
Severe mixed neutrophil and 
lymphocyte  
Moderate Not seen Present 
NF-κB1 null H. felis Moderate 
Moderate lymphocyte 
dominant 
Mild Not seen Present 
NF-κB1 null H. felis Moderate, 
Moderate lymphocyte 
dominant 
Mild Not seen Not seen 
NF-κB1 null H. felis Marked 
Moderate lymphocyte 
dominant 
Marked Extensive Present 
NF-κB1 null H. felis Marked Marked lymphocyte dominant Marked Focal nest Present 
NF-κB1 null H. felis Moderate  
Moderate lymphocyte 
dominant 
Moderate Moderate  Not seen 
NF-κB1 null H. felis Mild Mild lymphocyte dominant Mild Not seen Present 
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Table 5-2: Histopathological features of individual mice infected with Helicobacter felis and then aged for 48 weeks (continued) 
Genotype Treatment Mucosal Hyperplasia Inflammatory cell infiltrate Atrophy Metaplasia Dilated glands 
NF-κB2 null H. felis Moderate  
Moderate lymphocyte 
dominant 
Not seen Not seen Not seen 
NF-κB2 null H. felis Not seen Not seen Not seen Not seen Not seen 
NF-κB2 null H. felis Focal mild Mild neutrophil dominant Not seen Not seen Not seen 
NF-κB2 null H. felis Not seen Not seen Not seen Not seen Not seen 
c-Rel null H. felis Mild 
Moderate lymphocyte 
dominant 
Moderate Not seen Present 
c-Rel null H. felis Moderate  
Moderate lymphocyte 
dominant 
Mild  Not seen Present 
c-Rel null H. felis Marked  
Moderate lymphocyte 
dominant 
Mild Not seen Present 
c-Rel null H. felis Mild  Mild lymphocyte dominant Moderate Not seen Not seen 
c-Rel null H. felis Not seen B-cell Lymphoma  Severe Not seen Not seen 
c-Rel null H. felis Moderate  
Moderate lymphocyte 
dominant with prominent 
nucleoli and nuclear atypia in 
lymphoid component 
Moderate Not seen Not seen 
 227 
  
 
  
 
A 
C D 
B 
Figure 5-10: Representative images of dilated gastric glands (A and C) and metaplastic glands (B and D) 
from gastric corpus sections of NF-κB1 null mice infected with Helicobacter felis for 48 weeks. Original 
magnifications *20 for A and B and *40 for C and D. Arrows highlight goblet type cells, indicative oof 
metaplasia. 
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Figure 5-11: Representative images of c-Rel null mouse with B-cell lymphoma infiltrating the gastric corpus 
mucosa. Solid black arrow denotes lymphocytic infiltrate with mucosal destruction, broken black arrow 
demonstrates high proliferation rate of lymphocytic infiltrate. Solid white arrow demonstrates purely CD20 
positive infiltrating lymphocytes, broken white arrow annotates occasional CD3 positive intraepithelial 
lymphocytes. 
Images all taken using *40 objective. Staining as marked. 
Haematoxylin and Eosin 
Ki67 Immunostaining 
DAPI 
CD3 immunofluorescence 
CD20 immunofluorescence 
Composite DAPI, CD3 and CD20 
  
Images of B-cell lymphoma detected in a single 
infected c-Rel null mouse 
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5.4 Discussion 
In the present study, aged wild-type mice showed essentially normal gastric 
mucosa, whilst Helicobacter felis infection of these mice for 48 weeks induced 
marked lymphocyte predominant inflammatory cell infiltration, parietal cell loss, 
mucosal thickening and concomitantly increased epithelial proliferation indices. 
Cystic glandular structures were also seen in these animals. These observations 
resemble findings of previously reported infections in other laboratories, where 
similar pathological changes have been reported after C57BL/6 mice which have 
been infected with Helicobacter felis for 1 year (300).  
Ageing c-Rel null and NF-κB2 null mice in a conventional animal facility caused no 
effect on gastric mucosal histology in either the antrum or the corpus, either when 
scored on a quantitative basis, or following morphological assessment by a qualified 
veterinary pathologist. In contrast, NF-κB1 null mice develop a lymphocytic infiltrate 
and significantly higher inflammation scores were observed in the antrum of these 
animals compared to aged wild-type mice. Subtle evidence of gastric corpus 
atrophy was also observed by morphological assessment, but not by quantitative 
measures of parietal cell number or mucosal thickness. These mice also showed 
increased apoptotic indices in the gastric corpus compared to aged wild-type mice, 
as well as a trend towards increased gastric corpus proliferation indices. NF-κB1 null 
mice were also the only group in which dilated gastric glands were observed in the 
absence of Helicobacter felis infection. Together these features suggest that NF-κB1 
deletion leads to spontaneous mucosal inflammation and progression towards 
mucosal atrophy. Whether this pathology would progress in animals with NF-κB1 
deletions to frank gastric malignancy after a more extended period is not clear from 
our studies. Similar observations have not been published in other strains of NF-κB 
depleted mice, and suggest a specific role for NF-κB1 in inhibiting mucosal 
inflammation in mice maintained in standard animal house conditions. From our 
studies it is not possible to ascertain whether the observed inflammatory response 
in uninfected NF-κB1 null mice is due to spontaneous autoimmunity, or whether it 
is a response to bacterial, food or other antigens present within the animal house 
environment. This question warrants further investigation which could be achieved 
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through examining the gastric mucosa of animals aged in different facilities with 
specific pathogen free conditions or in a gnotobiotic environment.  
Following infection with Helicobacter felis, NF-κB1 null animals continued to display 
a different phenotype to wild-type mice, with marginally higher parietal cell loss 
scores by visual analogue scoring and a trend towards lower absolute numbers of 
parietal cells by quantitative assessment. This was associated with intestinal 
metaplasia being seen more frequently and more extensively than in wild-type mice 
on pathological assessment. These features are in keeping with the observations 
made by Shibata et al (75) who observed more advanced pathology in mice with 
gastric epithelium specific deletion of IKK-β that had been infected with 
Helicobacter felis. These animals were generated on a mixed CD1 and C57BL/6 
genetic background, wild-type mice were therefore resistant to Helicobacter felis 
induced pathology. In contrast mice with gastric epithelial cell specific deletion of 
IKK-β demonstrated progression of pre-neoplastic changes such that gastric corpus 
atrophy was seen 3 months after Helicobacter felis infection and dysplastic lesions 
were observed at 12 months. 
In c-Rel null mice subjected to prolonged Helicobacter felis infection quantitative 
analyses of all parameters assessed were similar to NF-κB1 null mice, however the 
gastric corpus histology observed in these mice was quite different. The observed 
inflammatory cell infiltrate was again seen to be predominantly lymphocytic, with a 
similar degree of mucosal atrophy being observed, however no intestinal 
metaplasia was seen in any of the infected c-Rel null mice by morphological 
assessment. The role of c-Rel in intestinal metaplasia of the gastric epithelium has 
not previously been investigated, and few mechanistic studies have been published 
regarding the impact that any NF-κB signalling pathway has on this process. 
Recently there has been some interest in the role that CagA stimulated NF-κB 
signalling might have on Cdx2 activation, but the published data on this subject are 
limited to a single abstract. Cell culture studies demonstrated that induction of 
transcription of Cdx2 by a CagA positive Helicobacter pylori strain was dependent 
upon NF-κB signalling (301). These data are supported by a larger body of work that 
demonstrate that Cdx2 activation is RelA and p50 dependent in intestinal 
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metaplasia of the oesophagus (302-306), but even in this context the role of c-Rel 
does not appear to have been investigated. This could potentially be further 
investigated in-vivo by examining gene expression and immunostaining for Cdx2 
and other markers of intestinal metaplasia, and possibly ex-vivo by replicating cell 
line studies using primary cultures of gastric glands co-cultured with Helicobacter 
species and analysing Cdx2 expression by quantitative PCR or immunostaining. 
In addition to differences in epithelial pathology observed in c-Rel null mice, two 
animals in this group demonstrated abnormalities of the lymphoid infiltrate. One 
animal had a frank lymphoma, with destruction of the gastric mucosa, whilst 
another was infiltrated with lymphocytes that demonstrated marked nuclear atypia, 
along with an increased proliferation index, but not fulfilling the morphological 
criteria to diagnose a lymphoma. In both these cases the infiltrating lymphocytes 
were CD20 positive and CD3 negative, and hence of B-cell origin.  
Few data have been published concerning the potential importance of c-Rel in 
Helicobacter associated MALT lymphoma (307). However c-Rel has been extensively 
investigated in the more generic context of B-cell lymphomagenesis. c-Rel is highly 
expressed in mature B-cells, forming the predominant NF-κB dimer in these cells in 
conjunction with NF-κB1 p50. Avian, human and murine c-Rel have been shown to 
act as oncogenes when over-expressed in an avian model of B-cell lymphoma (308), 
however there remains a distinct absence of evidence for wild-type c-Rel acting as 
an oncogene either in-vivo or in models of B-cell mutagenesis derived from murine 
or human cells. There are reports of B-cell lymphomas with specific S525P mutated 
c-Rel being present. This form of c-Rel is found to be more oncogenic than wild-type 
c-Rel when transfected into avian spleen cells, but has reduced transcriptional 
activity compared to wild-type c-Rel (309). It has been hypothesised that the 
mutated form of c-Rel is unable to signal B-cell apoptosis in response to appropriate 
stimuli during aberrant B-cell maturation. This provides a hypothetical mechanism 
through which deletion of c-Rel could enhance B-lymphomagenesis in response to 
Helicobacter felis infection in our model.  
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Unfortunately only 4 infected NF-κB2 null mice survived the 48 week infection 
protocol, due to 2 animals developing features of chronic pyelonephritis at 6 and 8 
months respectively. NF-κB2 null mice are known to have altered splenic structure 
and an increase in T- and reduction in B- lymphocytes when un-stimulated (250). 
They also have impaired B-cell maturation and immunoglobulin responses, effects 
which may render them more susceptible to infection, however specific studies 
investigating the susceptibility of this strain of mouse to urosepsis, or specific 
urinary tract pathogens are lacking. 
Despite the smaller number of infected NF-κB2 null mice available for analysis there 
was a profoundly different response to Helicobacter felis infection compared to 
wild-type mice. There was less gastric atrophy on the basis of both visual analogue 
and quantitative scoring of parietal cell number. Indeed there was no significant 
difference in the number of parietal cells between untreated and infected NF-κB2 
null mice even after prolonged infection with Helicobacter felis. Supporting these 
findings the thickness of the gastric corpus mucosa in long-term infected NF-κB2 
null mice was similar to the thickness of young adult untreated wild-type mice. 
Similarly no differences in the gastric corpus proliferation or apoptotic indices were 
observed in these animals. Reporting of the gastric corpus histology of the four mice 
studied after Helicobacter infection demonstrated that 2 were entirely normal 
morphologically, whilst one had a mild neutrophilic infiltrate and the other had a 
moderate lymphocytic infiltrate. Neither of these individual NF-κB2 null mice 
showed any dilated gastric glands or evidence of intestinal metaplasia 
morphologically. 
Our studies have not been designed to address the mechanisms that underlie the 
reduced pathology seen in NF-κB2 null mice after long term infection with 
Helicobacter felis, but it is clear that there are differences in both inflammatory and 
epithelial responses in these animals. It would therefore be interesting to 
investigate the same model of Helicobacter induced pathology either in chimeric 
mice which were NF-κB2 null with wild-type bone marrow reconstitution, or vice 
versa, or to investigate a gastric epithelial cell specific NF-κB2 knockout mouse. It 
would also be interesting to examine an alternative model of inflammation 
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associated cancer in the NF-κB2 null mouse. This might be able to address whether 
the differential effects that are observed in the stomach are solely due to the 
differences in B-cell physiology that have previously been described in NF-κB2 null 
mice (250). The predominant cell type that infiltrates into the gastric corpus of H. 
felis infected mice is the B-lymphocyte, therefore investigating a different model of 
inflammation associated cancer would test whether the observed effect is B-cell 
specific, or whether there is a more generic impact upon inflammation and 
carcinogenesis. The azoxymethane / dextran sulphate sodium model of colitis 
associated carcinogenesis might be a good model to test, as this stimulus induces a 
mixed myeloid cell inflammatory response, and is an established model of colitis 
associated cancer. 
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6 Discussion 
6.1 Major findings of the project and consequent conceptual 
advances 
The aims of this project have been to investigate the roles of individual members of 
the NF-κB transcription factor family in gastric epithelial pathology, particularly in 
the development of gastric pre-neoplasia. To address these aims we have 
investigated the effects of constitutive deletion of specific NF-κB proteins in 
transgenic mice, studying epithelial cell turnover at baseline and in response to γ-
irradiation as well as the effects of short and long term Helicobacter felis infection. 
The models used have given insights into the roles of both classical and alternative 
pathway NF-κB signalling in the stomach, and have demonstrated specific effects of 
deletion of NF-κB1, NF-κB2 and c-Rel.  
6.1.1 The effects of classical pathway NF-κB deletion 
Amongst untreated young adult animals, classical pathway NF-κB signalling was 
shown to have an effect on epithelial cell turnover, as demonstrated by increased 
proliferation and apoptosis scores in both the antrum and corpus of NF-κB1 null 
mice. These animals also had elevated Th1 cytokine transcript abundance in the 
stomach, suggesting a tendency towards developing a spontaneous inflammatory 
phenotype, observations supported by the detection of spontaneous lymphocyte 
infiltration of the gastric corpus in untreated NF-κB1 null mice that had been aged 
for 12 months. This is in keeping with previous observations that a number of NF-κB 
deficient mice demonstrate spontaneous inflammatory phenotypes, including the 
intestinal epithelial cell specific IKK-γ (NEMO) deficient mouse, which develops 
spontaneous colitis (229), the RelB null mouse which demonstrates a mixed 
inflammatory cell infiltrate in the lungs, liver and lymphoid tissues (254) and the c-
Rel-ΔC mouse, which lacks a transcription activation domain, and which develops 
spontaneous gastric lymphoid hyperplasia (257). Intriguingly the only previous 
reports of increased inflammatory cell infiltration amongst mice with abrogated NF-
κB1 function comes from the p105-ΔC mouse, which produces a constitutively 
active form of NF-κB1 and develops lymphocytic infiltration in the lungs and liver 
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(255). The observation that gastric atrophy is associated with NF-κB1 deletion in 
many uninfected aged mice is novel and has not been reported in other published 
data examining the effect of deletion of any other NF-κB subunits. Our data 
demonstrate that this is an NF-κB1 specific event as aged, uninfected NF-κB2 null 
mice and c-Rel null mice demonstrated no discernible gastric phenotype in our 
hands. These observations raise the question of whether NF-κB1 deletion is 
sufficient to lead to gastric carcinogenesis without further stimulation. The 
observations in aged untreated NF-κB1 null mice are analogous to the INS-Gas 
model, where aged mice develop gastric atrophy and subsequent gastric neoplasia 
even without Helicobacter infection. In the INS-Gas model, amidated gastrin is up-
regulated from birth, and spontaneous gastric atrophy occurs over the first 10 
months, with gastric malignancies occurring over 20 months in 6 of 8 mice (93). We 
have not examined the gastric mucosa of NF-κB1 null mice at 20 months, however 
we did observe increased proliferation and apoptosis scores in these animals, which 
were also noted, but not quantified in aged untreated INS-Gas mice (93). The 
mechanism underlying increased proliferation in INS-Gas mice involves enhanced 
transforming growth factor-α and heparin binding-epidermal growth factor, and 
builds upon the known role of amidated gastrin as a gastric epithelial growth factor. 
These growth factors have not been assessed in NF-κB1 null mice, but we have 
demonstrated both enhanced gastric epithelial cell turnover in untreated NF-κB1 
null mice and increased gastric Th1 cytokine transcript abundance, which may be a 
mechanism through which increased epithelial proliferation is induced. NF-κB1 null 
mice have also been shown to be significantly more sensitive to radiation induced 
apoptosis and both short and long-term Helicobacter felis infections than wild-type 
mice. Again there was a marked increase in the gastric abundance of Th1 cytokine 
transcripts compared to wild-type mice after these stimuli, possibly explaining the 
more severe pathology that was observed, however ex-vivo analyses of primary 
cultures of gastric glands derived from NF-κB1 null mice demonstrated that direct 
Th1 induced epithelial cell apoptosis was in fact suppressed in this model. Therefore 
there is a consistent finding that NF-κB1 null mice undergo unstimulated gastric 
inflammation when maintained in standard animal house conditions, and are more 
sensitive to developing the epithelial pathology that is induced by both irradiation 
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and Helicobacter felis infection. It would be interesting to investigate the effect of 
standard animal house flora on age related pathology in NF-κB1 null mice. The INS-
Gas mouse has been shown to develop advanced pre-malignant lesions even when 
aged in a germ-free environment, however the development of this pathology was 
delayed in comparison to mice housed in standard conditions and disseminated 
malignancies did not occur in mice housed in a germ free environment. No data 
have yet been published on the effect of commensal flora on the gastric mucosa of 
either NF-κB1 null mice or any other model of abrogated NF-κB signalling subjected 
to Helicobacter infection.  
Similar studies performed using c-Rel null mice demonstrated that the observations 
in NF-κB1 null mice were protein subunit specific rather than being due to a generic 
classical pathway effect. These animals showed no significant unstressed 
phenotype, and only a modest phenotype in response to γ-irradiation, where they 
demonstrated marginally increased gastric corpus apoptosis compared to wild-type 
mice 6 hours after irradiation. In response to short term Helicobacter felis infection 
c-Rel null mice did demonstrate epithelial inflammation and a degree of parietal cell 
loss, equivalent to the pathology seen in wild-type mice. The most marked 
difference in pathology seen in Helicobacter infected, c-Rel null mice was the 
observation that following long term infection with Helicobacter felis, c-Rel null 
mice had marked abnormalities within the lymphoid compartment. One animal 
developed a frank lymphoid malignancy, whilst another had atypical lymphocytes 
within the lymphoid infiltrate. The epithelial pathology seen in these animals was 
quantitatively indistinguishable from wild-type mice, and on morphological 
assessment c-Rel null mice did not demonstrate intestinal metaplasia, supporting 
the hypothesis that NF-κB1 has a greater effect on the gastric epithelial 
compartment than c-Rel.  
It is clear from recent studies of the c-Rel null mouse that c-Rel is important in the 
orchestration of immunological responses to infections. In a multibacterial model of 
sepsis, c-Rel null mice showed worse survival, and altered cytokine profiles 
compared to wild-type mice, despite having similar microbial clearance rates (310). 
c-Rel has also previously been recognised to be an important transcription factor in 
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lymphomagenesis, but previous publications have not shown c-Rel null mice to have 
an increased incidence of lymphoma. An association between the REL oncogene 
(the human equivalent of c-Rel) and human MALT lymphomas has however 
previously been reported (311), and there is now an increasing body of work that 
has demonstrated the importance of NF-κB signalling in the pathogenesis of gastric 
MALT lymphomas. The commonest genetic aberration in these tumours is the 
translocation t(11;18)(q21;q21), which results in the production of a Birc3-MALT1 
fusion protein. Birc3 is synonymous with c-IAP2 and is an inhibitor of apoptosis with 
a caspase recruitment domain, whilst MALT1 encodes a potent NF-κB activator. This 
fusion protein is abundant in MALT lymphomas, and has been shown to result in the 
up-regulation of classical pathway NF-κB activity. No data have been published to 
demonstrate whether alternative pathway NF-κB signalling is involved in this 
process, or which specific members of the classical pathway NF-κB proteins are 
involved in this process (312).  
6.1.2 The effects of alternative pathway NF-κB deletion 
Untreated NF-κB2 null mice had no discernible gastric phenotype compared to wild-
type mice, either at 12 weeks of age, or after being aged to 54 weeks. When 
subjected to 12Gy γ-irradiation, these animals had minimally increased apoptotic 
indices at 6 hours post irradiation, a phenotype that was indistinguishable from c-
Rel null mice. In contrast, alternative pathway NF-κB signalling appeared to have a 
different effect on progression of Helicobacter felis induced pathology compared to 
classical pathway NF-κB signalling. NF-κB2 null mice did not develop gastric atrophy 
in any of the experimental conditions tested, suggesting that NF-κB2 mediated 
signalling is essential for the development of gastric atrophy in response to 
Helicobacter felis infection. Presumably as a consequence of not developing 
atrophy, the later stages of pre-malignant gastric pathology were also not seen in 
NF-κB2 null mice infected with Helicobacter felis. It remains to be investigated 
whether this is purely an effect of removing the pro-inflammatory environment 
generated by infiltrating lymphocytes, but it is of significance that the cytokine 
profile of infected NF-κB2 null mice did show significant changes from untreated 
NF-κB2 null mice. 
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6.2 Strengths and weaknesses of the adopted scientific 
approach, and potential future approaches 
6.2.1 The mouse model 
Germline deletions of NF-κB proteins have not yet been reported in humans and 
hence animal models currently represent the only way of studying the effects of 
deleting single NF-κB family members in a complex organism. The murine system 
represents a compromise between a model of the human immune system and the 
availability of transgenesis. As discussed in chapter 1, there are animal models, 
particularly the Mongolian gerbil, which develop gastric malignancies in response to 
Helicobacter pylori, and might be considered to be a superior model of gastric 
carcinogenesis for this reason, but to date transgenesis has not been possible in this 
species, and hence it is currently an unsuitable model for the studies undertaken 
here. Other model systems in which transgenesis is readily available would include 
zebrafish and Xenopus, and whilst these models may be suitable for some studies 
there are no published models of gastric carcinogenesis in these species. 
The transgenic models used in our studies have been effective in assessing the 
consequences of constitutive deletion of NF-κB family members, but cannot address 
either the timing of NF-κB deletion or the effect of tissue specific deletions. 
Investigating NF-κB protein deletion at different time points could provide 
additional information about the role of NF-κB family members during Helicobacter 
colonisation, during embryogenesis of the foregut, or in on-going signalling events 
in the chronically infected stomach. These time points could be addressed either 
through a transgenic mouse model incorporating an inducible knockout mechanism, 
or possibly through administration of short interfering RNA to whole animals. In 
practical terms it is more likely that an inducible transgenic animal would be 
effective in investigating these effects than siRNA knockdown as whole organism 
gene suppression would be likely to be more reliable. 
In addition to the timing of an effect of NF-κB deletion, the cell type or types 
responsible for the effects of NF-κB deletion have not been elucidated in our 
current studies. As discussed in previous chapters, either lineage specific deletions 
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of NF-κB, or possibly bone marrow chimeras could be utilised to assess the effects 
of deletion of specific NF-κB family proteins in either gastric epithelial or bone 
marrow compartments. This would address the question of whether the different 
responses in mice with NF-κB deletions are due to epithelial, immunological, or 
mixed epithelial and immunological signalling effects. Cre-lox systems already exist 
for the expression of cre-recombinase specifically in gastric epithelial (75), myeloid 
cell (74), and in B-cell lineages (313). Crossing mice expressing these cre 
recombinases with mice that have floxed NF-κB genes would provide further 
insights into the relative importance of NF-κB signalling upon different cell types in 
the development of gastric epithelial pathology. 
6.2.2 Helicobacter induced cancer model 
The use of Helicobacter felis to induce gastric cancers is well established in murine 
research, however it is commonly criticised for not directly replicating the human 
disease. The criticisms of Helicobacter felis as an agent to induce gastric malignancy 
often stem from the pathogenicity factors that are present in Helicobacter pylori 
but not in H. felis. Recently the genome of Helicobacter felis has been published, 
and comparisons have been made with that of H. pylori (314). Most bacterial 
virulence factors are common between the two organisms, with two important 
exceptions. The Cag pathogenicity island and VacA toxin are absent from H. felis. In 
the view of many, this has been considered to be a critical difference in these 
organisms, leading to the argument that infection with H. felis is not analogous to H. 
pylori infection. Furthermore, arguments have been put forward that as CagA is 
known to activate classical pathway NF-κB signalling, it is essential to study a CagA 
expressing bacterium to investigate the role of NF-κB signalling in gastric 
carcinogenesis. These arguments fail to recognise the observations that whilst CagA 
positive strains of Helicobacter pylori may be associated with more severe 
pathology and a higher incidence of gastric carcinogenesis, CagA negative strains 
are nonetheless associated with a higher incidence than that seen in uninfected 
individuals. Helicobacter felis is also known to successfully induce an inflammatory 
response in the gastric mucosa of mice. This second fact is particularly relevant as 
whilst there is some evidence of NF-κB signalling being directly induced by 
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Helicobacter infection, it appears likely that the host immune system is responsible 
for an amplification of this response through recruitment of innate and acquired 
immune systems, mechanisms that whilst not unconnected with the triggering 
event, do not necessarily require a direct bacterial interaction with NF-κB pathway 
proteins. 
The H. felis model reliably induces gastric pre-malignant pathology that is 
morphologically similar to the pre-malignant pathology seen in humans. We were 
unable to extend the model to a point where frank malignancies occured, as a 
number of factors made this impractical and potentially undesirable. Firstly time 
and cost restraints ensured that a pragmatic approach to the duration of infections 
was taken, with the intention to infect mice for 12 months being defined due to 
previous studies that have reported advanced epithelial pathology in wild-type mice 
at that time point. Secondly, our animal model demonstrated that there was an 
increased risk of death in aged animals, particularly in the NF-κB2 null group, thus 
reducing the feasibility of extending infections beyond 1 year. It may be useful to 
investigate other models of Helicobacter induced pathology in our animal model. 
Previous studies have shown that oral gavage of Helicobacter pylori 
lipopolysaccharide can induce an acute gastritis indistinguishable from acute 
Helicobacter infection in mice. Repetition of these studies in animals with NF-κB 
deletions would provide insights into the role of specific NF-κB proteins in the 
recognition of this bacterial antigen, and the ability of these animals to respond to 
this organism. In parallel with these studies, it would be valuable to analyse 
whether NF-κB2 null mice in particular are capable of mounting an adequate 
immunological response to any orally administered infectious agent or bacterial 
antigen. Other Helicobacter models that may be worthy of investigation would 
include the SS1 strain of Helicobacter pylori. In normal mice, infection with this 
organism induces gastritis, but little progression towards gastric atrophy or 
metaplasia. Investigating the susceptibility of mice with deletions of NF-κB family 
members to this strain of H. pylori would be particularly important, as not only 
might it clarify an increased susceptibility to pathology in NF-κB1 null mice, but 
there are also isogenic mutants of this organism available that lack specific 
 241 
pathogenicity factors. These organisms may also help to elucidate how Helicobacter 
infection stimulates NF-κB signalling, and whether specific virulence factors are 
essential or important in achieving this.  
6.2.3 Methods for investigating underlying mechanisms 
Our studies have provided some insights into the mechanisms that may be involved 
in NF-κB mediated gastric pathology, however these were defined by assays 
examining selected targets, and were demonstrated by abundance of messenger 
RNA only. To support the data we have so far, validation of differences in mRNA 
through assessment of protein abundance by Western blotting or 
immunohistochemistry would be useful. 
It is clear however that NF-κB mediated transcription influences multiple different 
signalling pathways, and can have profoundly different influences over these 
pathways in different situations. The factors that influence the outcomes of NF-κB 
activation are complex, and depend upon multiple factors including the exact 
stoichiometry of NF-κB proteins, their inhibitors and the mechanisms through which 
NF-κB signalling is triggered. To attempt to understand the processes that underlie 
differences seen between animals with NF-κB deletions, a non-hypothesis driven 
approach would be superior. Our studies were limited to investigation of a very 
small number of targets, addressing some of the most obvious inflammatory and 
apoptosis mediating pathways, but we were unable to address the role of 
proliferative pathways such as MAP kinase pathways which are known to be 
involved in a number of solid organ malignancies. Current technology would favour 
a transcriptomic approach to generate data on a wide array of targets at the 
messenger RNA level.  
6.3 Future research directions 
A number of potential further experiments have been discussed throughout this 
thesis that would provide useful methods for clarifying the mechanisms behind the 
differences in outcome of Helicobacter felis infection and γ-irradiation in animals 
with aberrant NF-κB signalling. The overall aim of research into Helicobacter 
induced carcinogenesis is to better understand, and potentially impact, human 
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gastric carcinogenesis. Towards this, it is clear that new research strands are 
necessary. To ensure that the observations made in our animal model are relevant 
to humans it is therefore essential to extend studies into humans.  
The initial stage of this work should be to quantify NF-κB activity in gastric biopsy 
samples obtained from patients with all types of Helicobacter pylori induced gastric 
pathologies. Clearly this requires the development of robust, sensitive and specific 
assays for quantifying NF-κB activity. In the murine model, these have been elusive, 
principally due to the absence of reliable commercially available antibodies 
targeting specific members of the NF-κB family. More data have been published on 
quantification of NF-κB activity in human cell lines, which offers the potential for 
establishing either electrophoretic mobility shift assays, or chromatin 
immunoprecipitation assays. Both of these assays are reliant upon robust 
antibodies to target the specific NF-κB proteins, which whilst they remain the 
limiting factor for quantification of specific members of the NF-κB family of proteins 
in murine models are in regular use in human research. 
6.4 Potential future translational impact 
Current management strategies for individuals with gastric pre-neoplasia are 
inadequate. Whilst Helicobacter pylori eradication therapy is adequate to halt 
pathological progression in some individuals, others continue to progress towards 
gastric carcinogenesis. Previous studies have considered endoscopic surveillance of 
at risk individuals. In areas of high gastric cancer prevalence, this approach has 
merit, and has been demonstrated to be a cost effective surveillance modality 
(315). In areas of lower Helicobacter pylori associated gastric cancer incidence 
endoscopic surveillance of gastric metaplasia is controversial (316) and has been 
shown to lack cost effectiveness (317). In this context a role for preventative 
therapies persists.  
Some drugs that may provide benefit to these patients have been defined, including 
the selective COX-2 inhibitor celecoxib (131). Currently available selective COX-2 
inhibitors have significant cardiovascular side effects (318), and are therefore 
unsuitable for long term administration for secondary prophylaxis, alternative 
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strategies for risk reduction therefore need to be considered. The studies presented 
in this thesis demonstrate the importance of classical and alternative pathway NF-
κB signalling in controlling gastric epithelial cell turnover and in the development of 
gastric atrophy. These pathways are therefore potential targets for future 
therapeutic interventions aimed towards either delaying progression along the 
Correa sequence, or at the restoration of normal gastric mucosal structure.  
Understanding the function of NF-κB signalling during gastric carcinogenesis offers 
potential opportunities both for the development of novel targeted therapeutics, 
and for adopting novel strategies for the use of established drugs that are known to 
influence NF-κB signalling. 
6.5 Conclusions 
These studies have demonstrated differential roles for specific NF-κB proteins in the 
modulation of Helicobacter induced pathology in the stomach. NF-κB1 mediated 
signalling is involved in the maintenance of a neutral inflammatory environment. 
When NF-κB1 is deleted an unstimulated increase in inflammatory mediators 
occurs, which is amplified in response to both irradiation and Helicobacter infection. 
This leads to increased apoptosis following irradiation, and to increased 
inflammation and more severe gastric epithelial pathology in the context of 
Helicobacter infections. These effects are specific to NF-κB1. Deletion of another 
classical pathway signalling protein, c-Rel, has distinct effects. c-Rel appears to be 
critical for the maintenance of a stable B-cell lineage, with B-cell malignancies being 
observed in c-Rel null mice exposed to chronic Helicobacter felis infection. 
In contrast to the more severe epithelial and lymphoid pathology that was observed 
in mice with deletions of NF-κB proteins that signal through the classical pathway, 
mice with NF-κB2 deletions were protected from Helicobacter felis induced gastric 
atrophy, in both short and long term experiments. This suggests that alternative 
pathway NF-κB2 mediated signalling is essential for the onset of gastric atrophy and 
hence other forms of gastric neoplasia. Whether this is due to NF-κB2 mediated 
signalling in the epithelial or immune systems remains unclear, however it 
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demonstrates the importance of further research in this area to elucidate the 
specific roles of these transcription factors in human disease.  
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